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A STUDY OF FACTORS ASSOCIATED WITH GIARDIA AND CRYPTOSPORIDIUM  
 




  Giardia spp. and Cryptosporidium spp. are two of the leading causal agents of parasitic 
diarrhea in humans, dogs and cats. The two pathogens contain both host-adapted and zoonotic 
strains and dogs and cats can harbor both strains. There is critical need to understand factors 
potentially associated with the risk and prevalence of infection due to Giardia spp. and 
Cryptosporidium spp. in dogs, cats and humans. This will ultimately aid in disease management 
and control. Furthermore, molecular characterization of the human, dog or cat isolates may 
identify zoonotic genotypes and may provide further information concerning the transmission 
routes between humans, dogs and cats. 
In Chapter 1, a review of literature regarding Giardia duodenalis and Cryptosporidium 
spp. in humans and companion animals (dogs and cats) was conducted. The review involves a 
brief description of the two pathogens’ current taxonomy, epidemiology, and diagnostic 
methods.  
Chapter 2 presents a retrospective study designed to analyze results from dog and cat 
polymerase chain reaction (PCR) panels from the commercial laboratory, ANTECH Diagnostics. 
The main purpose of this study was to evaluate associations between the probability of testing 
positive to Giardia spp. and Cryptosporidium spp. and risk factors such as animal’s age, sex, 
region, and season. The results of this study showed that age (younger animals) was significantly 
associated with the risk of PCR positive results for Giardia spp. and Cryptosporidium spp. in 
iii  
both dogs and cats. Region was significantly associated with Cryptosporidium spp. in both dogs 
and cats, whereas season was only associated with Giardia spp. in dogs. 
Chapter 3 describes the validation and optimization a previously published 60 kDa 
glycoprotein (gp60) gene-based PCR assay. The objective of this study was to use the assay to 
subtype C. parvum and C. hominis isolated from human fecal samples. The analytical sensitivity 
of this PCR assay was determined by assaying serial dilutions of C. parvum oocysts and C. 
hominis DNA. The analytic specificity was determined by assaying Cryptosporidium and non-
Cryptosporidium spp. DNA. The gp60 PCR assay consistently detected DNA of C. parvum if 
oocysts were present at 104/mL. The assay was detected the DNA of C. hominis in the lowest 
concentration. 
In Chapter 4, a prospective study was conducted to assess the risk of factors potentially 
associated with Giardia duodenalis and Cryptosporidium spp. infections and estimate the 
prevalence of these two pathogens in senior veterinary students and their pet dogs and cats. A 
structured questionnaire was developed to assess a baseline exposure of the students to large and 
small animals. In addition, a single voluntary sample was requested from students and their dogs 
or cats that live within the household. Giardia duodenalis and Cryptosporidium spp. were 
detected by the PCR and immunofluorescence (IFA) assays in students and their dogs and cats. 
As a result of the recruitment, 51 surveys, 42 human fecal samples, 31 dog fecal samples, and 17 
cat fecal samples were collected. Clinical rotation, track preference, gender, pet ownership and 
farm exposure were factors selected to be evaluated for the risk of both pathogens in senior 
veterinary students. As a result of this evaluation, none of these factors selected was statistically 
associated with the risk of infection due to G. duodenalis or Cryptosporidium spp.  All Giardia 
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isolated from dogs were host-adapted assemblages. However, a zoonotic Cryptosporidium 
genotype (C. parvum subtype family IIa) was identified in one human sample.   
The analysis conducted in this dissertation provided an evaluation of potential risk factors 
associated with giardiasis and cryptosporidiosis in pet dogs and cats. The results of this research 
enhanced the understanding of the disease prevalence of Giardia spp. and Cryptosporidium spp. 
among senior veterinary students and their dogs and cats. The survey collected valuable and 
novel information on the students’ characteristics, student health status, their pets’ health status 
and activities that may have led to an increased risk of infection during their clinical rotations or 
intense handling of small or large animals.  The analysis of the survey provided an evaluation of 
potential risk factors associated with the risk of infection in senior veterinary students. Molecular 
analysis of isolates of human, dog and cat origin helped in differentiating between G. duodenalis 
assemblages and Cryptosporidium spp. genotypes.  
Future directions may include an evaluation for associations of positive test results with 
clinical findings and further studies determining the likelihood dogs or cats are carrying zoonotic 
Giardia spp. or Cryptosporidium spp.. National research is recommended to be conducted to 
identify risk factors in veterinary students from different states in the United States. Additionally, 
a larger study should be performed to determine the baseline exposure of veterinary school 
faculty, specifically, those who work on large animal rotations and collect fecal samples from 
their pet dogs and cats to for genotyping to detail whether zoonotic infections with these two 
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CHAPTER 1: GIARDIA DUODENALIS AND CRYPTOSPORIDIUM SPP.: A REVIEW 
Introduction to Internal Parasites: 
 Most internal parasites that infect dogs and cats and colonize in the gastrointestinal tract 
are worms such as hookworms, roundworms, whipworms and tapeworms and single-celled 
organisms such as coccidia and Giardia.1 In this chapter, G. duodenalis, and Cryptosporidium 
spp. will be addressed in humans, dogs and cats. 
1.1 Giardia duodenalis 
1.1.1 Taxonomy 
Based on the new systematic data for the taxonomical classification of the parasite, 
Giardia duodenalis belongs to the kingdom: Protista; subkingdom: Protozoa; phylum: 
Metamonada; subphylum: Trichozoa; class: Trepomonadea; subclass: Diplozoa; order: Giardiida 
and Family Giardiidae.2 
Giardia was first described in 1859 by Lambl.3 He described a flagellate in the human 
intestine that he named Cercomonas intestinalis. In 1875, Davaine described a strain of Giardia 
that infected a rabbit and called it Hexamita duodenalis.3 Even though the generic name 
described by Davaine was incorrect, Filice (1952) proposed that this name is valid and the 
species name (duodenalis) has priority over (intestinalis) according to the Rules of Zoological 
Nomenclature.4 The latter generic name of Giardia was accepted by several scientists to be used 
to name isolates from humans and animals. Filice suggested in a later evaluation that the 
taxonomy of Giardia would be more meaningful if it was based on the organism morphology not 
the host due to the lack of reliable experimental evidence.3,4 Thus, Filice divided Giardia into 
three morphologically distinct groups based on the shape of the trophozoites and the median 
bodies. In short, the current scientific name of Giardia is Giardia duodenalis.  The use of G. 
2 
lamblia or G. intestinalis interchangeably is based on personal preference and has no taxonomic 
justification.3,4  
Giardia duodenalis trophozoites, which was the first group of organisms classified by 
Filice, are pyriform-shaped and have a distinctive “claw-hammer” median body and adhesive 
disc as well as four pairs of flagella5 (Figure 1.1). The second group, G. muris species 
trophozoites have rounded median bodies and a rounder trophozoite shape. The third group is G. 
agilis whose trophozoites have long narrow bodies and long club-shaped median bodies. Three 
more species were later identified including G. psittaci, G. ardeae and G. microti (Table 1.1).6-
8,10 
Giardia spp. are single celled organisms that share many biological characteristics with 
anaerobic prokaryotes.6,9 Laboratory classification of G. duodenalis strains defined all species 
using the ribosomal RNA gene sequencing.11,12 In fact, G. duodenalis genotypes are named after 
identifying substantial sequence differences in the glutamate dehydrogenase (GDH), triose-
phosphate isomerase (TPI) and β-giardin (βG) genes using phylogenetic analysis.11,12 The closely 
related genotypes are grouped into assemblages and sub-assemblages. Recent genotypic 
classification of G. duodenalis isolates has identified a change in the rule of sub-assemblage 
grouping that is based on three different loci not genes. Due to the inconsistency of the usage of 
genotype, assemblage, sub-assemblage, and sub-genotype in international literature, and because 
sub-genotype means under the category genotype, one study suggested avoiding the use of sub-





Figure 1.1 Giemsa-stained trophozoite of Giardia duodenalis showing multiple flagella, nuclei 
and median bodiesa 
aAdapted from Thompson, RC. The zoonotic significance and molecular epidemiology of 
Giardia and giardiasis. Vet Parasitol. 2004; 126:15–35. doi: 10.1016/j.vetpar.2004.09.008.11 
  
A proposed nomenclature for Giardia duodenalis A-G Assemblages has been recently 
published. In that proposal, assemblage A is called G. duodenalis, assemblage B is G. enterica, 
assemblage C and D are G. canis, assemblage E is G. bovis, assemblage F is G. cati, and 






1.1.2 Epidemiology  
Giardiasis was recently added to the World Health Organization’s Neglected Disease 
Initiative. 14 This initiative includes a spectrum of parasitic, bacterial, and viral diseases that are 
widespread in developing countries. Major risk factors that influence the occurrence of the 
disease in such countries can include poverty, climate, and lack of access to medical services. 
These factors, when considered together, lead to an increase in the disease global burden.14 
Multiple factors contribute to the variability in the prevalence estimates of Giardia infection. 
First, giardiasis is only reportable in some countries. Second, the diagnostic methods used have 
variable analytical sensitivity and specificity. Third, many infected people in endemic areas are 
asymptomatic and have no access to the medical care nor they do not seek out medical 
treatment.15 Regardless, G. duodenalis is the most common causes of protozoal diarrhea in most 
countries in the world.15 In a meta-analytic study of giardiasis and cryptosporidiosis in European 
countries, it has been estimated that the prevalence of Giardia is 3.0% in asymptomatic human 
patients and 6.0% in symptomatic ones.16 In a review article published evaluating 33 different 
studies, it was found that prevalence estimates varied drastically and the risk was higher in rural 
areas, among poor communities, in males, among college students, in the elderly, in HIV-
positive patients, and in patients with gastric carcinoma.17 It also has been reported that co-
infections with other parasites frequently occur in patients with giardiasis.18 A mix of prospective 
and retrospective studies in the Netherlands was used to determine the incidence of 
gastroenteritis due to parasitic agents. The target population ages ranged from infants to 65 years 
old. The authors determined the incidence of giardiasis was 3.3% in asymptomatic people 
compared to 5.4% in the symptomatic ones. 19,20 In several European countries, the overall 
incidence rate is about 58 cases per 100,000 persons.19 
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The incidence rates of giardiasis in people in the United States ranged from 1-30 cases 
per 100,000 during the period from 2003-2005. The number of annual reported cases per 
100,000 people in the United States is higher in the northern states than that in the southern 
states.18  
  Giardia outbreaks vary in their occurrence due to the season. For instance, a marked 
seasonality in the onset of illness was described in early summer through early fall.18 Also, the 
odds of disease transmission through summer time is two times higher than other seasons due to 
the increased outdoor activities and swimming.15  
Giardia outbreaks are most frequently waterborne, i.e. the consumption of contaminated 
drinking water).22,23 Before 2007, more than 100 water-related Giardia outbreaks were reported 
worldwide. 24 It was reported that G. duodenalis was responsible for about 132 out of 325 
waterborne outbreaks recorded from World War I until 2003. Of these 132 Giardia outbreaks, 
103 (78%) were associated with contaminated drinking water systems.24 In 2010, a large Giardia 
outbreak in Belgium was caused by consumption of drinking water contaminated with river 
water.25 Generally, waterborne giardiasis is more important than foodborne giardiasis26 because 
of the large water bodies such as rivers or lakes that serve as water supplies for a large 
communities; thus, if water is contaminated with viable Giardia cysts and distributed, a large 
number of individuals who drink this contaminated water can become infected. 
Epidemiologically this is called a point-source outbreak. Transmission in this type of outbreak is 
terminated when the source of contamination is eradicated. Interestingly, the majority of 
waterborne outbreaks were reported in the United States where improved contamination 
detection and monitoring systems for drinking water supply are more likely to be in place. In the 
underdeveloped countries, giardiasis is considered an endemic disease where water supply 
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detection and monitoring systems are usually not in place which puts these countries at an 
increased risk of giardiasis.27 However, in recent years, it was reported that outbreaks associated 
with drinking water have been significantly reduced due to the establishment of water treatment 
and regulations.26  
Giardia duodenalis also has been identified as the cause of recreational water outbreaks. 
28-30 These waters include swimming and wading pools, thermal and other natural springs, fresh 
and marine waters, water parks, interactive fountains, and any other places where water contact 
occurs. Contamination of water bodies occurs due to urban and non-urban run-off, industrial 
pollution, storm waters, and human or animal fecal matter. Contamination of swimming pools is 
often associated with accidental fecal contamination, poor pumping, poor filtration systems, and 
insufficient use of disinfectants.28-30  
In terms of sporadic cases, the routes of transmission usually are unknown. Some studies 
have identified potential risk factors for giardiasis that include: person to person transmission, 
travel to endemic areas, interaction with livestock and consumption of potable and recreational 
fresh water.15 In addition to the risk factors of sporadic giardiasis mentioned above, other studies 
have determined the cause of sporadic cases is because of consumption of contaminated lettuce, 
drinking treated tap water, and consumption of green salads on a daily basis.31,32  
Foodborne giardiasis has received relatively little attention compared to waterborne 
outbreaks and few outbreaks have been reported. These outbreaks have implicated mainly food 
handlers, but direct contamination of foodstuffs is possible. Regardless, foodborne Giardia





Giardia cysts are relatively small in size (8-12 µm).33 One feature that influences 
Giardia’s infectivity is that the cysts are readily infectious when excreted in feces into the 
environment. Furthermore, the cysts are extraordinarily stable in the environment and can 
survive from weeks to months.15 The life cycle of Giardia duodenalis consists of two key stages: 
a trophozoite stage and a cyst stage.34,35 An infectious Giardia cyst excysts in the upper part of 
the small intestine to release the two trophozoites. After ingestion by the host, the trophozoites 
will attach to the intestinal epithelial wall and reproduce asexually by the binary fission. The 
trophozoite encysts again after an exposure to the biliary salts to produce immediately infectious 
cysts when passed via feces to the environment. This life cycle is completed within 72 hours 
after ingestion.34,35  
1.1.2.2 Host 
Giardia duodenalis is distributed worldwide and it causes diarrhea in variety of hosts 
including humans. Giardia duodenalis is transmitted via ingestion of the cysts, commonly called 
the fecal – oral route, either directly or indirectly.12 Giardiasis is usually reported in younger 
populations that range in age from 1 to 9 years old and younger adults from 35 to 39 years. Older 
hosts can develop adaptive immunity which results in less cyst excretion; however, they also can 
be considered as a source of infection.36 Research has been conducted to study the adverse health 
effects of Giardia infection in children from underdeveloped countries. The research involved 
investigating whether the health effects followed by Giardia infection are temporary or cause 
long-term health problem such as poor cognitive function or death. However, the possibility that 
Giardia causes long term health problems determined from such research have been 
controversial.15 A study conducted in Guatemala concluded that the reduced age effect observed 
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in diseased children compared to non-diseased was confounded with co-infections with other 
endo-parasites.37 The parents of infected children, especially mothers, are more prone to 
infection with Giardia compared to the general public and outbreaks of giardiasis have been 
reported in daycare centers.15 Additionally, children who have the voluntary consumption 
behavior that tend to eat mud or sand (also known as geophagia or ‘p ca’) are more susceptible to 
giardiasis.38 The host immune system can be suppressed due to malnutrition, HIV infection, 
cancer, and immune-suppressive therapy. Immunity can influence the severity of infection due to 
giardiasis in the host. For example, giardiasis is more frequently reported in immune-
compromised individuals compared to immune-competent individuals.39 However, the severity 
of giardiasis in HIV positive individuals is not significantly different from HIV negative 
individuals.39 Also, in immune-compromised individuals’ giardiasis tend to become a chronic 
infection.40  
Physiopathology of Giardiasis 
People can be infected with G. duodenalis without exhibiting any symptoms and can be 
considered healthy carriers.12 The mechanism of pathogenesis that causes some individuals to 
develop clinical signs and others to remain asymptomatic still is not fully understood (Figure 
1.2). Personal risk factors such as the immune status, nutritional status and age of the host can be 
potential risk factors for acquiring the disease. Also, environment-related factors can be 
responsible for differences in the severity of infection.11 Infection with Giardia produce 
alterations in villus and microvillus which can cause decreased crypt/villus ratio, shortening of 
the microvillus brush border and brush border enzyme deficiencies. This outcome is due to 
trophozoite/epithelium interaction and host immune reaction. Also, pathogenesis of giardiasis 
can involve enterocyte apoptosis along with cytoskeletal re-organization induced by trophozoite 
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toxic products which result in an increased epithelial permeability and local disruption of tight-
junctional proteins. 41-43 The toxins excreted by the trophozoites along with the T-cell activation 
lead to a diffuse shortening of brush border microvilli and a decreased activity of the small 
intestinal brush border enzymes, especially lipase, some proteases and the disaccharidases 
lactase, and maltase44 Malabsorption due to giardiasis is associated with an increased number of 
intraepithelial lymphocytes and a decreased villus to crypt ratio. The malabsorptive diarrhea can 
lead to a lower weight gain.45 In addition, the presence of the mucous in diarrheal stool is due to 
the reduced activity of lipase and the increased production of mucine by goblet cells.45 Giardiasis 
can lead to decreased transit time of food in the gut and an increase in gut contractility. The 
increased contractility may explain the abdominal cramps that frequently are reported in 
giardiasis.46  
1.1.2.3 Environmental risk factors 
Generally, surface water can become contaminated with Giardia cysts through the 
discharge of untreated human sewage and/or from urban or rural land drainage containing animal 
fecal waste, especially livestock feces. In fact, the presence of cattle and livestock around water 
resources is considered a risk factor for water contamination with Giardia cysts, especially if 
these animals are infected with this protozoan.12 Usually large rivers and lakes receive 
agricultural runoff and both treated and untreated local wastewater.47 Additionally, aquatic 
rodents such as muskrats, beaver, nutria and wild otter play an important role in water 
contamination with Giardia spp. cysts.12  
One of the risk factors associated with Giardia contamination of the environment is that 
Giardia spp. cysts are readily infectious to the new host once they are excreted in the 
environment and do not require sporulation.48 These cysts are hardy and can survive in surface 
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water and soil for 2-3 months, but the cysts do not persist well in cold environments.49 A other 
factor is that a large number of cysts are shed to the environment from infected animals. The 
prolonged excretion period of infectious cysts to the environment can be another factor that go 
hand in hand with the high excretion rate from infected individuals that contribute to a 
significant environmental contamination.27  
Several challenges can contribute to the persistent of Giardia in the environment. 
According to previous studies, Giardia cysts may remain viable or infective for at least one 
month at low temperatures and in the absence of freeze-thaw cycles.50,51 The survival of the cysts 
is due to their filamentous cyst wall. This wall contains an even ratio of carbohydrate to protein. 
The filament has a unique type of carbohydrates that is not degradative by any enzyme.52 
Second, Giardia cysts are resistant to many water treatment procedures which means treated 
water can be contaminated with Giardia cysts. Third, some Giardia assemblages can be 
zoonotic. This increases the potential for ongoing environmental spread of contamination by 
many mammals.27 Fourth, the spread of disease by transport hosts such as wild and aquatic birds 
and insects can facilitate environmental contamination by Giardia.53-55   
1.1.3 Giardia in Humans  
The infective dose of G. duodenalis for symptomatic humans irelatively low and is 
thought to be about 10 to 100.15 Infected humans shed Giardia cysts intermittently12 up to 2 x 
106/gram of feces.56 Human giardiasis can range from mild or self-limiting illness to severe or 
life threatening. Common clinical symptoms include abdominal cramps and diarrhea, bloating 
and flatulence, nausea and weight loss.12 The illness usually lasts from 1-2 weeks, but in some 
cases it can extend to up to seven weeks. Giardiasis can become chronic illness in malnourished 
children.57   
11 
Giardia duodenalis usually inhabits the upper part of the small intestine.58 This can be 
attributable to agent factors such as the virulence of the infective strains or the infective dose (i.e. 
number of cysts ingested) or host factors such as age, the status of the immune system at the time 
of infection.15 Human giardiasis can be classified into acute and chronic phases. The acute phase 
is usually short, characterized by flatulence and abdominal distension with cramps, small bowel 
watery diarrhea that becomes greasy, and bulky with mal odors. The chronic phase of giardiasis 
includes malaise, weight loss, and other features of malabsorption. Diarrhea in the chronic phase 
is characterized as pale or yellow, frequent and small in volume.39  
1.1.4 Giardia in Companion Animals 
The G. duodenalis assemblages responsible of infection in dogs are C and D whereas 
assemblage F is responsible for infection in cats. However, assemblages A and B can also infect 
both dogs and cats.59 The estimated prevalence of G. duodenalis in companion animals varies 
depending on the region of the study, the diagnostic method used and the general health 
condition of the host. In the USA, the prevalence estimated for 38 kennel/shelter dogs using 
microscopic examination was 39.0%, whereas the prevalence estimate for 79 household dogs 
using the same method of diagnosis was 34.0%.60 In another study conducted in the USA, the 
estimate of the prevalence was 15.6% for 16,064 clinically affected dogs using a 
immunochromatography (ICG) method61 whereas the prevalence estimate was only 4.0% for 
1,119,293 clinically affected dogs in a study in the USA using microscopic examination.62 The 
prevalence estimates of Giardia in 211,105 cats in a study conducted using microscopic 
examination was relatively low (0.58%) compared to dogs.63 
  Young animals tend to shed more cysts than adult animals do, and this can be attributed to 
the slow development of adaptive immune system by the host.64 Thus, young animals may be 
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more likely to transmit the agent directly to other susceptible hosts as well as contribute to the 
environmental contamination with Giardia cysts.59  
1.1.5 Zoonotic Consideration of Giardia duodenalis 
     Giardia duodenalis was characterized as zoonotic agent by the World Health Organization 
because of the waterborne outbreaks in people by infected beavers.65 Zoonosis means disease can 
be transmitted from animals to humans.66,14 Reverse zoonosis (i.e. infection from humans to 
animals) can also occur with giardiasis.67 The clinical impact of zoonotic transmission due to 
Giardia has not been explained yet. Among G. duodenalis eight assemblages that include 
assemblage A-H, assemblages’ A and B are isolated in both humans and animals.67 A semblage 
A has four subgroups (AI, AII, AIII, and AIV). These subgroups were described by the analysis 
of 10 isolates at 23 genetic loci in a study. The subgroup of assemblage A normally isolated from 
humans is AII. Subgroups AIII and AIV are frequently isolated from animals. The subgroup AI 
is isolated from humans and animals’ isolates; thus, it is the only subgroup that has a zoonotic 
potential.68 Additionally this study supported the existence of four subgroups of assemblage B 
(BI, BII, BIII and BIV).68 The zoonotic potential among the subgroups is minimal if it exists.68 In 
this study, one human isolate characterized in subgroup BIII also was close to subgroups BI and 
BII. Assemblage B subgroups BIII and BIV are commonly isolated from humans. Animal 
isolates belong to subgroups BI and BII. Assemblage A and B can be maintained by direct 
transmission between humans. In addition, these two assemblages can infect companion animals, 
livestock and wildlife.3  
Giardia isolates in assemblage A have a greater zoonotic risk than isolates in assemblage 
B.69 However, some studies have reported the zoonotic potential for assemblage A only.70,71 For 
example, a prospective study conducted in daycare centers in Western Australia concluded that 
13 
the odds of diarrhea in children infected with assemblage A were 26 times higher than with 
assemblage B of Giardia isolates.72 Furthermore, in a study conducted in Bangladesh, patients 
infected with assemblage A (genotype AII) isolates had the highest probability of developing 
diarrhea compared to patients infected with assemblage B.72-74 However, several studies have 
shown that assemblage B patients can also develop persistent diarrhea.75,76 These studies reveal 
evidence of genetic variation between and within the genotypes3,71,77  
In most case-control studies, companion animals appeared to be negatively associated with 
risk to their owners.47 In fact, the issue of whether there is potential zoonotic transfer of Giardia 
spp. infection between companion animals and their owners is controversial. Numerous studies 
conducted in different parts of the world demonstrated that dogs or cats can be infected with 
host-adapted and/or zoonotic Giardia assemblages.78,79 However, there is a lack of data that 
support the frequency of zoonotic transmission in dogs or cats to humans.11,78 A study conducted 
in northern India indicated that there is potential that dogs that live in close contact with humans 
can transmit Giardia to humans, but the molecular data of the study was rather unconvincing.80 
In contrast, a study conducted in Bangkok, Thailand has provided more epidemiological 
evidence supporting the role of dogs in disease transmission to humans.81 
1.1.6 Diagnosis  
The diagnosis of Giardia infections is difficult in that the clinical signs are not specific to 
the disease. Therefore, the clinical diagnosis is confirmed by detecting the parasite in fecal 
samples. The diagnostic assays for giardiasis include: microscopic examination after fecal 
flotation, immunofluorescence antibody assay (IFA), fecal antigen tests or polymerase chain 
reaction (PCR). The intermittent shedding of Giardia cysts requires collecting multiple samples 
from the same animals to increase the clinical sensitivity of the test. Also, sampling in young 
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animals should be performed routinely at 2-4 weeks of age where the peak excretion is reached 
even if they do not exhibit clinical signs.59 
1.1.6.1 Microscopic Examination  
Giardia trophozoites can only be detected by fecal smear on a fresh sample. Giardia cysts can be 
detected by microscopic examination, either directly (fecal smear) or after concentration with 
sucrose, zinc sulfate or sodium nitrate. Frequently, the cysts are preferred for diagnosis over the 
trophozoites because the latter requires the fecal samples to be fresh.59 The cysts can be stained 
using common stains such as iodine and trichrome.82,83 The main advantage of microscopic 
examination is the lower cost associated with the test and the main disadvantages are the need for 
an experienced and skilled microscopist, the lower sensitivity of the test and that the assay is 
time consuming.59 The test also is less specific because pseudoparasites or other particles can be 
diagnosed as Giardia cysts.84 
1.1.6.2 Antigen Detection 
Antigen detection tests include commercially available assays such as 
immunofluorescence assays (IFA), enzyme-linked immunosorbent assays (ELISA) and rapid 
solid-phase qualitative immunochromatography assays. These assays were developed and 
evaluated for use in human and animal stool samples. 85-87 Even though the IFA assay is 
relatively sensitive,88 there is a higher cost associated with the technique compared to 
microscopy, it is time consuming and requires experienced personnel.59  
The immunochromatography assay uses monoclonal antibodies directed against specific 
cyst wall proteins. This assay enables on-site diagnosis within 15 minutes. The commercial 
antigen detection assays in human medicine include dip-sticks and rapid membrane assays. 
Similarly, in veterinary medicine the SNAP Giardia test (IDEXX Laboratories Inc., Westbrook, 
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Maine, USA) has been approved to be used with dog and cat samples.88 Commercial fecal 
ELISA kits are effective for dogs and cats.59  
1.1.6.3 Molecular Typing 
The lack of morphological differentiation among Giardia spp. isolates is a limitation in 
understanding the taxonomy, epidemiology and public health impact of this important 
pathogen.14 However, molecular tools have expanded the understanding of the variation among 
isolates of this parasite.36 The PCR- based procedures allow for direct characterization of the 
parasite isolates from fecal and environment samples which eliminates the need for laboratory 
culture. Multilocus genotyping has improved the species level taxonomy for Giardia spp. and 
obviates the disagreement of the results when comparing genotyps.89,90 Advanced molecular 
analysis such as multiplexing, real-time PCR and melting curve analysis also facilitate genotype 
and multiple species detection. The value of sub-genotyping or strain characterization tools is to 
help define the map of transmission in a  outbreak analysis.47 In some cases, the detection limit 
of the PCR is one cyst which substantially improves the diagnostic sensitivity.91 One of the 
disadvantages of this assay is the presence of PCR inhibitors which are known to occur in DNA 
extracted from fecal samples.92 The other disadvantage is that it can be too expensive and labor 
intensive for some veterinary diagnostic laboratories.92 
1.2 Cryptosporidium spp.  
1.2.1 Taxonomy 
Cryptosporidium spp. belong to the kingdom: Protozoa, phylum: Apicomplexa, class: 
Coccidea, order: Eucoccidiorida, family: Cryptosporidiida.93,94 Cryptosporidium spp. are rather 
divergent from other Coccidea by several characteristics, both genomic and biochemical.95,96 In 
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addition, Cryptosporidium spp. are closely related to Gregarines, which are a diverse group of 
apicomplexan parasites that inhabit vertebrates and invertebrates hosts.97,98 
Ernest Edward Tyzzer, a British physician, was first to describe the genus 
Cryptosporidium and recognize its multispecies nature.90 During this period, the pathogens C. 
muris and C. parvum were identified and named by Tyzzer.98 A few years after Tyzzer, C. 
meleagridis was described by Slavin.94,99 Since Tyzzer’s discovery of Cryptosporidium in 1907, 
more than 40 species and over 40 genotypes have been reported. However, only 25 species have 
been confirmed by the International Code for Zoological Nomenclature (ICZN) in the genus 
Cryptosporidium (Table 1.2). 94,100  
Molecular tools and phylogenetic analysis (that have been widely used to characterize 
Cryptosporidium) have provided insights about the biology, epidemiology and the public health 
significance of this pathogen.90,101 Because hosts can be naturally infected with multiple species 
of Cryptosporidium, differentiating those species based on morphology alone is not sufficient. 
Instead, genetic differences between species that have been identified by PCR and DNA 
sequence analysis have been used to determine the identity of the organism.90 Cryptosporidium 
spp. genes such as 18S ribosomal RNA (rRNA) and 60-kDa glycoprotein (gp60) have been 
widely used as genetic markers to identify different species and help determine the mode of 
transmission.102-104 For instance, the gp60 gene character has tandem repeats and extensive 
sequence differences in the non-repeat regions, that characterize C. parvum and C. hominis each 
to several subtype families.102  
1.2.2 Epidemiology in Humans 
Like Giardia spp., Cryptosporidium spp. were included in the “Neglected Diseases 
Initiative” in 2004.14 Cryptosporidiosis is a reportable disease in the USA105 and the first full year 
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of reporting was 1995.106 The transmission route of Cryptosporidium spp. is fecal-oral. This 
means the pathogen is excreted from the gastro-intestinal tract of an infected person to the 
environment and enter another person’s gut via mouth.107  
Cryptosporidiosis can occur through several modes of exposure. Contaminated water 
(either drinking, recreational or surface water) is one mode of Cryptosporidium exposure and 
likely the most common one. In the USA, the first waterborne outbreak due to Cryptosporidium 
spp. was reported in 1984 in Braun Station, a suburb of San Antonio, Texas.108 Two years later, 
another outbreak due to Cryptosporidium spp. among college students was identified in Carroll 
County in Georgia, USA.109 Since the 1980’s, approximately 43 waterborne outbreaks due to 
Cryptosporidium spp. have been reported worldwide.110 Exposure to reactional water led to nine 
waterborne outbreaks due to Cryptosporidium spp. worldwide during the period from 1987-
1996.110 In 1993, Cryptosporidium spp. caused the largest documented waterborne outbreak in 
Milwaukee, Wisconsin.111 Cryptosporidium was considered the main causative agent of all 
waterborne outbreaks that occurred during 2001-2010 in the USA.112 Each year, an estimated 
748,000 human cases occur in the USA caused by Cryptosporidium spp.113 However, this 
number of cases can be an underestimate because less than 2.0% of cases are reported to health 
authorities.114 Human cryptosporidiosis can result in hospitalizations that can cost an estimate 
$45.8 million annually.115 
Another mode of Cryptosporidium spp. transmission is person-to-person either directly or 
indirectly. Studies suggest that Cryptosporidium spp. can be transmitted sexually.116 Data also 
has shown that the risk of acquiring cryptosporidiosis is higher in homosexual men compared to 
intravenous drug users and HIV positive individuals.116 Another example of person to person 
contact of cryptosporidiosis was in one study that reported 19.0% of family members that have 
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children with cryptosporidiosis in Brazil developed clinical signs of the disease.117 Additionally, 
5.4% of Milwaukee residents developed diarrhea due to contact with infected family members 
during the Cryptosporidium epidemic in 1993.118 Cryptosporidium infections due to contact with 
infected individuals also can occur in hospitals and daycare facilities if sanitation is 
inadequate.117,119  
Cryptosporidium spp. can be transmitted via animal to-human or animal-to- nimal 
contact. In one study, dairy farmers had a 44% Cryptosporidium seroprevalence compared to 
24% seroprevalence in individuals that are not exposed to cattle.120 Dogs and cats infected with 
host adapted Cryptosporidium, also can be infected with C. parvum and C. meleagridis that 
mainly infect cattle and birds, respectively.121,122  
Another mode of transmission for C yptosporidium spp. infection in humans can be via 
food. Even though waterborne cryptosporidiosis is of greater public health significance than 
foodborne cryptosporidiosis,123 it has been recognized that food may play a more significant role 
in the transmission of cryptosporidiosis than formerly believed.124 Cryptosporidium spp. oocysts 
have been detected in shellfish such as oysters, clams, and mussels.125-127 Other foods such as 
raw vegetables128-130, milk and chicken salad have been implicated in causing cases of 
cryptosporidiosis.131,132  
Although uncommon, airborne transmission of Cryptosporidium spp. have been 
suggested in numerous papers.116,133 Generally, the epidemiologic triad of Cryptosporidium spp. 
is described in the flowing sections.  
1.2.2.1 Agent 
Cryptosporidium spp. oocysts are subspherical in shape. The dimensions of the oocysts 
slightly vary among species of Cryptosporidium, but in general, the length ranges from 4.5 to 7.5 
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µm and the width ranges from 4.2 to 5.7µm.93 The sporozoites of the pathogen are 4.5 to 7.5 µm 
long and 1.2 to 1.8 µm wide. The pathogen completes its sexual and asexual life cycle in one 
host. The ingestion of the sporulated oocysts by the host results in Cryptosporidium spp. 
infection. This pathogen does not reproduce outside the host.105 Additionally, all stages of 
Cryptosporidium spp. life cycle occur within one host93 (Figure 1.3). After ingestion, the oocysts 
excyst in the epithelial cells of the gastrointestinal tract or other tissue such as the respiratory 
tract. This process (excystation) releases the infective sporozoites which become trophozoites. 
These trophozoites asexually proliferate by merogony to produce two types of meronts: type I 
meronts (contain eight merozoites) invade other epithelial cells where they develop into more 
type I meronts or type II meronts. The latter contains four merozoites. Type II meronts do not 
undergo merogony but produce sexual reproductive stages (gamonts).  The zygotes formed by 
sexual reproduction (gametogony between male microgamonts and female macrogamonts) form 
either thick-walled or thin-walled oocysts, each containing four sporozoites. Thick walled 
oocysts then are passed in the infected host feces.134 The oocysts which are shed in the feces are 
readily infectious and highly resistant to environmental conditions.93 This pathogen can cause 
infection with a very low dose. For instance, some studies have demonstrated that healthy 
individuals can be develop cryptosporidiosis with as low as 10 oocysts for C. h minis or C. 
parvum.135,136 It has been reported that infected persons can shed 107–108 oocysts in a single 
bowel movement137 and continue to excrete the oocysts for up to 60 days after recovering from 
the clinical signs of the disease.137  
It has been reported that C. parvum oocysts can remain viable in the environment for 
months.110 The oocysts can resist moderate temperatures at 20˚C and remain infectious to 
suckling mice.138 In experimental conditions, the oocysts lose their infectivity at 55˚C and 
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59.7˚C139,140 and are killed at 71.7˚C.141 Furthermore, the oocysts remain infectious at -5˚C for up 
to two months. Additionally, oocysts survived at -20˚C or -10˚C for a week and 8 hours, 
respectively.138,142 Extreme low temperature like -70˚C resulted in immediate killing of the 
oocysts.143,144 Oocysts are killed in extremely dry conditions or desiccation. Only 3.0% of 
oocysts were viable after 2 hours of desiccation and 100% killing was reported at 4 hours.143,144  
1.2.2.2 Host  
Cryptosporidium spp. infect the small intestine of a wide range of vertebrate hosts, 
including humans. Clinical signs vary from self-limiting to acute or life threatening depending on 
the immune status of the infected host.90 For instance, Cryptosporidium spp. infection is more 
common in children, elderly, and immunosuppressed individuals, and the prognosis of 
cryptosporidiosis can be more severe in patients that are immunocompromised such as HIV+ 
individuals.105,145-147 Cryptosporidiosis occurs more often in children under five years of age114 
(in the USA and developing countries) and clinical signs develop in children younger than two 
years of age in developing countries.148-150 Overall, cryptosporidiosis rates were higher among 
females than males. For specific age groups, rates were higher among males than females aged 
<15 years and higher among females than males aged ≥15 years.105 Even though it is unclear 
why the risk of cryptosporidiosis is elevated in females at this age, females aged ≥15 years are 
more likely to fill caregiver roles for young children, which is considered a risk factor for 
Cryptosporidium infection.151 
Physiopathology 
The mechanism of diarrhea due to Cryptosporidium spp. is not fully understood. It has 
been suggested that diarrhea occurs due to the disruption of microvillus surface area, the 
presence of an enterotoxin, or adhesion factors affecting parasite attachment to host cells.152 
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Generally, diarrhea due to Cryptosporidium spp. is profuse, watery, and non-bloody. Other 
symptoms are non-specific and can include weight loss, abdominal pain, anorexia, fatigue, 
cramps, headache, fever, and vomiting.153 However, diarrhea does not develop in the majority of 
infections and are classified as asymptomatic infections.154-157 Recurrence of symptoms after 
apparent recovery has been reported. Regardless, illness is self-limiting, and symptoms typically 
resolve completely within 2–3 weeks in immunocompetent persons.158  
1.2.2.3 Environment  
The pathogenic oocysts enter the environment in feces from both human and other 
hosts.159 One of the challenges presented by Cr ptosporidium spp. is that it is ubiquitous in the 
environment. This characteristic allows for several transmission routes of Cryptosporidium 
infectious to humans and other animals.160 
It has been reported that livestock manure production is approximately 5.45 billion metric 
tons per year.161 In developed countries, most of this manure is deposited to the soil with little or 
no treatment which can result in an accumulation of numerous number of pathogens. Also, 
Cryptosporidium spp. oocysts have been detected in the soil.161  
Other sources that play a role in Cryptosporidium spp. contamination to the environment 
are wild animals and insects. Examples of wild animals are Canadian geese, Peking ducks, bears, 
marsupials, mountain gorillas, and red deer.110,162 Furthermore, insects such as flies, and 
cockroaches have been reported to serve as reservoirs for C. parvum oocysts and capable of 
transmitting of the agent into the environment.110,163  
1.2.3 Cryptosporidium spp. in Companion Animals 
Cryptosporidium canis is a Cryptosporidium genotype that infects dogs.164 This genotype 
was first identified as a dog genotype in 1999165and classified as a species in 2001 on the basis 
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that C. canis oocysts were genetically distinct from all other species and were not infectious to 
mice.164 Cryptosporidium canis and its sub-genotypes (C. canis fox genotype and C. canis 
coyote genotype) have been reported in dogs, foxes and coyotes.101 Cryptosporidium canis also 
has been reported worldwide in humans. 101,166,167  
Canine cryptosporidiosis is more prevalent in pups compared to adult dogs and the risk of 
the disease increases when coinfections with other pathogens are present.168-173 Commonly 
reported clinical signs in dogs include: diarrhea, anorexia, and weight loss. The diarrhea is small 
bowel and is characterized as watery, non–mucoid or non-bloody. Vomiting is uncommon unless 
other abnormalities exist. The small intestines may feel slightly thickened when the abdomen is 
palpated.174  
Cats become infected with C. felis which were first described in 1979.175 When the 
oocysts from a cat were fed to mice, rats, guinea pigs and dogs, and infection was induced only 
in cats. 175,176 Cryptosporidium felis also has been detected in cattle and in human cases.166,167,177-
181 Immunocompetent cats may not develop diarrhea due to cryptosporidiosis and sub-clinically 
infected cats can shed Cryptosporidium oocysts.175,176,182 
Clinical signs of cats with cryptosporidiosis include diarrhea, anorexia and weight loss. 
Factors such as weakened immune system, pre-existing diseases in the intestinal tract or 
coinfection with other infectious or non-infectious causes can lead to the risk of developing 
clinical signs.183-185 Coinfection with pathogens such as Cystoisospora spp., Toxocara cati, 
coronavirus, and Campylobacter have been documented in cats with cryptosporidiosis.184,186-189  
1.2.4 Zoonotic Consideration of Cryptosporidium spp. 
Infection with Cryptosporidium spp. is believed to be primarily zoonotic.47 
Cryptosporidiosis has been reported among veterinarians and farm workers. In these populations, 
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it was found that the oocysts were transmitted from cattle infected with C. parvum. 190,191  In the 
late 1990’s, genetic analysis of C. parvum identified type I which is considered human exclusive 
(now named C. hominis) and type II C. parvum that infects both humans and cattle.47,192,193  
Even though some species are considered host adapted, such as C. cani  and C. felis have 
been detected in humans,194-197 the pet’s role in transmitting the infection to their owners has not 
been defined.47 
1.2.5 Laboratory Diagnosis 
To diagnose Cryptosporidium spp. disease or infection in humans and animals, several 
techniques have been employed. These techniques include: ultrastructural examination of biopsy 
material for life cycle stages, microscopic examinations, and molecular based techniques. Types 
of specimens that are submitted for Cryptosporidium detection can include: feces, sputum, bile, 
mucoid secretions and tissue biopsies. Fecal specimens are the primary type of samples 
examined for Cryptosporidium.198 In this section, microscopic examination of the oocysts, 
Cryptosporidium spp. antibody and antigen tests, and molecular testing for Cryptosporidium spp. 
DNA from fecal specimens of humans and companion animals will be discussed.  
1.2.5.1 Microscopic Examination  
Detection of Cryptosporidium spp. oocysts using microscopy has been widely used in the 
diagnostic workup of diarrhea.199 This examination can be performed by several methods.  
Concentration Techniques 
 Prior to the microscopic examination of fecal specimens, it is recommended to use 
concentration procedures for detection of the oocysts. These procedures are useful in maximizing 
the recovery of the oocysts.198 Sheather’s sucrose flotation, zinc sulfate flotation, saturated 
sodium chlorine methods,200 discontinuous sucrose, isopropynic Percoll, discontinuous Percoll, 
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or cesium chloride gradient centrifugation201,202 are used as concentration methods for fecal 
specimens. 
Staining Methods 
 Two types of stains are used to stain the Cryptosporidium spp. oocysts. These include: 
acid-fast staining and non-acid-fast staining. The acid fast Ziehl-Neelsen stain is widely used in 
the Cryptosporidium spp. oocysts staining procedure for fecal smears.203 This stain permits a 
better differentiation from fecal matter after counter-staining with malachite green or methylene 
blue.204 The oocysts have distinct walls and stain from light pink to bright red color. This stain is 
used for oocyst detection.205 The acid-fast carbol-fuchsine also may be used to stain the 
oocysts.204 The oocysts in this type of stain appear ringlike (4-6 µm in diameter) and exhibit a 
characteristic bright fluorescence (brilliant green) against a dark red background.198 Other acid-
fast staining methods include safranin-methylene blue,206 Trichrome,205 and Kinyoun207 stains. In 
the staining procedures using safranin and trichrome stains, the detection of the oocysts can be 
accomplished, but these techniques are not adequate for the confirmation.205 The Kinyoun stain 
is preferable to the enzyme immunoassays.207 This assay is considered the gold standard assay by 
many laboratories for Cryptosporidium spp. oocyst detection.205 The non-acid-fast staining 
techniques include: negative stains such as light–green or mercuramine, and fluorescent stains 
such as phenol auramine.  The advantage of these techniques is that they allow a fast screening 
of the specimen, but they require a fluorescent microscope.204  
Monoclonal antibody based immunofluorescence staining of Cryptosporidium spp. 
oocysts is a type of staining that involves detection of an immunologic reaction between 
antibody and antigen. The IFA detects antigen using a fluorescent antibody performed either 
directly or indirectly. The direct IFA method involves the conjugation of a specific monoclonal 
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immunoglobulin (antibody) with a fluorescent dye and this complex is added to a concentrated 
fecal specimen. The product then combines with specific antigen and results in an antigen-
antibody complex. This complex is visualized using a fluorescent microscope. The indirect IFA 
involves adding an unlabeled immunoglobulin (antibody) to the fecal specimen. The antigen-
antibody complex then is labeled with fluorescein-conjugated anti-immunoglobulin antibody 
with the resulting triple complex visualized with a fluorescent microscope.208 Studies have found 
no significant difference in the limit of detection of stool samples from asymptomatic carriers 
when this assay was compared to the acid-fast staining techniques.204   
Wet Mount  
 This type of examination is used for screening of oocysts. It is useful when the specimen 
contains a high number of oocysts. Fresh or concentrated fecal specimens can be examined, 
using either conventional bright light, phase contrast or differential interference contrast 
microscopy without staining of the sample.209 In this method, the oocysts appear as small 
spherical structures (on average 5μm), but misdiagnoses can occur if yeast is present.205 
1.2.5.2 Immunological Methods 
Enzyme-Linked Immunosorbent Assay (ELISA) 
 The enzyme-linked immunosorbent assay (ELISA) has been used to detect both the 
antibody and antigen of C. parvum. Cryptosporidium spp. such as C. parvum induce mucosal 
infection and C. parvum IgA antibody is released in the feces. Thus, ELISA has been developed 
to detect this antibody in the fecal samples.210 Fecal anti-C. parvum IgA, IgM, and IgG were 
monitored by ELISA in calves that were experimentally and naturally infected with C. 
parvum.210 In this experiment, even though experimentally infected calves had high level of 
colostral antibodies in their feces, they were all infected with C. parvum and three of five died. 
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Calves naturally infected with C. parvum, had only diarrhea. Experimental infection was 
followed by a rise in local anti-C. parvum IgM levels. In naturally infected calves, serum anti-C. 
parvum IgG levels rose during maximal oocyst excretion, whereas serum anti-C. parvum IgA 
levels peaked later than did local IgA levels.210 In addition, ELISA has been used to detect the 
free fecal antigen of Cryptosporidium spp. in feces.134 This approach has been widely applied in 
laboratories that do not have a fluorescent microscope, and in situations when processing batch 
specimens may be crucial due to its increased sensitivity compared to microscopy for 
Cryptosporidium spp. diagnosis.134 Seven commercial ELISA kits were evaluated for their 
sensitivity using the IFA as a reference test. The sensitivity of five kits ranged from 94.5% - 
100% which was equivalent to the sensitivity of the IFA assay.204 However, two ELISA kits 
performed poorly with sensitivity ranged from 29%-93%.204 The sensitivity of a fecal ELISA kit 
was compared to carbol fuchsine stain (microscopy) in the detection of Cryptosporidium in 
canine and feline samples in a study.211 Twenty-six of 270 dog samples (9.5%) tested positive for 
Cryptosporidium by microscopy. However, only eight of 270 (2.95%) tested positive by the fecal 
ELISA. Whereas none of the 100 cats tested positive for Cryptosporidium by microscopy, but 22 
of 100 (22.4%) tested positive by the fecal ELISA, in the same study.211 
1.2.5.3 Molecular Techniques 
Molecular techniques or DNA – based methods include polymerase chain reaction (PCR) 
assays. The PCR assays are characterized by the increased sensitivity, specificity and 
reproducibility. In addition, the PCR product results are easy to interpret.134 It has been reported 
that PCR has increased sensitivity of detection in comparison to microscopic and 
immunological-based techniques for clinical samples.92,212 Several PCR protocols have been 
developed to differentiate Cryptosporidium spp. using 18srRNA, HSP70,162 and GP60213 genes.  
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Molecular techniques also can include sub-genotyping tools. These tools are helpful in 
the epidemiological investigation of outbreak situations because they provide more accurate 
identification of the causative agent and hopefully the mode of transmission.214 Sub-genotyping 
tools available include: DNA sequence analysis of microsatellites,215,216 HSP-70 gene,217 GP60 
gene,218,219 and a double stranded (ds) RNA.220 Molecular tools based the oocyst wall protein 
(COWP) have limited usefulness in genotyping Cryptosporidium spp. of animals because of their 
narrow specificity.221 
There are several benefits in using subtyping tools, especially in understanding the 
epidemiology of Cryptosporidium spp. for instance, these tools provide understanding of the 
complexity of human cryptosporidiosis at the genotype and sub-genotype levels.221 Furthermore, 
subtyping provides understanding of the transmission routes of Cryptosporidium in developing 
and developed countries and has improved the understanding of infection sources in humans.221 
1.2.6 Prevention and Control of Giardiasis and Cryptosporidiosis  
In humans, the prevention of giardiasis can be accomplished by practicing good hygiene 
such as handwashing and avoid direct contact with animal’s feces, especially young animals. 
Because giardiasis is more frequently reported in young children, those with diarrhea should not 
be sent to the daycare until the disease has resolved. Also, hands must be washed after changing 
diapers. Contaminated food or water with Giardia cysts or Cryptosporidium oocysts should be 
avoided. Disinfection of public drinking water is not effective in inactivating Giardia cysts. 
However, Giardia cysts can be inactivated by thorough steam cleaning or using effective 
detergent regimes.222,223  
Routine diagnosis of Cryptosporidium cases and reporting the disease in humans to local 
and national surveillance organizations is an important measure for disease prevention. 
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Furthermore, implementing of water treatment procedures and enforce better regulations can be 
useful in controlling the spread of Cryptosporidium contamination to the environment, yet this 
protocol can be challenging, especially in swimming pools. Additionally, as a preventative 
measure, travel-related causes should be examined and controlled.224 
Prevention measures for Giardia transmission include treating water collected from the 
environment by either filtration or boiling. For premises contaminated with feces containing 
Giardia cysts, steam cleaning or quaternary ammonium compounds should be used. To control 
the spread of the pathogen in infected animals, treatment or bathing of all animals as well as 
prompt removal of feces from infected animals should be implemented. Even though 
Cryptosporidium spp. oocysts are environmentally resistant, they can be controlled by steam 
cleaning. This application can rupture the oocysts wall. Best prevention measures for 
cryptosporidiosis are avoiding contaminated water or food.225 
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1.3 Tables  
Table 1.1 Giardia species based on original taxonomic description and new nomenclature in 
different hostsa 
 
Species Assemblagesb Hosts 
Giardia duodenalis  Assemblagec  A Humans and other primates, dogs, 
cats, livestock, rodents, wild 
mammals 
Assemblaged  B Humans and other primates, dogs, 
cats, wild mammals 
Assemblagee  C/D Dogs, canids 
Assemblagef  E Cattle, hoofed livestock 
Assemblageg  F Cats  
Assemblageh  G Rats  
Assemblagei  H Pinnipeds  
Assemblagei  -- Marsupial (Quenda, bandicoot) 
G. muris  Rodents 
G. microti  Rodents 
G. psittaci  Birds  
G. ardeae  Birds  
G. agilis  Amphibians 
b New proposed nomenclature 
c G. duodenalis  
d G. enterica 
e G. canis 
f G. bovis 
g G. cati 
h G. simondi 
i Novel lineages or likely new species of Giardia that have not been formally described yet 
aModified from Thompson RCA, Monis P. Giardia – from genome to proteome. Adv Parasitol. 














































aAdapted from Ryan U, Xiao L. Taxonomy and molecular taxonomy. In: Cacciò SM, Widmer G, 

















Species Host Reference 
C. hominis Humans 227  
C. viatorum Humans 228  
C. parvum Cattle, sheep, humans, whiting (fish), 
barramundi (fish) 
229,230,231  
C. parvum like whiting (fish), barramundi (fish) 229,231 
C. bovis Cattle  232  
C. ryanae Cattle  233  
C. andersoni Cattle  234  
C. xiaoi Sheep, whiting (fish), barramundi (fish) 229,231,235  
C. ubiquitum Sheep/ wildlife 236  
C. felis Cats 175  
C. canis Dogs 164  
C. muris Rodents, (ringed, harbor, hooded) seals   98,237,238 
C. tyzzeri Mice  239  
C. suis Pigs, 240  
C. scrofarum Pigs, whiting (fish), barramundi (fish) 229,231,241 
C. wrairi Guinea pigs 242 
C. cuniculus Rabbits  243,244 
C. fayeri Marsupials 245  
C. macropodum Marsupials 246  
C. meleagridis  Turkey, Indian ring-necked parrot, red-
legged partridge, cockatiels, Bohemian 
waxwing, rufousturle dove, fan-tailed 





aFrom http://www.cdc.gov/parasites/giardia/pathogen.html 258 
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CHAPTER 2: EVALUATION OF FACTORS ASSOCIATED WITH THE RISK OF TESTING 
POSITIVE TO GIARDIA SPP. AND CRYPTOSPORIDIUM SPP. IN PET DOGS AND CATS 
IN THE USA 
Summary 
 Giardia spp. and Cryptosporidium spp. are protozoans that colonize and reproduce in the 
intestines of several domesticated animals, including dogs and cats and can include a range of 
manifestations from subclinical infection to severe diarrhea. Cryptosporidium spp. infection rates 
in dogs and cats are largely unknown as sensitive diagnostic procedures were not previously 
available.  Polymerase chain reaction (PCR) assays are now available to amplify Giardia spp. 
and Cryptosporidium spp. DNA from feces. 
     The main purpose of this study was to estimate the risk of testing positive for Giardia 
or Cryptosporidium among pet dogs and cats in the USA. Additionally, whether the animals’ 
age, sex, region of origin, and time of the year (season) were associated with the risk of testing 
positive for these pathogens were evaluated. Finally, coinfections due to Giardia spp. and 
Cryptosporidium spp. among the studied pets was quantified.   
Data from fecal samples processed at ANTECH® Diagnostics during the period 2010-
2015 were analyzed for this study. PCR assays were performed on fecal samples from 22,959 
dogs and 16,273 cats.  The assays amplified Giardia spp. and Cryptosporidium spp. in dogs and 
Giardia spp., Cryptosporidium felis and Cryptosporidium spp. in cats. Descriptive analysis, 
univariable, and multivariable logistic regression analyses were conducted to assess associations 
between age, sex, region, and season with the risk of testing positive to either Giardia spp. or 
Cryptosporidium spp. in pet dogs and cats.  
The percentage of Giardia spp. positive test results among pet dogs was 7.7 (95% CI: 
7.3, 8.0). For Cryptosporidium spp. in dogs the percentage of positive results was 5.4 (95% CI: 
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5.1, 5.7).  Whereas in pet cats, the percentage of positives to Giardia spp. was 5.2 (95% CI: 4.9, 
5.5), for C. felis was 5.1 (95% CI: 4.7, 5.4) and for C yptosporidium spp. was 7.4 (95% CI: 7.0, 
7.9).  
The results of logistic regression models showed that age was a significant factor 
associated with both Giardia spp. and Cryptosporidium spp. in dogs and cats. Region was also 
significantly associated with the risk of Cryptosporidium spp. infections in dogs and cats. Season 
variable was significantly associated with the risk of Giardia spp. in pet dogs only. 
Cryptosporidium spp. was detected in fecal samples of 336 (19.1%) of the 1,762 Giardia 
spp. positive dogs and Giardia spp. was detected in fecal samples of 336 (27.2%) of the 1,237 
Cryptosporidium spp. positive dogs.  For cats, Cryptosporidium spp. was detected in 132 
(15.7%) of 843 Giardia spp. positive cats.  Of the 843 Giardia spp. positive cats, 97 (11.8%) 
were positive for C. felis.   
  Our study results indicate that Giardia spp. and Cryptosporidium spp. are common 
pathogens in pet dogs and cats. In all multivariate models, the results showed that age was a 
significant predictor associated with Giardia spp. and Cryptosporidium spp. in dogs and cats.  
This finding calls suggests that infection by these protozoans should be suspected more highly in 
younger dogs and cats. Our multivariate analysis has also identified that the regional distribution 
is significantly associated with Cryptosporidium spp. infections in dogs and cats, whereas 
seasonal distribution is only associated with the risk of Giardia spp. in pet dogs.  Thus, 
veterinarians in the Midwest region may be more likely to encounter Cryptosporidium infections 
in dogs and cats and veterinarians evaluating dogs with diarrhea in the summer season are more 
likely to encounter Giardia spp. infections.  Coinfections with both pathogens can occur in pet 
dogs and cats.   
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As the histories from these dogs and cats are unknown, additional studies will be required 
to evaluate for associations of positive test results with clinical findings and to determine the 
likelihood dogs or cats are carrying zoonotic G ardia spp. or Cryptosporidium spp.  
2.1 Introduction  
Giardia spp. and Cryptosporidium spp. both are intestinal protozoan parasites that 
colonize and reproduce in the intestines of domesticated animals included dogs and cats and can 
be associated with diarrhea.1 The clinical signs in dogs and cats depend greatly on the status of 
the host immune system, which is considered one determinant of whether disease will occur.2 F r 
instance,  immune-competent cats may not develop diarrhea when they are infected with 
Cryptosporidium felis even though the cats are shedding the oocysts.3 However, in 
immunocompromised cats, clinical signs associated with feline cryptosporidiosis can involve 
diarrhea, anorexia and weight loss.4 Another determinant of whether disease will occur is the age 
of the host. For example, infections with Cryptosporidium spp. in dogs are more prevalent in 
young animals compared to older ones.4 Furthermore, cryptosporidiosis can be acute if the 
animal had underlying conditions such as preexisting disease in the intestinal tract, or coinfection 
with other infectious or non-infectious agents.4 For example, cryptosporidiosis in pups can result 
in severe diarrhea when associated with co-infections of parvovirus, distemper or parasitism.5-7 
Intestinal malabsorption was reported in an adult dog with cryptosporidiosis suggesting the 
infection can be chronic.8 
Regarding feline giardiasis, it has been documented that kittens are more susceptible to 
the infection and diarrheal disease than adult cats.9 Diarrhea in cats is usually mucoid, pale, soft, 
has a strong odor, and steatorrhea may also be seen.9  
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Canine giardiasis is common and Giardia associated diarrhea in dogs is usually self-
limiting in immunocompetent animals. Immune-compromised animals may develop chronic 
malabsorption; therefore, weight loss may be detected.10  
The diagnosis of these two protozoans still is challenging for a considerable number of 
veterinary practices. Even for animals presenting with diarrhea, direct diagnosis of the causal 
agent is not easy.11 While conventional diagnosis techniques such as microscopy, immuno-
fluorescence assay (IFA) or enzyme-linked immunosorbent assay (ELISA) are widely used in 
veterinary medicine to diagnose Cryptosporidium spp. and Giardia spp., these techniques have 
several limitations. 
Cryptosporidium spp. diagnosis can be initially performed by microscopic examination 
as initial diagnostic workup. However, this technique is commonly falsely negative due to poor 
sensitivity and cannot be used to determine the species of Cryptosporidium-associated with the 
infection. In addition, infected dogs and cats shed Cryptosporidium spp. intermittently; thus, 
multiple samples from the same infected animal are required to confirm results.12 
The diagnosis of giardiasis can be challenging for a number of reasons and can result in 
underdiagnosis, misdiagnosis or overdiagnosis.13 Giardia cysts are shed intermittently which can 
cause false negative results; therefore, repeated fecal analysis may be required.  Identification of 
Giardia cysts requires a trained microscopists as examination by less trained individual may 
result in a misdiagnosis.12,13 Either pseudoparasites and yeasts can be easily mistaken as Giardia 
cysts giving false positive results.  In addition, Giardia cysts can deteriorate in fecal flotation 
solutions giving false negative results.13   
 Several polymerase reaction chain (PCR) protocols have been used to amplify 
Cryptosporidium spp. and Giardia spp. DNA from fecal specimens of pet dogs and cats and now 
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are available in many commercial diagnostic laboratories.   Genotyping can also be performed 
with some molecular techniques and has been used to study potentially zoonotic species of both 
protozoans and transmission probability to pet owners.14-18  
 Several studies19-31 conducted throughout the USA that have used microscopy, ELISA 
and IFA have shown that intestinal parasites such as Gi rdia spp. and Cryptosporidium spp. are 
common in pet dogs and cats.  Several of those studies were conducted during the period of 
1999-2012. For instance, the reported prevalence of canine giardiasis ranged from  5.0 % - 7.0% 
in dogs with no clinical signs, 0.4 % - 16.0% in dogs with clinical signs, and 3.0% - 4.0% in dogs 
with unknown clinical signs.19-25 For feline giardiasis, the reported prevalence estimates were 
2.0% in cats with no clinical signs, and ranged from 8.0% - 14.0% in cats with clinical signs, and 
2.0% in cats with unknown clinical signs.22,26-29 The reported prevalence of canine 
cryptosporidiosis in dogs with clinical signs ranged from 2.3% - 5.6%, and 1.7% in dogs without 
clinical signs20,25. Whereas feline cryptosporidiosis estimates in cats with clinical signs ranged 
from 3.9% - 25.0% and from 1.9% - 10.0% in cats without clinical signs.29,30,31  
 Fewer studies have been conducted in different regions of the USA using PCR assays for 
genotyping or confirmation of a positive result for Giardia spp. and Cryptosporidium spp., 
during the period of 2000-2012.20,28,32 In addition, fewer studies have evaluated the prevalence of 
Giardia spp. in dogs and cats by regional distribution in the United States.23,24 
In this retrospective study, we analyzed results of PCR panels performed by a 
commercial service laboratory (ANTECH® Diagnostics) on feces from dogs and cats. The 
purpose of this cross-sectional study was to evaluate associations between the probability of 
testing positive to Giardia spp. and Cryptosporidium spp. and to determine potential risk factors 
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including animals’ age, sex, region of origin, and time of the year in which fecal samples were 
collected (season).    
2.2 Materials and Methods 
2.2.1 Study Samples  
 PCR results of testing for Giardia spp. and Cryptosporidium spp. in canine and feline 
species were obtained from ANTECH® Diagnostic laboratories in January, 2015. The data 
contained information about fecal samples collected by veterinarians from fifty states in the 
United States from the period of 2010-2015. A total of 22,959 PCR canine test results for 
Giardia spp. and Cryptosporidium spp. and a total of 16,273 PCR feline test results for Gia dia 
spp., Cryptosporidium spp. and Cryptosporidium felis were analyzed in this study. 
2.2.2 Inclusion and Exclusion Criteria 
 The original data received from ANTECH contained test results of PCR panels for 13 
pathogens. For the purpose of this study, only data regarding Giardia spp. and Cryptosporidium 
spp. in both dogs and cats was evaluated.  Most of the samples were submitted by clinics located 
within the United States; however, the data also contained a few samples from commonwealth 
territories such as the Virgin Islands, Guam and Puerto Rico as well from Japan, Canada and 
South Korea.  Test results from these regions were excluded from the dataset.  The outcome of 
interest in our analysis was a “positive” or “negative” test results for Giardia spp. and 
Cryptosporidium spp. and only complete records containing test result information were included 
in our analysis.    
2.2.3 Data Organization   
 The accession result identifier (i.e. animal identity) was used to track the same animal test 
results for the different pathogens. The fifty states of the United States were placed in the 
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Northeast (Connecticut, Delaware, Washington DC, Massachusetts, Maryland, Maine, New 
Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Midwest (Iowa, 
Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, North Dakota, Nebraska, Ohio, South 
Dakota, Wisconsin), South (Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, 
Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West 
Virginia), or West (Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, New 
Mexico, Nevada, Oregon, Utah, Washington, Wyoming) according to the U.S. Census Bureau 
classification for regions as previously described and as displayed in Figure 2.1.23  
The months in which the fecal sample was obtained were grouped and characterized 
based on the meteorological season classification of the northern hemisphere into four season 
categories: spring, summer, fall and winter. Each category contained three months.33 Spring 
months were March, April and May, summer months were June, July, and August, autumn 
months were September, October, and November), and winter months were December, January, 
and February.33 Animal age was categorized and analyzed as acategorical variable including five 
age categories were created: 1) <6 months, 2) 6 months – 1 year, 3) 1-2 years, 4) 3-7 years, and 
5) >7 years similar to previously described.23  
2.2.4 Causal Model 
Causal model was created for the study variables as presented in Figure 2.2. The factors 
in the model are displayed per their causal order and relationship to the outcome variable on the 
far right (i.e. Giardia spp. and Cryptosporidium spp. infections in dogs and cats).  
2.2.5 Regression Model Building Steps 
 Four predictor variables (age, sex, region, and season) were evaluated for inclusion in the 
models. The outcome variable in this study is dichotomous i.e. it represents the probability of 
62 
testing either positive or negative to either Giardia spp. or Cryptosporidium spp. or both. Thus, 
logistic regression analysis was used to analyze the data and identify associations between risk 
factors and the outcome of interest.  
2.2.5.1 Descriptive Analysis   
  The outcome of interest and risk factors distributions were evaluated using standard 
descriptive statistics. The distribution (%’s) of test positive dogs and cats for Giardia spp. or 
Cryptosporidium spp. was calculated with the corresponding 95% CI, and similarly, the 
frequency distribution for age, sex, region and season, was calculated and presented as 
percentages with the corresponding 95% CI for each category.  
2.2.5.2 Logistic Regression Analysis 
 As a first screening step, associations between individual risk factors and the outcome 
(testing positive or negative to Giardia spp., or Cryptosporidium spp.) were evaluated using 
univariable logistic regression analysis. Odds ratios and their corresponding 95% CIs were 
calculated. To account for the effect of multiple factors in the outcome and to control for 
potential confounding, associations between potential risk factors and the outcome were 
evaluated using a multivariable logistic regression. Factors showing a p-value <0.25 at the 
univariable analysis were used in the multivariable model. The likelihood ratio test (LRT) was 
used to determine the statistical significance of individual predictors in the multivariable model. 
The Hosmer – Lemeshow goodness of fit test was used to evaluate the overall fit of the final 
models generated. The presence of outliers and/or influential observations that could affect the 
model fit was evaluated. This evaluation was conducted by plotting the standardized residuals.34  
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2.3 Statistical Analysis 
STATA® 13.0 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, 
TX: StataCorp LP.) was used for data manipulation, descriptive analysis, univariate and 
multivariate logistic regressions. These analyses were carried out to assess and compare of the 
risk of testing positive to Giardia spp. or Cryptosporidium spp., in dogs and cats. Associations 
between two predictor variables were evaluated using Chi-squared tests to determine collinearity. 
Logistic regression analysis was used to obtain the odds ratios with their corresponding 95% 
confidence interval and p-values when comparing the risk of testing positive to Giardia spp. or 
Cryptosporidium spp., in dogs and cats. Statistical significance was declared at p<0.05.  
2.4 Results  
2.4.1 Descriptive Analysis  
The Outcome of Interest 
 The proportion of positive results for Giardia spp. and Cryptosporidium spp. in dogs and 
cats are shown in Tables 2.1-2.2. In total, 1,762 dogs were positive to Giardia spp., representing 
7.7% (95% CI: 7.3, 8.0%) of the dog samples. In total, 1,237 dogs were positive to 
Cryptosporidium spp. representing 5.3% (95% CI: 5.1, 5.7%) of all dog samples.  For cats, the 
percentage of positives for Giardia spp. was 5.2% (95% CI: 4.9, 5.5%), C. felis was 5.1% (95% 
CI: 4.7, 5.4%), and Cryptosporidium spp. was 7.4% (95% CI: 7.0, 7.9%) (Table 2.2).    
Coinfections  
Cryptosporidium spp. DNA was amplified from fecal samples of 336 (19.1%) of the 
1,762 Giardia spp. positive dogs and Giardia spp. DNA was amplified from fecal samples of 
336 (27.2%) of the 1,237 Cryptosporidium spp. positive dogs.  For cats, Cryptosporidium spp. 
64 
DNA was amplified from 132 (15.7%) of 843 Giardia spp. PCR positive cats.  Of the 843 
Giardia spp. PCR positive cat samples, 97 (11.8%) were positive for C. felis DNA.   
Risk Factors Distribution of Dogs and Cats 
 The distribution of dog and cat ages is shown in Table 2.3. The majority of dogs were at 
age between 3-7 years old (29.3%; 95% CI: 29, 30%) whereas the majority of cats were at age > 
7 years old (29.4%; 95% CI: 29, 30%). The sex categories used in this study are described in 
Table 2.4.  As shown in the Table, the majority of dogs were castrated males and spayed females 
(34%; 95% CI: 34, 35%), but the majority of cats were castrated males (42.1%; 95% CI: 41.3, 
42.8%). The analysis of region variable is shown in Table 2.5 for dogs and cats. The majority of 
dogs (38.2%; 95% CI: 37.6, 38.9%) and cats (31.0%; 95% CI: 30.3, 31.7%) were located in the 
west region.  
Four season categories for dogs and cats are shown in Table 2.6. For dogs, the majority 
of samples were submitted in autumn (26.4%; 95% CI: 25.9, 27.0%) as well as for cats (29.9%;
95% CI: 29.2, 30.6%).  
Giardia spp. PCR Test Results Distribution by the Risk Factors of Dogs 
The distribution of PCR test results (positive or negative) of Giardia spp. for dogs by 
age, sex, region and season are displayed in Table 2.7. For the age variable, the majority of test 
positive dogs were at age < 6 months (19.4%; 95% CI: 18.1, 20.8%). For the sex variable, the 
higher percentage positive were in intact female and male dogs (13.6%, 13.2%), respectively. 
The Midwest region had highest percentage positive compared to other region categories (9.9%; 
95% CI: 8.7, 11.1%). For the season, spring represented highest percent positive dogs for 
Giardia PCR test (8.6%; 95% CI: 7.8, 9.3%).  
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Cryptosporidium spp. PCR Test Results Distribution by the Risk Factors of Dogs 
The distribution of PCR test results of Cryptosporidium spp. for dogs by age, sex, region 
and season are shown in Table 2.8. For the age variable, the majority of test positive dogs were at 
age < 6 months (14.7%; 95% CI: 13.4, 15.9%). For the sex variable, the highest percentage 
positive was in intact female dogs (9.8%; 95% CI: 8.7, 11.0%). The west region had the highest 
percentage positive compared to other region categories (6.8%; 95% CI: 6.3, 7.3%). For the 
season, there was not much variability among the four categories.  
Giardia spp. PCR Test Results Distribution by the Risk Factors of Cats 
The distribution of PCR test results (positive or negative) of Giardia spp. for cats by age, 
sex, region and season are displayed in Table 2.9. For the age variable, the majority of test 
positive cats were at age between 6 months – one-year-old (8.8%; 95% CI: 7.4, 10.3%). For the 
sex variable, the highest percentage positive was in intact female cats (8.1%; 95% CI: 6.9, 9.4%). 
The Midwest region had highest percentage positive compared to other region categories (5.8%; 
95% CI: 4.8, 6.9%). For the season, autumn represented highest percent positive cats for Gi rdia 
PCR test (5.6%; 95% CI: 5.0, 6.3%). 
Cryptosporidium felis PCR Test Results Distribution by the Risk Factors of Cats 
The distribution of test results (positive or negative) of Cryptosporidium felis for cats by 
age, sex, region and season is shown in Table 2.10. For the age variable, the majority of test 
positive cats were at age between 6 months – one-year-old (10.7%; 95% CI: 9.2, 12.4%). For the 
sex variable, the highest percentage positive was in intact female cats (6.8%; 95% CI: 5.7, 8.0%). 
The west region had highest percentage positive compared to other region categories (6.4%; 95% 
CI: 5.7, 7.1%). For the season, autumn represented highest percent positive cats for C. felis PCR 
test (5.5%; 95% CI: 4.9, 6.2%). 
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Cryptosporidium spp. PCR Test Results Distribution by the Risk Factors of Cats 
The distribution of test results (positive or negative) of Cryptosporidium spp. for cats by 
age, sex, region and season is shown in Table 2.11.  For the age variable, the majority of test 
positive cats were at age between 6 months – one-year-old (15.1%; 95% CI: 13.3, 17.1%). For 
the sex variable, the highest percentage positive was in intact male cats (9.8%; 95% CI: 8.5, 
11.3%). The south region had highest percentage positive compared to other region categories 
(9.1%; 95% CI: 8.3, 10.0%). For the season, autumn represented highest percent positive cats for 
Cryptosporidium spp. PCR test (8.1%; 95% CI: 7.3, 8.9%).  
2.4.2 Univariate Logistic Regression Analysis  
2.4.2.1 Univariate Analysis for Dogs  
Giardia spp.  
The results of univariate logistic regression for individual risk factors for Giardia spp. are 
shown in Table 2.12. For age, all categories were compared to the reference category (>7 years 
old) with 21,622 total dogs with complete data for this factor. There was no difference in the 
odds of testing positive to Giardia spp. when comparing dogs aged 3 -7 years old to dogs older 
than 7 years old (p = 0.62). The odds of testing positive for Giardia spp. in dogs aged 1-2 years 
old were 3.0 times higher than the odds of testing positive for Giardia spp.in dogs older than 7 
years old, and this difference was statistically significant (p < 0.0001). The odds of testing 
positive for Giardia spp. in dogs aged 6 months to one-year-old were 6.6 times higher than the 
odds of testing positive for Giardia spp. in dogs older than 7 years old, and this difference was 
statistically significant (p < 0.0001). The odds of testing positive for Gia dia spp. in dogs aged 
less than six months old were 7.8 times higher than the odds of testing positive for Giardia spp. 
in dogs older than 7 years old, and this difference was also statistically significant (p < 0.0001). 
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The overall p-value for this variable was p <0.00001; therefore, age category met the p < 0.25 
entry criteria and it was subsequently included in the multivariate logistic regression analysis.  
Regarding sex, all categories were compared to the reference category castrated male 
with 22,629 total dogs with complete data regarding sex. The odds of testing positive to G ardia
spp. in intact females was 2.6 times higher than in castrated males (p < 0.0001). The odds of 
testing positive for Giardia spp. in intact male dogs were 2.5 times higher than the odds of 
testing positive for Giardia spp. in castrated male dogs (p < 0.0001).  The odds of testing 
positive for Giardia spp. decrease as female cats are spayed (OR= 0.83, p < 0.01). There was no 
difference in the odds of testing positive to Giardia spp. when comparing dogs with unknown 
sex to castrated male dogs (OR = 1.3, p 0.16). The overall p-value for sex was p < 0.00001; 
therefore, sex met the p < 0.25 entry criteria and it was subsequently included in the multivariate 
logistic regression analysis. 
The Northeast region was used as the reference category when comparing the risk of 
testing positive to Giardia spp. among regions. Complete data on region was available for 
22,948 dogs. The odds of testing positive to Giardia spp. in dogs from the Midwest were 1.3 
times higher than those located in the Northeast, and this difference was statistically significant 
(p < 0.0001).  However, there was no difference in the odds of testing positive to Giardia spp. in 
dogs from the Southern (OR = 0.90, p = 0.14) or Western (OR = 1.0, p = 0.85) regions in the 
USA compared to Northeast region. The overall p-value for region was p < 0.0001; therefore, 
region met the p < 0.25 entry criteria and it was subsequently included in the multivariate logistic 
regression analysis. 
Winter was used as the reference category in the season variable with complete 
information being available from 22,959 total dogs. There was no difference in the odds for dog 
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samples submitted in spring compared to samples submitted in winter (p = 0.65). However, the 
odds of testing positive for Giardia spp. in samples submitted in summer were 0.79 times less 
than the odds of testing positive for Giardia spp. in winter time, and this difference was 
statistically significant (p < 0.001). Also, the odds of testing positive for Gia dia spp. in samples 
submitted in autumn were 0.87 times the odds of testing positive for Giardia spp. in winter. This 
difference was statistically significant (p = 0.04). The overall p-value for season was p < 0.0003;
therefore, season met the p < 0.25 entry criteria and it was subsequently included in the 
multivariate logistic regression analysis. 
Cryptosporidium spp.  
The results of univariate logistic regression for individual risk factors for 
Cryptosporidium spp. are shown in Table 2.13. For age, all categories were compared to the 
reference category (> 7 years old) with 21,622 total dogs with complete data for this factor. The 
odds of testing positive for Cryptosporidium spp. in dogs aged 3-7 years old were 0.63 times less 
than the odds of testing positive for C yptosporidium spp. in dogs older than 7 years old, and this 
difference was statistically significant (p < 0.0001). There was no difference in the odds of 
testing positive to Cryptosporidium spp. when comparing dogs aged 1-2 years old to dogs older 
than 7 years old (p = 0.25). The odds of testing positive for C yptosporidium spp. in dogs aged 6 
months to one-year-old were 2.1 times higher than the odds of testing positive for 
Cryptosporidium spp. in dogs older than 7 years old, and this difference was statistically 
significant (p < 0.0001). The odds of testing positive for Cryptosporidium spp. in dogs aged less 
than six months old were 4.4 times higher than the odds of testing positive for Cryptosporidium 
spp. in dogs older than 7 years old, and this difference was also statistically significant (p < 
0.0001). The overall p-value for this variable was p < 0.00001; therefore, age category met the p 
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< 0.25 entry criteria and it was subsequently included in the multivariate logistic regression 
analysis.  
Regarding dogs’ sex, all categories were compared to the reference category castrated 
male with 22,630 total dogs with complete data regarding sex. The odds of testing positive to 
Cryptosporidium spp. in intact females was 2.5 times higher than in castrated males (p < 0.0001). 
The odds of testing positive for Cryptosporidium spp. in intact male dogs were 2.3 times higher 
than the odds of testing positive for C yptosporidium spp. in castrated male dogs (p < 0.0001).  
The odds of testing positive for Cryptosporidium spp. decrease as female cats are spayed (OR= 
0.82, p < 0.02). The odds of testing positive for Cryptosporidium spp. were 1.9 in dogs with 
unknown sex compared to the reference category. This difference was statistically significant (p 
< 0.001). The overall p-value for sex was p < 0.00001; therefore, sex met the p < 0.25 entry 
criteria and it was subsequently included in the multivariate logistic regression analysis. 
The Northeast region was used as the reference category when comparing the risk of 
testing positive to Cryptosporidium spp. among regions. Complete data on region was available 
for 22,948 dogs. The odds of testing positive to Cryptosporidium spp. in dogs from the Midwest 
were 1.8 times higher than those located in the Northeast, and this difference was statistically 
significant (p < 0.0001).  However, there was no difference in the odds of testing positive to 
Cryptosporidium spp. in dogs from the Southern (OR = 1.2, p = 0.12) region. The odds of testing 
positive to Cryptosporidium spp. in dogs from Western region were 1.8 times higher than those 
in the Northeast region and this difference was statistically significant (p < 0.0001).  The overall 
p-value for region was p < 0.00001; therefore, region met the p <0.25 entry criteria and it was 
subsequently included in the multivariate logistic regression analysis. 
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Winter was used as the reference category in the season variable with 22,959 total 
number of dogs for season variable. The univariate analysis for season revealed this variable 
insignificant at 0.05 level of significance. The overall p-value for season was p < 0.60; therefore, 
season did not meet the p < 0.25 entry criteria and it was excluded from the multivariate logistic 
regression analysis. 
2.4.2.2 Univariate Analysis for Cats  
Giardia spp. 
The results of univariate logistic regression for individual risk factors for Giardia spp. are 
shown in Table 2.14. For age, all categories were compared to the reference category (> 7 years 
old) with 15,003 total cats with complete data for this factor. The odds of testing positive for 
Giardia spp. in cats aged 3-7 years old were 2.3 times higher than the odds of testing positive for 
Giardia spp. in cats older than 7 years old, and this difference was statistically significant (p < 
0.0001). The odds of testing positive for Giardia spp. in cats aged 1-2 years old were 4.6 times 
higher than the odds of testing positive for Giardia spp. in cats older than 7 years old, and this 
difference was statistically significant (p < 0.0001). The odds of testing positive for Giardia spp. 
in cats aged 6 months to one-year-old were 5.4 times higher than the odds of testing positive for 
Giardia spp. in dogs older than 7 years old, and this difference was statistically significant (p < 
0.0001). The odds of testing positive for Giardia spp. in cats aged less than six months old were 
4.3 times higher than the odds of testing positive for Gia dia spp. in cats older than 7 years old, 
and this difference was also statistically significant (p < 0.0001). The overall p-value for this 
variable was (p < 0.00001); therefore, age category met the (p < 0.25) entry criteria and it was 
subsequently included in the multivariate logistic regression analysis.  
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Regarding cats’ sex, all categories were compared to the reference category castrated 
male with 15,946 total cats with complete data regarding sex. The odds of testing positive to 
Giardia spp. in intact females was 1.9 times higher than in castrated males (p < 0.0001). The 
odds of testing positive for Giardia spp. in intact male dogs were 1.7 times higher than the odds 
of testing positive for Giardia spp. in castrated male dogs (p < 0.0001).  There was no difference 
in the odds of testing positive toCryptosporidium spp. in spayed female cats (p = 0.34) and cats 
with unknown sex (p = 0.42) compared to castrated males. The overall p-value for sex was (p < 
0.00001); therefore, sex met the (p < 0.25) entry criteria and it was subsequently included in the 
multivariate logistic regression analysis. 
The Northeast region was used as the reference category when comparing the risk of 
testing positive to Giardia spp. among regions. Complete data on region was available for 16, 
269 cats. The univariate analysis for region showed that none of this variables categories was 
significant at (p = 0.05). The overall p-value for region was (p = 0.43); therefore, region did not 
meet the (p < 0.25) entry criteria and it was excluded from the multivariate logistic regression 
analysis. 
Winter was used as the reference category with 16,273 total number of cats for season 
variable. There was no difference in the odds for cat samples submitted in spring compared to 
samples submitted in winter (p = 0.07). In addition, there was no significant difference in the 
odds of testing positive to Giardia for cat samples submitted in summer (p = 0.12) and autumn 
(p = 0.88). The overall p-value for season was (p = 0.08); therefore, season met the (p < 0.25) 
entry criteria and it was subsequently included in the multivariate logistic regression analysis. 
Cryptosporidium felis 
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The results of univariate logistic regression for individual risk factors for 
Cryptosporidium felis are shown in Table 2.15. For age, all categories were compared to the 
reference category (> 7 years old) with 15,003 total cats with complete data for this factor. There 
was no difference in the odds of testing positive to C. felis when comparing cats aged 3-7 years 
old to cats older than 7 years old (p = 0.23). The odds of testing positive for C. felis in dogs aged 
1-2 years old were 3.2 times higher than the odds of testing positive for C. felis in cats older than 
7 years old, and this difference was statistically significant (p < 0.0001). The odds of testing 
positive for C. felis in cats aged 6 months to one-year-old were 6.6 times higher than the odds of 
testing positive for C. felis in cats older than 7 years old, and this difference was statistically 
significant (p < 0.0001). The odds of testing positive for C. felis in cats aged less than six months 
old were 5.6 times higher than the odds of testing positive for C. felis in cats older than 7 years 
old, and this difference was also statistically significant (p < 0.0001). The overall p-value for this 
variable was (p < 0.00001); therefore, age category met the (p < 0.25) entry criteria and it was 
subsequently included in the multivariate logistic regression analysis.  
Regarding cat’s sex, all categories were compared to the reference category castrated 
male with 15,946 total cats with complete data regarding sex. The odds of testing positive to C. 
felis in intact females was 1.4 times higher than in castrated males (p < 0.001). The odds of 
testing positive for C. felis in intact male cats were also 1.4 times higher than the odds of testing 
positive for C. felis in castrated male cats (p < 0.004).  The odds of testing positive for C. felis 
decrease as female cats are spayed (OR = 0.81, p < 0.02). There was no significant difference in 
the odds of testing positive to C. felis in cats with unknown sex compared to the reference 
category (p = 0.34). The overall p-value for sex was (p < 0.00001); therefore, sex met the (p < 
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0.25) entry criteria and it was subsequently included in the multivariate logistic regression 
analysis. 
The Northeast region was used as the reference category when comparing the risk of 
testing positive to C. felis among regions. Complete data on region was available for 16,269 cats. 
The odds of testing positive to C. felis in cats from the Midwest were 2.2 times higher than those 
located in the Northeast, and this difference was statistically significant (p < 0.0001). The odds 
of testing positive to C. felis in cats from Southern region were 2.4 times higher than those in the 
Northeast region and this difference was statistically significant (p < 0.0001).  The odds of 
testing positive to C. felis in cats from Western region were 2.6 times higher than those in the 
Northeast region and this difference was statistically significant (p < 0.0001).  The overall p-
value for region was (p < 0.00001); therefore, region met the (p < 0.25) entry criteria and it was 
subsequently included in the multivariate logistic regression analysis. 
Winter was used as the reference category in the season variable with 16,273 total 
number of cats. There was no significant difference in the odds of testing positive to C. f lis 
compared to the reference category (p = 0.69).  The odds of testing positive to C. felis from cat 
samples collected in summer were 0.71 times less than the reference category and this difference 
was statistically significant (p < 0.001). The overall p-value for season was p < 0.002; therefore, 
season met the (p < 0.25) entry criteria and it was subsequently included in the multivariate 
logistic regression analysis. 
Cryptosporidium spp.  
The results of univariate logistic regression for individual risk factors for 
Cryptosporidium spp. are shown in Table 2.16. For age, all categories were compared to the 
reference category (> 7 years old) with 15,003 total cats with complete data for this factor. There 
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was no difference in the odds of testing positive to Cryptosporidium spp. when comparing cats 
aged 3-7 years old to cats older than 7 years old (p = 0.33). The odds of testing positive for 
Cryptosporidium spp. in dogs aged 1-2 years old were 2.8 times higher than the odds of testing 
positive for Cryptosporidium spp. in cats older than 7 years old, and this difference was 
statistically significant (p < 0.0001). The odds of testing positive for Cryptosporidium spp. in 
cats aged 6 months to one-year-old were 5.7 times higher than the odds of testing positive for 
Cryptosporidium spp. in cats older than 7 years old, and this difference was statistically 
significant (p < 0.0001). The odds of testing positive for Cryptosporidium spp. in cats aged less 
than six months old were 4.9 times higher than the odds of testing positive for Cryptosporidium 
spp. in cats older than 7 years old, and this difference was also statistically significant (p < 
0.0001). The overall p-value for this variable was (p < 0.00001); therefore, age category met the 
(p < 0.25) entry criteria and it was subsequently included in the multivariate logistic regression 
analysis.  
Regarding cat’s sex, all categories were compared to the reference category castrated 
male with 15,946 total cats with complete data regarding sex. The odds of testing positive to 
Cryptosporidium spp. in intact females was 1.4 times higher than in castrated males (p < 0.0001). 
The odds of testing positive for Cryptosporidium spp. in intact male cats were 1.5 times higher 
than the odds of testing positive for C yptosporidium spp. in castrated male cats (p < 0.0001).  
There was no significant difference in the odds of testing positive to Cryptosporidium spp. in 
spayed female cats (p = 0.10) and cats with unknown sex (p = 0.80) compared to the reference 
category. The overall p-value for sex was (p < 0.00001); therefore, sex met the (p < 0.25) entry 
criteria and it was subsequently included in the multivariate logistic regression analysis. 
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The Northeast region was used as the reference category when comparing the risk of 
testing positive to Cryptosporidium spp. among regions. Complete data on region was available 
for 16,269 cats. The odds of testing positive to Cryptosporidium spp. in cats from the Midwest 
were 1.8 times higher than those located in the Northeast, and this difference was statistically 
significant (p < 0.0001). The odds of testing positive to Cryptosporidium spp. in cats from 
Southern region were 2.1 times higher than those in the Northeast region and this difference was 
statistically significant (p < 0.0001).  The odds of testing positive to Cryptosporidium spp. in cats 
from Western region were 2.0 times higher than those in the Northeast region and this difference 
was statistically significant (p < 0.0001).  The overall p-value for region was (p < 0.00001); 
therefore, region met the (p < 0.25) entry criteria and it was subsequently included in the 
multivariate logistic regression analysis. 
Winter was used as the reference category in the season variable with 16,273 total 
number of cats. There was no significant difference in the odds of testing positive to 
Cryptosporidium spp. in cat samples collected in spring (p = 0.62) and samples collected in 
autumn (p = 0.60) compared to the reference category.  The odds of testing positive to 
Cryptosporidium spp. from cat samples collected in summer were 0.81 times less than the 
reference category and this difference was statistically significant (p < 0.02). The overall p-value 
for season was (p < 0.02); therefore, season met the (p < 0.25) entry criteria and it was 
subsequently included in the multivariate logistic regression analysis. 
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2.4.3 Multivariate Logistic Regression Analysis  
2.4.3.1 Multivariate Analysis for Dogs  
Giardia spp. 
The results of multivariate logistic regression are shown in Table 2.17. After adjusting for 
the effect of other factors in the model, age, region and season were included in the final main 
effects model for dogs with Giardia spp..  
As shown in Table 2.17, there was no difference in the odds of testing positive to Giardia 
spp. when comparing 3-7 years old to > 7 years old dogs (OR=0.95, 95% CI: 0.77, 1.2, p = 0.63). 
The odds of testing positive for Giardia spp. in dogs aged 1-2 years old were 3.0 times higher 
than the odds of testing positive for Giardia spp. in dogs older than 7 years old. This difference 
was statistically significant (p < 0.0001) and the 95% CI (2.5, 3.6). The odds of testing positive 
for Giardia spp. in dogs aged 6 months – one-year-old were 6.6 times higher than the odds of 
testing positive for Giardia spp.in dogs older than 7 years old. This difference was statistically 
significant (p < 0.0001) and the 95% CI (5.4, 8.0). The odds of testing positive for Giardia spp.in 
dogs aged <6 months old were 7.8 times higher than the odds of testing positive for Giardia spp. 
in dogs older than 7 years old. This difference was statistically significant (p < 0.0001) and the 
95% CI (6.6, 9.2). 
For region, the odds of testing positive for Giardia spp. in dogs located in the Midwest 
region are 1.3 times higher than dogs located in the Northeast, and this difference was 
statistically significant (p < 0.001) and the 95% CI (1.1, 1.6). The odds of testing positive for 
Giardia spp. in dogs located in the South are 0.84 less than dogs located in the Northeast. This 
difference was statistically significant (p = 0.03) and the 95% CI (0.72, 0.98). However, there 
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was no difference between dogs located in the West than dogs located in the Northeast (OR=1.0, 
p = 0.52) and the 95% CI (0.73, 1.0). 
For the season variable, there was no significant difference in samples submitted in 
spring than those submitted in winter time (OR=1.0, 95% CI: 0.90, 1.2, p = 0.60). However, the 
odds of testing positive to Giardia spp. in samples submitted in the summer time were 0.80 less 
than those submitted in winter time, and this difference was statistically significant (p = 0.002) 
and the 95% CI (0.69, 0.92). Also, the odds of testing positive to Giardia spp. in samples 
submitted in autumn were 0.84 less than those submitted in winter time. This difference was 
statistically significant (p = 0.02) and the 95% CI (0.73, 1.0). The total number of dogs of this 
final model were 21,612.  
Cryptosporidium spp.  
Table 2.18 contained a summary of multivariable analysis for the predictor variables age, 
sex and region with testing positive to Cryptosporidium spp. in dogs as the binary outcome. 
After adjusting for the effect of other factors in the model, age, sex and region were the final 
predictors for dogs with Cryptosporidium spp.  
As shown in Table 2.18, the odds of testing positive to Cryptosporidium spp. in dogs 
significantly decrease as age increase by one year (OR=0.62, 95% CI: 0.50, 0.77, p < 0.0001). 
There was no significant difference of testing positive to Cryptosporidium spp. between dogs 
that are 1-2 years old and those that are more than 7 years old (OR=1.1, 95% CI: 0.90, 1.3, p = 
0.37). However, the odds of testing positive to Cryptosporidium spp. in dogs aged 6 months – 1 
year were 2.0 times higher than those that are more than 7 years old. This difference is 
statistically significant (p < 0.0001) and the 95% CI (1.6, 2.6). In addition, the odds of testing 
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positive to Cryptosporidium spp. in dogs aged < 6 months were 4.0 times higher than those that 
are more than 7 years old and the 95% CI (3.2, 4.8). 
Regarding the sex, there was no significant difference in the probability of testing 
positive to Cryptosporidium spp. in intact females compared to castrated males (OR = 1.2, 95% 
CI: 0.94, 1.4, p = 0.20). Likewise, there was no significant difference in the probability of testing 
positive to Cryptosporidium spp. in intact males compared to castrated males (OR = 1.2, 95% 
CI: 0.95, 1.4, p = 0.10). However, odds of testing positive to Cryptosporidium spp. in spayed 
females decrease by 0.84 compared to castrated males. This difference was statistically 
significant (p = 0.05) and the 95% CI (0.71, 1.0). There was no significant difference in the 
probability of testing positive to Cryptosporidium spp. in unknown sex dogs compared to 
castrated males (OR = 1.4, 95% CI: 0.81, 2.4, p = 0.23).  
For the region variable, the odds of testing positive to Cryptosporidium spp. in dogs 
located in the Midwest were 1.7 times higher than those located in the Northeast. This difference 
was statistically significant (p < 0.0001) and the 95% CI (1.4, 2.1). In contrast, there was no 
difference in the odds of testing positive to Cryptosporidium spp. in dogs located in the South 
and those located in the Northeast (OR=1.1, 95% CI: 0.90, 1.3, p = 0.35). However, the odds of 
testing positive to Cryptosporidium spp. in dogs located in the West were 2.0 times higher than 
those located in the Northeastern region, as shown in Table 2.18 and the 95% CI (1.7, 2.3). The 
total number of dogs of this final model were 21,448. 
2.4.3.2 Multivariate Analysis for Cats 
Giardia spp. 
Regarding multivariate logistic regression models in cats, Table 2.19 represented   a 
summary of multivariable analysis for the predictor variables age and sex with testing positive to 
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Giardia spp. as the binary outcome. After adjusting for the effect of other factors in the model, 
age, and sex were identified as significant predictors for Gia dia spp. in cats. 
As shown in Table 2.19, the odds of testing Giardia spp. in cats aged 3-7 years old were 
2.4 times higher than those aged more than 7 years. This difference was statistically significant p 
< 0.0001 and the 95% CI (1.8, 3.2). Also, the odds of testing Giardia spp. in cats aged 1-2 years 
old were 4.5 times higher than those aged more than 7 years. This difference was statistically 
significant p < 0.0001 and the 95% CI (3.4, 5.9). Furthermore, the odds of testing Giardia spp. in 
cats aged 6 months to one-year-old were 5.2 times higher than those aged more than 7 years. 
This difference was statistically significant p < 0.0001 and the 95% CI (4.0, 6.9). Finally, the 
odds of testing Giardia spp. in cats aged less than 6 months were 3.7 times higher than those 
aged more than 7 years. This difference was statistically significant p < 0.0001 and the 95% CI 
(2.8, 4.9).  
The odds of testing positive to Giardia spp. in intact female cats were 1.3 times higher 
than in castrated male cats. The difference was statistically significant (p < 0.0001) and the 95% 
CI (1.1, 1.7). However, the odds of testing positive to Giardia spp. in intact male cats were not 
statistically significant than in castrated male cats (OR = 1.2, p = 0.07) and the 95% CI (0.98, 
1.6). Likewise, the odds of testing positive to Giardia spp. in spayed female cats were not 
statistically significant than in castrated male cats (OR = 0.91, 95% CI: 0.76, 1.1, p = 0.33). 
Also, the odds of testing positive to Giardia spp. in unknown sex cats were not statistically 
significant than in castrated male cats (OR = 0.92, 95% CI: 0.40, 2.1, p = 0.85). The total number 
of cats in this final model were 14,891. 
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Cryptosporidium felis  
Table 2.20 display a summary of multivariable analysis for the predictor variables age, 
region, and season with testing positive to Cryptosporidium felis as the binary outcome. After 
adjusting for the effect of other factors in the model, age, region, and season were identified as 
significant predictors for C. felis in cats. 
As shown in Table 2.20, there was no significant difference for testing positive to C. felis 
in cats that are 3-7 years old compared to cats that are more than 7 years old (OR = 1.2, 95% CI: 
0.88, 1.7, p = 0.21). However, the difference was statistically significant (p < 0.0001) in cats 
aged 1-2 years old compared to the reference category. The odds of testing positive to C. felis in 
cats aged from 1-2 years are 3.3 times higher than in cats that are older than 7 years and the 95% 
CI (2.5, 4.3). The odds of testing positive to C. felis in cats aged from 6 months to one-year-old 
are 6.4 times higher than in cats that are older than 7 years. The difference was statistically 
significant (p < 0.0001) and the 95% CI (4.9, 8.5). Additionally, the odds of testing positive to C. 
felis in cats aged less than 6 months are 5.6 times higher than in cats that are older than 7 years. 
The difference was statistically significant (p < 0.0001) and the 95% CI (4.5, 7.2). 
Regarding region variable, the odds of testing positive to C. felis in cats located in the 
Midwest are 2.1 times higher than in cats that were located in the Northeast. The difference was 
statistically significant (p < 0.0001) and the 95% CI (1.6, 2.8). Also, the odds of testing positive 
to C. felis in cats located in the South were 2.2 times higher than in cats that are located in the 
Northeast. The difference was statistically significant (p < 0.0001) and the 95% CI (1.7, 2.8). 
Furthermore, the odds of testing positive to C. felis in cats located in the West were 2.5 times 
higher than in cats that are located in the Northeast. The difference was statistically significant (p 
< 0.0001) and the 95% CI (2.0, 3.2). 
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Regarding season, there was no significant difference in the odds of testing positive to C. 
felis in cats between samples submitted in spring to samples submitted in winter time (OR=1.0, p 
= 0.77) and the 95% CI (0.83, 1.3). Whereas the odds of testing positive to C. felis in samples 
submitted in summer time were 0.7 times less than in samples submitted in winter time. The 
difference was statistically significant (p = 0.002) and the 95% CI (0.60, 0.88). Lastly, there was 
no significant difference in the odds of testing positive to C. felis in cats between samples 
submitted in autumn to samples submitted in winter time (OR = 1.0, p = 0.94) and the 95% CI
(0.82, 1.2). The total number of cats for this final model were 14,999.  
Cryptosporidium spp. 
Table 2.21 represented a summary of multivariable analysis for the predictor variables 
age and region with testing positive to Cryptosporidium spp. as the binary outcome. After 
adjusting for the effect of other factors in the model, age, and region were identified as 
significant predictors for Cryptosporidium spp. in cats. 
As shown in Table 2.21, there was no significant difference for testing positive to 
Cryptosporidium spp. in cats that are 3-7 years old compared to cats that are more than 7 years 
old (OR = 1.1, p = 0.30) and the 95% CI (0.88, 1.5). However, the difference was statistically 
significant (p < 0.0001) in cats aged 1-2 years old compared to the reference category. The odds 
of testing positive to Cryptosporidium spp. in cats aged from 1-2 years are 2.8 times higher than 
in cats that are older than 7 years and the 95% CI (2.3, 3.6). Also, the odds of testing positive to 
Cryptosporidium spp. in cats aged from 6 months to one-year-old are 5.7 times higher than in 
cats that are older than 7 years. The difference was statistically significant (p < 0.0001) and the 
95% CI (4.6, 7.2). Additionally, the odds of testing positive to Cryptosporidium spp. in cats aged 
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less than 6 months are 4.9 times higher than in cats that were older than 7 years. The difference 
was statistically significant (p < 0.0001) and the 95% CI (4.0, 5.9). 
Regarding region variable, the odds of testing positive to Cryptosporidium spp. in cats 
located in the Midwest are 1.8 times higher than in cats that are located in the Northeast. The 
difference was statistically significant (p < 0.0001).  Also, the odds of testing positive to 
Cryptosporidium spp. in cats located in the South are 2.0 times higher than in cats that are 
located in the Northeast. The difference was statistically significant (p < 0.0001) and the 95% CI
(1.7, 2.4). Furthermore, the odds of testing positive to Cryptosporidium spp. in cats located in the 
West are 2.1 times higher than in cats that are located in the Northeast. The difference was 
statistically significant (p < 0.0001) and the 95% CI (1.7, 2.5).  The total number of cats for this 
final model were also 14,999 cats. 
2.4.4 Model Evaluation 
Hosmer – Lemeshow (HL) goodness – of – fit test for Giardia spp. model in dogs 
indicated no significant lack of fit (p = 0.07). For C yptosporidium spp. model in dogs, the HL 
goodness – of – fit test indicated no significant lack of fit (p = 0.37). The HL goodness – of – fit 
test for Giardia spp. model in cats indicated no significant lack of fit (p = 0.16). For C. felis 
model in cats, the HL goodness – of – fit test indicated no significant lack of fit (p = 0.12) and 
for Cryptosporidium spp. model indicated no significant lack of fit (p = 0.36). The evaluation of 
outliers and/or influential observations showed no effect of these observations on the model fit 
(Figures 2.3-2.4). 
2.5 Discussion 
 Intestinal parasites such as Giardia spp. and Cryptosporidium spp. are common in pet 
dogs and cats in the United States. According to the USA source book in 2012, there are about 
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70 million pet dogs in the United States.34 Several studies have identified the prevalence of 
different intestinal parasites in pets in the USA using diagnostics such as microscopy, ELISA, 
IFA or PCR.20-23,25,26,27,29,30,35 In these studies, sample sizes ranged from 129-16,114 dogs or cats 
or both. Our study is considered novel in that a large data set was evaluated (22,959 pet dogs and 
16,273 pet cats), information was available from all states in the USA, and a standardized and 
sensitive test modality was used (PCR assays). In addition, our study evaluated the prevalence of 
Giardia spp. and Cryptosporidium spp. in pet dogs and cats using the real-time PCR assay and 
evaluated risk factors such as age, sex, region and season. Most veterinarians order PCR tests 
only for dogs and cats with clinical signs (i.e. diarrhea) and not for those without clinical signs. 
Therefore, we suspect the samples collected from dogs and cats in this study were from those 
with diarrhea.  
 The results of this study showed that the prevalence of positive tests for Giardia spp. in 
dog samples was 7.7%. This result falls into the range of prevalence estimates (0.4% – 16.0 ) in 
pet dogs in the USA with clinical signs of diarrhea diagnosed by centrifugal fecal flotation, 
ELISA and IFA.19-25 Regarding Cryptosporidium spp. prevalence in pet dogs, the proportion was 
5.4%, and also this result falls within the range of estimates of 2.3% and 5.6% for pet dogs with 
diarrhea diagnosed by microscopy and ELISA.20,25  
Regarding cat percentage of positive estimates, the prevalence of Giardia spp. in 
diarrheic cats was 5.2% as shown in Table 2.2. This estimate was less than prevalence estimates 
(8.0% - 14.0%) of cat giardiasis determined by previous studies.22,26-29 This disagreement in the 
estimates could merely be due to increased false negative rates measured by the PCR assays of 
our study.  Fecal PCR inhibitors are known to lead to false negative results in Giardia PCR 
assays.36 Regarding the prevalence of Cryptosporidium spp. DNA in feline feces, the average of 
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proportion of positives due to C. felis and Cryptosporidium spp. was approximately 6.3% (Table 
2.2). This estimate is within the range of prevalence estimates (3.9% -25.0%) in pet cats with 
diarrhea.29,30,31 
 Co-infections in dogs and cats can occur. Our study showed that nearly 30% of dogs with 
Cryptosporidium spp. were also positive to Giardia spp.  Also, a smaller proportion of cats 
positive to Cryptosporidium were positive to Giardia spp.. One study37 found that dual or triple 
infections are significantly associated with the clinical signs, specifically, diarrhea. In that study, 
the prevalence for Giardia spp. and Cryptosporidium spp.  with bacterial agents was 6.2% and 
triple infection with viral and bacterial agents was approximately 21.9%.37 Also, some studies 
reported that dogs that are naturally infected with Cryptosporidium spp. are likely to be infected 
with Giardia spp.10,38 In a study, cats infected with Giardia spp. were more likely to shed 
Cryptosporidium spp. oocysts.28 Triple or quadruple infections with pathogens other than 
Giardia spp. and Cryptosporidium spp. were not investigated in this study.  Coinfections with 
Giardia spp. and Cryptosporidium spp. are not surprising as both have similar risk factors, are 
immediately infectious when passed in feces, and are both transmitted primarily by fecal-oral 
contact. 
 The distribution of PCR test results with the risk factor, age, showed also that the 
majority of animals tested positive to Giardia spp. and Cryptosporidium spp. in dogs and cats 
were in puppies and kittens less than 6 months old. This indicates that the likelihood of disease 
or infection due to both protozoans is more prevalent in young animals which is with accordance 
with previous study.19 One study conducted nationally found the prevalence of Giardia spp. 
using microscopy examination in dogs that were less than 6 months old was 13.1% compared to 
<1.0% in dogs that were greater than 3 years old.23 In another study, Giardia antigen was 
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detected in 6.1% pet cats that were less than 1 year of age.29  The increased risk of infection due 
to both pathogens in younger animals can be attributed to their immature immune systems.39  
 The descriptive analysis of this showed that the majority were from dogs (69.5%) and 
(73.5%) from cats that were spayed or neutered (Table 2.4).  This is attributed to legislations of 
some states that require pets to be spayed or neutered. However, this procedure is not mandatory, 
but the American Society for the Prevention of Cruelty to Animals (ASPCA) supports 
spay/neuter programs at low to no cost in some states.40 In our study, the risk of testing positive 
to Giardia spp. in dogs was higher in intact males and females (13.4%) compared to castrated 
males and spayed females (5.3%) (Table 2.7). Similarly, the risk of testing positive to 
Cryptosporidium spp. was higher in intact male and female dogs (9.3%) compared to castrated 
males and spayed females (3.8%) (Table 2.8). This result is consistent with different studies 
conducted elsewhere and the reason why the percentage positive is higher in intact males and 
females compared to neutered or spayed is merely related to differences in the exposure to both 
parasites of these two animal groups.41,42 However, one study indicated no significant difference 
of testing positive to Giardia spp. in dogs between intact males or females vs spayed/neutered 
males or females (OR= 1.31 vs 1.0), respectively.19    
 Regarding region, statistics showed that the majority (38.2%) of the dogs were located in 
the Western region (Table 2.5). However, the risk of contracting G ardia spp. was higher in the 
Midwest (9.9%) (Table 2.7). Per the National Oceanic and Atmospheric Administration 
(NOAA), the Midwest region characterized by a wide range of t mperature and precipitation 
extremes due to cold air masses from the far north, and warm, humid air masses from the Gulf of 
Mexico.43 Since Giardia cysts are affected by humidity, temperature, and 
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freeze–thaw cycle, climatic conditions of the Midwest region are favorable to those cysts which 
might remain infective for longer periods of time.44,45 A study found that the prevalence of 
Giardia spp. by state was highest in Maine (4.0%) and Colorado (2.6%) and lowest (0.10%) in 
11 different states (WA, ID, ND, IA, OK, AR, LA, MS, AL, GA, and FL). Also, the highest 
regional prevalence of Giardia in pet dogs was reported in the Mountain region (1.4%) followed 
by the New England region (0.80%).19 The actual regional differences in Giardia transmission 
cycles or giardiasis reporting capacity across states might be related to the geographic 
differences in the prevalence estimates of the disease.46 The risk of contracting Cryptosporidium 
spp. in dogs was not different among all four regions, but it was the lowest in the Northeastern 
region (3.8%) (Table 2.8). For cats, most samples also were obtained from the Western region 
(31.0%). Cross-tabulation with the outcome, the risk of contracting Cryptosporidium spp. was 
highest in cats located in the South (9.1%) (Table 2.11) and there was no difference in the risk of 
contracting both Giardia spp. and C. felis (Tables 2.9, and 2.10).    
 The descriptive analysis of the variable, season, showed the highest percentages of 
positives noticed in spring (8.6%) and autumn (7.3%)  (Table 2.7).  This finding is consistent 
with seasonal patterns observed in a different study where the increased rates of the disease can 
be related to the increased outdoor activities (i.e. camping, hiking, swimming, etc.).46  In 
contrast, a study evaluated the prevalence by season or dogs tested positive to G ardia spp. and 
found slight seasonal increases during the winter and summer.19 For dogs with cryptosporidiosis, 
there was no difference in the percentage of positives due to seasonal distributions (Table 2.8).  
For cats with Giardia spp., there was no difference in the percentage of positives due to seasonal 
distributions (Table 2.9). The percentage of positives in cats infected with C. felis was lowest in 
the summer time (3.9%) compared to other seasons (5.4%) (Table 2.10). For cats with 
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Cryptosporidium spp., the percentage of positives was highest in autumn (8.1%) (Table 2.11).  
This finding of variations in percentages positives from season to the other may be coincides 
with the effect of climate on the parasite or host physiology.47,48 
2.6 Conclusion 
 Giardia spp. and Cryptosporidium spp. are common protozoan pathogens that can be 
associated with diarrhea in pet dogs and cats.  Age was identified as significant predictor that is 
associated with the probability of testing positive to Giardia spp. and Cryptosporidium spp. in 
both dogs and cats.  The probability of testing positive to either pathogens was likely in the very 
young animals which calls for more attention should be paid in this population. Additionally, 
region and season were identified as significant predictors of both pathogens in pet dogs and cats 
by the logistic regression models.  One strength of this study was the use of a highly sensitive 
and standardized PCR assay to estimate prevalence rates of the infections.  However, since the 
clinical histories are not known, we cannot use the results to determine associations with 
diarrhea.  Additionally, this study successfully identified risk factors associated with infection in 
a large sample size. This study provided a base of future studies to be conducted for pet dogs and 
cats using PCR test results. Future research may involve an evaluation for associations of 
positive test results with clinical findings in pets. In addition, research should be performed to 









Table 2.1 Percentage of positive PCR test results of Giardia spp., Cryptosporidium spp. in dogs 
Pathogen Total Positives Percentage  95% CI 
Giardia spp. 22,959 1,762 7.7 (7.3, 8.0) 
Cryptosporidium spp. 22,959 1,237 5.4 (5.1, 5.7) 
 
Table 2.2 Percentage of positive PCR test results of Giardia spp., Cryptosporidium spp. in cats 
Pathogen Total Positives Percentage 95% CI 
Giardia spp. 16,273 843 5.2 (4.9, 5.5) 
Cryptosporidium felis  16,273 824 5.1 (4.7, 5.4) 
Cryptosporidium spp. 16,273 1,211 7.4 (7.0, 7.9) 
Table 2.3 Dogs and cats age distribution from submitted fecal samples 







>7 yrs. 6,112 28.1   (28.0, 29.0) 
3-7 yrs. 6,358 29.3 (29.0, 30.0) 
1-2 yrs. 4,254 19.6 (19.0, 20.0) 
6 mo. -1 yr. 1,728 8.0 (7.0, 8.0) 
<6 mo. 3,245 15.0 (14.0, 15.0) 




>7 yrs. 4,428 29.4 (29.0, 30.0) 
3-7 yrs. 3,173 21.1 (20.0, 22.0) 
1-2 yrs. 2,425 16.1 (16.0, 17.0) 
6 mo. -1 yr.  1,483 9.9 (9.0, 10.0) 
<6 mo. 3,538 23.5 (23.0, 24.0) 
Total 15,047 100  
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Table 2.4 Distribution of fecal samples by sex among dogs and cats 
 







Castrated Male (CM) 7,927 34.9 (34.3, 35.0) 
Intact Female (F) 2,651 11.7 (11.3, 12.0) 
Intact Male (M) 3,818 16.8 (16.3, 17.3) 
Spayed Female (SF) 7,866 34.6 (34.0, 35.3) 
Unknown Sex (U) 447 2.0 (1.8, 2.2) 




Castrated Male (CM) 6,731 42.1 (41.3, 42.8) 
Intact Female (F) 1,941 12.1 (11.6, 12.6) 
Intact Male (M) 1,905 11.9 (11.4, 12.4) 
Spayed Female (SF) 5,023 31.4 (30.8, 32.1) 
Unknown Sex (U) 398 2.5 (2.3, 2.7) 











Table 2.5 Distribution of fecal samples by region among dogs and cats 







Northeast 6,410 27.8 (27.3,  28.4) 
Midwest 2,612 11.3 (10.9, 11.8) 
South 5,201 22.6 (22.0, 23.1) 
West 8,807 38.2 (37.6, 38.9) 




Northeast 4,693 28.8 (28.0, 29.5) 
Midwest 2,004 12.3 (11.8, 12.8) 
South 4,571 28.0 (27.3, 28.7) 
West 5,053 31.0 (30.3, 31.7) 



















Table 2.6 Descriptive statistics of season  
 







Winter (12,1,2) 5,419 23.5 (23.0, 24.1) 
Spring (3,4,5) 5,560 24.1 (23.6, 24.7) 
Summer (6,7,8) 5,972 25.9 (25.4, 26.5) 
Autumn (9,10,11) 6,090 26.4 (25.9, 27.0) 




Winter (12,1,2) 4,244 26.0 (25.3, 26.7) 
Spring (3,4,5) 3,288 20.1 (19.5, 20.8) 
Summer (6,7,8) 3,909 23.9 (23.3, 24.6) 
Autumn (9,10,11) 4,884 29.9 (29.2, 30.6) 



















Table 2.7 Distribution of PCR test results for Giardia spp. by age, sex, region and season for 
dogs 
 
Variable Level Negative Positive Total 95% CI 
Age  >7 yrs. 5,909 (97.0%) 183 (3.0%) 6,092 (2.6, 3.5) 
3-7 yrs. 6,156 (97.1%) 181 (2.9%) 6,338 (2.5, 3.3) 
1-2 yrs. 3,881 (91.5%) 359 (8.5%) 4,240 (7.6, 9.3) 
6 mo. – 1 yr.  1,430 (83.1%) 291 (16.9%) 1,721 (15.2, 18.8) 
< 6 mo. 2,604 (80.6%) 628 (19.4%) 3,232  (18.1, 20.8) 
Total 
  
19,980 (92.4%) 1,642 (7.6%) 21,622 
 
  
Sex CM 7,445 (94.2%) 456 (5.8%) 7,901 (5.3, 6.3) 
F 2,283 (86.4%) 358 (13.6%) 2,641 (12.3, 14.9) 
M 3,302 (86.8%) 502 (13.2%) 3,804 (12.1, 14.3) 
SF 7,457 (95.2) 379 (4.8%) 7,837 (4.4, 5.3) 
U 414 (92.6%) 33 (7.4%) 447 (5.1, 10.2) 
Total 20,901 (92.4%) 1,728 (7.6%) 22,629 
  
 
Region  Northeast 5,891 (92.4%) 485 (7.6%) 6,377 (7.0, 8.3) 
Midwest 2,349 (90.1%) 257 (9.9%) 2,606  (8.7, 11.1) 
South 4,814 (93.1%) 356 (6.9%) 5,170  (6.2, 7.6) 
West  8,134 (92.5%) 662 (7.5%) 8,796  (7.0, 8.1) 
Total 21,188 (92.3%) 1,760 (7.7%) 22,948 
  
 
Season  Winter 4,961 (91.7%) 449 (8.3%) 5,410 (7.6, 9.1) 
Spring  5,064 (91.4%) 474 (8.6%) 5,538 (7.8, 9.3) 
Summer 5,549 (93.3%) 397 (6.7%) 5,946  (6.1, 7.3) 
Autumn  5,623 (92.7%) 442 (7.3%) 6,066  (6.6, 8.0) 




Table 2.8 Distribution of PCR test results for Cryptosporidium spp. by age, sex, region and 
season for dogs 
 
Variab le Level Negative Positive Total 95% CI 
Age >7 yrs. 5,868 (96.3%) 227 (3.7%) 6,091 (3.3, 4.2) 
3-7 yrs. 6,188 (97.6%) 152 (2.4%) 6,339 (2.03, 2.8) 
1-2 yrs. 4,064 (95.8%) 177 (4.2%) 4,240 (3.6, 4.8) 
6 mo. – 1 yr. 1,591 (92.4%) 131 (7.6%) 1,721 (6.4, 9.0) 
<6 mo. 2,759 (85.3%) 474 (14.7%) 3,231 (13.4, 15.9) 
Total 20,461(94.6%) 1,161 (5.4%) 21,622 
 
 
Sex CM 7,581 (95.9%) 323 (4.1%) 7,904 (3.7, 4.5) 
F 2,382 (90.2%) 258 (9.8%) 2,640 (8.7, 11.0) 
M 3,470 (91.3%) 333 (8.8%) 3,803 (7.9, 9.7) 
SF 7,571 (96.6%) 265 (3.4%) 7,836 (3.0, 3.8) 
U 414 (92.6%) 33 (7.4%) 447 (5.1, 10.2) 
Total 21,418 (94.7%) 1,212 (5.4%) 22,630 
 
 
Region Northeast 6,134 (96.2%) 242 (3.8%) 6,376 (3.3, 4.3) 
Midwest 2,433 (93.5%) 170 (6.5%) 2,603 (5.6, 7.5) 
South 4,949 (95.6%) 226 (4.4%) 5,175 (3.8, 5.0) 
West 8,197 (93.2%) 597 (6.8%) 8,794 (6.3, 7.3) 
Total 21,713 (94.6%) 1,235 (5.4%) 22,948 
 
 
Season Winter 5,115 (94.5%) 296 (5.5%) 5,411 (4.9, 6.1) 
Spring 5,235 (94.6%) 298 (5.4%) 5,533 (4.8, 6.0) 
Summer 5,647 (94.9%) 302 (5.1%) 5,949 (4.5, 5.7) 
Autumn 5,725 (94.4%) 341 (5.6%) 6,066 (5.1, 6.2) 








Table 2.9 Distribution of PCR test results for Giardia spp. by age, sex, region and season for cats  
 
Variable Level Negative Positive Total 95% CI 
Age >7 yrs.  4,335 (98.2%) 78 (1.8%) 4,413 (1.4, 2.2) 
3-7 yrs. 3,037 (96.0%) 128 (4.1%) 3,165 (3.4, 4.8) 
1-2 yrs. 2,234 (92.4%) 184 (7.6%) 2,418 (6.6, 8.7) 











Sex CM 6,412 (95.5%) 299 (4.5%) 6,711 (4.0, 5.0) 
F 1,777 (91.9%) 157 (8.1%) 1,934 (6.9, 9.4) 
M 1,764 (92.9%) 136 (7.2%) 1,900 (6.0, 8.4) 
SF 4,802 (95.9%) 205 (4.1%) 5,007 (3.6, 4.7) 
U 373 (94.7%) 21 (5.3%) 394 (3.3, 8.0) 
Total 15,129 (94.9%) 818 (5.1%) 15,946 
 
 
Region Northeast 4,441 (95.1%) 227 (4.9%) 4,668  (4.3, 5.5) 
Midwest 1,884 (94.2%) 116 (5.8%) 2,000  (4.8, 6.9) 
South 4,324 (94.9%) 232 (5.1%) 4,556  (4.5, 5.8) 
West 4,777 (94.7%) 268 (5.3%) 5,045 (4.7, 6.0) 
Total 15,426 (94.8%) 843 (5.2%) 16,269 
  
 
Season  Winter 3,996 (94.5%) 234 (5.5%) 4,230 (4.9, 6.3) 
Spring  3,124 (95.4%) 150 (4.6%) 3,274  (3.9, 5.4) 
Summer  3,713 (95.2%) 186 (4.8%) 3,899  (4.1, 5.5) 
Autumn 4,597 (94.4%) 273 (5.6%) 4,870  (5.0, 6.3) 







Table 2.10 Distribution of PCR test results for Cryptosporidium felis by age, sex, region and 
season for cats 
 
Variable Level Negative Positive Total 95% CI  
Age >7 yrs. 4,336 (98.2%) 79 (1.8%) 4,415 (1.4, 2.2) 
3-7 yrs. 3,094 (97.8%) 69 (2.2%) 3,163 (1.7, 2.8) 
1-2 yrs. 2,282 (94.5%) 134 (5.5%) 2,416 (4.7, 6.5) 
6 mo. – 1 yr. 1,322 (89.3%) 159 (10.7%) 1,481 (9.2, 12.4) 
< 6 mo. 3,202 (90.8%) 326 (9.2%) 3,528 (8.3, 10.2) 
Total 14,236 (94.9%) 767 (5.1%) 15,003 
 
 
Sex CM 6,384 (95.1%) 327 (4.9%) 6,715 (4.4, 5.4) 
F 1,802 (93.2%) 131 (6.8%) 1,934 (5.7, 8.0) 
M 1,777 (93.5%) 124 (6.5%) 1,901 (5.5, 7.7) 
SF 4,807 (96.01%) 200 (4.0%) 5,008 (3.5, 4.6) 
U 379 (96.2%) 15 (3.8%) 394 (2.1, 6.2) 
Total 15,149 (95.0%) 797 (5.0%) 15,946 
 
 
Region Northeast 4,547 (97.4%) 120 (2.6%) 4,667 (2.1, 3.1) 
Midwest 1,892 (94.6%) 108 (5.4%) 2,000 (4.5, 6.5) 
South 4,283 (94.0%) 273 (6.0%) 4,556 (5.3, 6.7) 
West 4,723 (93.6%) 323 (6.4%) 5,046 (5.7, 7.1) 
Total 15,445 (94.9%) 824 (5.1%) 16,269 
 
 
Season  Winter 3,999 (94.6%) 230 (5.4%) 4,229 (4.8, 6.2) 
Spring 3,099 (94.8%) 171 (5.2%) 3,270 (4.5, 6.0) 
Summer 3,749 (96.1%) 153 (3.9%) 3,902 (3.3, 4.6) 
Autumn 4,602 (94.5%) 270 (5.5%) 4,872 (4.9, 6.2) 








Table 2.11 Distribution of PCR test results for Cryptosporidium spp. by age, sex, region and 
season for cats 
 
Variable Level Negative Positive Total 95% CI 
Age >7 yrs. 4,282 (97.0%) 133 (3.0%) 4,415 (2.5, 3.6) 
3-7 yrs. 3,055 (96.6%) 108 (3.4%) 3,163 (2.8, 4.1) 
1-2 yrs. 2,222 (92.0%) 194 (8.0%) 2,416 (7.0, 9.2) 
6 mo. – 1 yr. 1,257 (84.9%) 224 (15.1%) 1,481 (13.3, 17.1) 
< 6 mo. 3,063 (86.8%) 465 (13.2%) 3,528 (12.1, 14.3) 
Total 13,879 (92.5%) 1,124 (7.5%) 15,003  
Sex CM 6,244 (93.1%) 467 (7.0%) 6,711 (6.4, 7.6) 
F 1,750 (90.5%) 183 (9.5%) 1,933 (8.2, 10.9) 
M 1,714 (90.2%) 187 (9.8%) 1,901 (8.5, 11.3) 
SF 4,697 (93.8%) 310 (6.2%) 5,007 (5.5, 6.9) 
U 365 (92.6%) 29 (7.4%) 394 (5.0, 10.4) 
Total 14,770 (92.6%) 1,176 (7.4%) 15,946 
 
 
Region Northeast 4,458 (95.5%) 209 (4.5%) 4,667 (3.9, 5.1) 
Midwest 1,848 (92.4%) 152 (7.6%) 2,000 (6.5, 8.8) 
South 4,142 (90.9%) 414 (9.1%) 4,556 (8.3, 10.0) 
West 4,610 (91.4%) 436 (8.6%) 5,046  (7.9, 9.4) 
Total 15,058 (92.6%) 1,211 (7.4%) 16,269 
  
 
Season  Winter  3,902 (92.3%) 327 (7.7%) 4,229  (6.9, 8.6) 
Spring  3,027 (92.6%) 243 (7.4%) 3,270 (6.5, 8.4) 
Summer 3,654 (93.6%) 248 (6.4%) 3,902  (5.6, 7.2) 
Autumn  4,479 (91.9%) 393 (8.1%) 4,872  (7.3, 8.9) 







Table 2.12 Univariate logistic regression analysis to evaluate associations between individual 
risk factors and the probability of testing positive to Giardia spp. for dogs 
Variable Level OR       95% CI P Value Overall P Value 
Age  >7 yrs.   
3-7 yrs.   
1-2 yrs.   
6 mo. – 1 yr.   
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Region  Northeast   
Midwest   

















  0.14 




Season Winter   
Spring   
Summer   
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  0.001 













Table 2.13 Univariate logistic regression analysis to evaluate associations between individual 
risk factors and the probability of testing positive to Cryptosporidium spp. for dogs 
Variable Level OR       95% CI P Value Overall P Value 
Age  >7 yrs. 
3-7 yrs.  
1-2 yrs.  
6 mo. – 1 yr. 
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Table 2.14 Univariate logistic regression analysis to evaluate associations between individual 





















Variable Level OR   95% CI P Value Overall P Value 
Age  >7 yrs.   
3-7 yrs.   
1-2 yrs.   
6 mo. – 1 yr.  
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Region  Northeast   
Midwest   
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0.43 
Season Winter   
Spring   
Summer   





















Table 2.15 Univariate logistic regression analysis to evaluate associations between individual 
risk factors and the probability of testing positive to Cryptosporidium felis for cats 
Variable Level OR    95% CI P Value Overall P Value  
Age  >7 yrs.  
3-7 yrs.  
1-2 yrs.  
6 mo. – 1 yr. 
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<0.001 
  0.83 










Table 2.16 Univariate logistic regression analysis to evaluate associations between individual 
risk factors and the probability of testing positive to Cryptosporidium spp. for cats 
Variable Level OR       95% CI P Value Overall P Value 
Age  >7 yrs.   
3-7 yrs.   
1-2 yrs.   
6 mo. – 1 yr.   
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Region   Northeast   
Midwest   
South   






















Season Winter     
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Summer   
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  0.02 
  0.60 











Table 2.17 Multivariate logistic regression analysis to evaluate associations between multiple 

























Variable Level Odds Ratio 95% CI 
 
P Value Total No. of 
Dogs 
Age >7 yrs. Ref.     
 3-7 yrs. 0.95 0.77 1.2   0.63 21,612 
 1-2 yrs. 3.0 2.5 3.6 <0.0001  
 6 mo. – 1 yr.  6.6 5.4 8.0 <0.0001  
 <6 mo. 
 
7.8 6.6 9.2 <0.0001  
Region Northeast Ref.     
 Midwest 1.3 1.1 1.6   0.001  
 South 0.84 0.72 0.98   0.03  
 West 1.0 0.92 1.2   0.52  
       
Season Winter Ref.     
 Spring 1.0 0.90    1.2   0.60  
 Summer 0.80 0.69     0.92   0.002  
 Autumn 0.84 0.73     1.0   0.02  
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Table 2.18 Multivariate logistic regression analysis to evaluate associations between multiple 













Variable Level Odds Ratio     95% CI   P Value Total No. of 
Dogs 
Age >7 yrs. Ref. 
   
 
 3-7 yrs. 0.62 0.50 0.77 <0.0001 21,448 
 1-2 yrs. 1.1 0.90 1.3   0.38  
 6 mo. – 1 yr.  2.0 1.6 2.6 <0.0001  
 <6 mo. 4.0 3.2 4.8 <0.0001  
       
Sex CM Ref.     
 F 1.2 0.94 1.4   0.20  
 M 1.2 0.95 1.4   0.10  
 SP 0.84 0.71 1.0   0.05  
 U 
 
1.4 0.81 2.4   0.23  
Region Northeast Ref.     
 Midwest 1.7 1.4 2.1 <0.0001  
 South 1.1 0.90 1.3   0.35  
 West 2.0 1.7 2.3 <0.0001  
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Table 2.19 Multivariate logistic regression analysis to evaluate associations between multiple 

























Variable Level Odds Ratio   95% CI P Value Total No. of 
Cats 
Age >7 yrs. Ref. 
   
 
 3-7 yrs. 2.4 1.8 3.2 <0.0001 14,891 
 1-2 yrs. 4.5 3.4 5.9 <0.0001  
 6 mo. – 1 yr. 5.2 4.0 6.9 <0.0001  







    
 F 1.3 1.1 1.7   0.01  
 M 1.2 0.98 1.6   0.07  
 SP 0.91 0.76 1.1   0.33  
 U 0.92 0.40 2.1   0.85  
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Table 2.20 Multivariate logistic regression analysis to evaluate associations between multiple 















Variable Level Odds Ratio 95% CI P Value Total No. of 
Cats 
Age >7 yrs. Ref. 
   
 
 3-7 yrs. 1.2 0.88 1.7   0.21 14,999 
 1-2 yrs. 3.3 2.5 4.3 <0.0001  
 6 mo. – 1 yr.  6.4 4.9 8.5 <0.0001  
 <6 mo. 5.6 4.5 7.2 <0.0001  
       
Region Northeast Ref.     
 Midwest 2.1 1.6 2.8 <0.0001  
 South 2.2 1.7 2.8 <0.0001  







    
 Spring 1.0 0.83 1.3   0.77  
 Summer 0.7 0.60 0.88   0.002  
 Autumn 1.0 0.82 1.2   0.94  
106 
Table 2.21 Multivariate logistic regression analysis to evaluate associations between multiple 
risk factors and the probability of testing positive to Cryptosporidium spp. for cats 
Variable  Level Odds Ratio 95% CI P Value Total No. of 
Cats 
Age >7 yrs. Ref. 
   
 
 3-7 yrs. 1.1 0.88 1.5   0.30 14,999 
 1-2 yrs. 2.8 2.3 3.6 <0.0001  
 6 mo. – 1 yr.  5.7 4.6 7.2 <0.0001  







    
 Midwest 1.8 1.4 2.2 <0.0001  
 South 2.0 1.7 2.4 <0.0001  



















2.8 Figures  
 
 
Figure 2.1 USA Census Bureau classification for regionsa 






Figure 2.2 A causal model for Giardia spp. in pet dogs in the United States 
 
 











Figure 2.4 Plot of standardized residuals of Giardia spp., C. felis and Cryptosporidium spp. 
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CHAPTER 3: VALIDATION OF A POLYMERASE CHAIN REACTION ASSAY FOR THE 
SUBTYPING OF CRYPTOSPORIDIUM SPP. ISOLATES OF HUMAN ORIGIN 
Summary 
 Cryptosporidium spp. have been associated with diarrhea in a wide range of hosts 
including humans. The objective of this study was to present the optimization and validation of a 
polymerase chain reaction (PCR) assay to subtype Cryptosporidium parvum and 
Cryptosporidium hominis from positive human isolates for application in a study of veterinary 
students.  A published 60 kDa glycoprotein (gp60) gene-bas d PCR assay was previously 
optimized elsewhere for subtyping of C. parvum and C. hominis. In this study, the gp60 PCR 
assay was validated in negative fecal samples experimentally inoculated with C. parvum oocysts 
and C. hominis DNA. After optimization experiments, the optimal primer concentration (0.2 
µM), DNA volume (2.0 µl) and annealing temperature (55̊ C) were selected to achieve the 
highest sensitivity. The gp60 assay amplified DNA from C. parvum and C. hominis as expected.  
 To evaluate the analytic sensitivity of the gp60 assay, five replicates of serial dilutions for 
C. parvum were prepared in three different methods: Method A involved preparing five sets of 
serial dilutions of the C. parvum oocysts. Method B involved making five sets of dilutions by 
adding 0.25 g of the fecal matter to the purified oocysts. Method C involved making five sets of 
dilutions by adding 2.5 g of fecal matter to the oocysts.  All C. parvum oocysts were at 
concentrations from 106 to 101/mL in PBS-EDTA in each set of dilutions. The lowest limit of 
detection for the gp60 PCR assay was 1x103 oocysts/mL for C. parvum oocysts and 0.001 ng/mL 
for C. hominis DNA, respectively.  
 To determine the analytic specificity of the gp60 PCR assay, DNA was extracted from C. 
parvum, C. canis, C. felis, as well as the C. hominis DNA. In addition, the DNA was extracted 
from non-Cryptosporidium spp. such as Cyclospora cayetanensis Toxoplasma gondii, and 
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Giardia duodenalis. While the gp60 PCR assay amplified DNA of C. hominis and C. parvum, no 
other non – targeted DNA was amplified. 
 In this study, we have presented the optimization and evaluation processes for the gp60 
assay. In our study, method C has been identified to be superior for C. parvum oocysts and it is 
recommended for use in the future research. The gp60 assay optimized is suitable to genotype 
and subgenotype isolate of human origin and this is considered a novel approach for our 
laboratory.  
3.1 Introduction 
 Cryptosporidium spp. are protozoans that can cause gastrointestinal disease in several 
species including cats, dogs and humans. Serologic studies report that 25% or more of the USA 
population has been exposed to Cryptosporidium spp..1    
 Human cryptosporidiosis is mainly caused by Cr ptosporidium hominis (previously 
known as the Cryptosporidium parvum anthroponotic genotype or genotype 1) and 
Cryptosporidium parvum.2,3 Cryptosporidium hominis is harbored almost exclusively by 
humans, but C. parvum is found in domestic livestock, wild animals, and humans.3 Since both 
Cryptosporidium spp. are detected in humans, two cycles of infection: the anthroponotic and the 
zoonotic cycles can cause human cryptosporidiosis.3 
 Several molecular techniques have been developed for the differentiation of 
Cryptosporidium at the genotype or species level.4 However, to understand the transmission 
dynamics of human cryptosporidiosis, subtyping within a species is critical. Subtyping analysis 
is more informative than genotyping alone as it can clarify genetic variation on a finer scale. 
Thus, to determine the proportion of C. parvum infections in humans attributable to zoonotic 
transmission, subtyping of this species is crucial.5  
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 One of the popular subtyping tools is the PCR amplification and DNA sequence analysis 
of the 60 kDa glycoprotein (gp60).4 An important feature of this gene is its high degree of 
sequence polymorphism, particularly among C. hominis and C. parvum isolates.2,3  The gp60 
gene has tandem repeats of the serine-coding trinucleotide at the end of the gene and also has 
extensive sequence differences in the non-repeat regions, which categorize C. parvum and C. 
hominis each to several subtype families.4 The gp60 PCR has shown at least 10 subtype allele 
families, IIa–IIj, among C. parvum isolates from humans and animals.6-8 Among these subtype 
families, only IIa and IId have been detected in cattle.8  
 The Center for Companion Animal Studies has extensive experience of performing 
Cryptosporidium spp. genotyping from canine and feline isolates.  However, the Center has not 
performed the gp60 PCR assay on isolates from humans. The hypothesis of this study is that the 
gp60 PCR assay followed by DNA sequencing analysis will allow for the C. parvum human and 
bovine subtype allele families’ differentiation from human isolates as previously reported.   The 
specific aim was for this technique to be optimized for use in a subsequent experiment using 
veterinary student feces (Chapter IV).    
3.2 Materials and Methods  
3.2.1 Gp60 Assay Verification  
 A published gp60 PCR assay was selected from published articles.3,9,10 The assay was 
verified in a feline fecal specimen (that was negative to Cryptosporidium spp. using the IFA and 
PCR assays) and experimentally inoculated with C. parvum oocysts and in C. hominis DNA. The 
sample was then evaluated in serial dilutions.  The DNA of C. parvum oocysts was extracted 
using a FastDNA® Kit (MP Biomedicals, LLC. Solon, OH) as previously described.11 The C. 
parvum and C. hominis isolates were then used for the analytic sensitivity testing.  
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3.2.2 Gp60 Optimization Process 
 The optimization process involved comparing different concentrations of each PCR 
component to determine which combination performs better under our laboratory conditions.  
AmpliTaq Gold™ DNA Polymerase (Life Technologies, Grand Island, NY) and two commercial 
premade, ready to use master mixes, these are: HotStar Taq Master Mix (QIAgen, Valencia, 
CA), and the Fast Cycling PCR Kit (QIAgen, Valencia, CA) were compared against each other. 
Annealing gradient ranged from (50°C - 65°C) were chosen to check which temperature would 
perform best. The primer concentrations (0.1, 0.2, and 0.5 µm) and different DNA volumes (1.0, 
2.0, and 5.0 µl) were tested in the gp60 PCR assay.   
3.2.3 Assay Validation        
 Validation provides the essential evidence to justify the continued use of the assay in 
further research projects.12  
3.2.3.1 Analytic Sensitivity Testing 
 The C. parvum oocysts isolate (99-13) was obtained from a positive cow. It was stored in 
(0.9 x108 /mL) phosphate buffer saline and antibiotics (1,000 U Penicillin 1,000 µg 
Streptomycin) at 4°C prior until required. Pure DNA of C. hominis from a positive human 
patient was donated by the global bioresource center (NR – 2520) of the American Type Culture 
Collection (ATCC/ Manassas, VA) as a commercial source of oocysts was not available.  
 A 1:9 dilution was made with C. parvum oocysts as (10.0 µl of the oocyst solution in 
90.0 µl of PCR water). Then, 10.0 µl of this solution were placed in a hemacytometer in order to 
count the oocysts. This procedure was repeated three times. 
  An average of three counts resulted in enumerating approximately 980 oocysts. The 
hemacytometer calculation was as follows: 980 (oocysts) x 10 (dilution factor) x 
2500=24,500,000 oocysts/mL. The oocysts were diluted to a concentration of 2,450,000 
119 
oocysts/mL. This stock was serially diluted to create oocyst concentrations from 1 x 106 to 1 x 
101 oocysts/mL. Five replicates of the serial dilutions for the C. parvum oocysts were prepared to 
be used for sensitivity testing.  
 The gp60 PCR assay detection limit was compared in three different methods of 
dilutions. Additionally, to determine the overall performance of the assay, it was compared with 
the IFA as well as two different PCR assays that include the Heat shock protein 70 (hsp70) and 
18SrRNA performed as described previously.13,14 
Method A 
 Cryptosporidium parvum oocysts with a concentration from 106 to 101 oocysts/mL were 
replicated five times in PBS-EDTA dilution.  No fecal matter was added to these concentrations 
using this method.  
Method B 
 Cryptosporidium parvum oocysts with a concentration from 106 to101 oocysts/mL were 
replicated five times in PBS-EDTA dilution. Then, an amount of 0.2-0.25 grams of a feline fecal 
specimen (that was negative to Cryptosporidium spp. using the IFA and PCR assays) was added 
to these concentrations. 
Method C 
 Cryptosporidium parvum oocysts with a concentration from 106 to 101 oocysts/mL were 
replicated five times in 5.0 mL of PBS-EDTA dilution. Then, an amount of 2.5-3.0 grams of a 
feline fecal specimen (that was negative to Cryptosporidium spp. using the IFA and PCR assays) 
was added to these concentrations. The samples then were concentrated using Sheather’s sugar 
centrifugation technique. The DNA for each method of dilutions was extracted using the 
FastDNA® extraction kit.11   
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Cryptosporidium hominis Dilutions: 
 Due to the unavailability of C. hominis oocysts, the three methods of dilutions (A, B and 
C) were not prepared. Instead, DNA of C. hominis with concentration of 10 ng/mL was used to 
make five sets of serial dilutions starting with 1.0 ng/mL to 0.0001 ng/mL.   
3.2.3.2 Analytic Specificity Testing 
 The main purpose of conducting the analytic specificity testing is to confirm whether the 
primers that have been chosen for this assay are binding only to the desired sequences or to 
additional irrelevant sequences. The analytic specificity of the gp60 PCR assay was assessed by 
testing the DNA from a range of Cryptosporidium spp.: C. parvum (obtained from a calf isolate), 
C. hominis (DNA), C. canis, C. felis, and non-Cryptosporidium spp.: C. cayetanensis (obtained 
from a human isolate), T. gondii, and G. duodenalis (obtained from a dog and a cow isolate).  
3.3 Results  
3.3.1 Gp60 Verification and Optimization Process 
 In terms of the assay optimization process, comparing the HotStarTaq and AmpliTaq 
Gold™ DNA Polymerase master mixes showed that the HotStar Taq master mix was more 
efficient because it produced brighter bands and less PCR byproducts compared to the AmpliTaq 
Gold. The Fast Cycling PCR master mix did not produce any bands. Therefore, the HotStar Taq 
master mix was selected for performing all PCR reactions.  The non-specific amplification has 
not occurred in any of the selected annealing temperature, however the highest yield was 
observed in annealing gradient of 55°C. The results of this optimization process were displayed 
in Figure 3.1. In terms of primer and DNA concentrations, optimal primer concentration that has 
worked best was 0.2 µM and 2.0 µl best volume for the DNA template.  
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3.3.2 Gp60 Assay Validation 
3.3.2.1 Analytic Sensitivity 
 To determine the overall performance of the gp60 PCR, this assay was compared to 
18SrRNA PCR assay, hsp70 Cryptosporidium PCR assay, and the IFA.  The maximal number of 
replicates detected by the gp60 assay varied by method (Tables 3.1, 3.2, and 3.3).  All 5 
replicates were positive in method A at the concentration of 106 oocysts/mL, method B at the 
concentration of 106 oocysts/mL, and method C at the concentration of 104 oocysts/mL. The 
lowest concentration of oocysts to be detected in the gp60 assay were 1 of 5 replicates positive at 
the concentration of 104 oocysts/mL in method A, 3 of 5 replicates at the concentration of 103 
oocysts/mL in method B, and 2 of 5 replicates at the concentration of 103 ocysts/mL in method 
C.  The gp60 assay was positive for C. hominis DNA in all 5 replicates at the concentration 
0.001 ng/mL and 2 of 5 replicates at the concentration of 0.0001 ng/mL (Table 3.4).  
 The results were similar for the 18sRNA PCR, the hsp70 PCR assay and the IFA (with 
some slight differences in the concentrations for which the most replicates were positive (Tables 
3.1, 3.2, and 3.3). 
 Cryptosporidium hominis DNA (Table 3.4) was amplified from more replicates at the 
0.0001 ng/mL for the gp60 (2 replicates) and hsp70 assay (4 replicates) than the 18sRNA PCR (0 
replicates). Since C. hominis oocysts were not available, the IFA technique was not performed 
for this method of dilutions. 
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3.3.2.2 Analytic Specificity 
 The results of blasting the primers selected in the C. parvum and C. hominis PCR 
reaction showed that those primers as specific to amplify the DNA of these two pathogens only 
and did not amplify the DNA of other pathogens included in the PCR reaction. As shown in 
Figure 3.2, the gp60 PCR assay revealed no cross-reactions with other genera and detected all 
the C. hominis and two out of six C. parvum samples correctly. 
3.4 Discussion  
 Cryptosporidium species are indistinguishable morphologically and species can only be 
identified using molecular techniques.  The gp60 PCR assay and DNA sequence analysis have 
been widely used in molecular epidemiology because it allows for both genotyping and 
subtyping of Cryptosporidium spp.4 Due to its high sequence polymorphism resolution, 
particularly among C. hominis and C. parvum isolates, and because these two species are 
commonly isolated from human samples, a gp60 PCR assay have been optimized to be applied 
for human samples.  
 In the sensitivity evaluation of the assay, dilutions prepared with purified C. parvum 
oocysts were used to spike feline feces. The use of feline feces instead of the human feces was 
merely because this protocol has been previously used in similar experiments in the laboratory.  
We do not believe that the use of cat feces affected the sensitivity of the assay even though 
human and feline feces were not compared. Our laboratory spiked different fecal matrices 
(bobcats, foxes, and other carnivores) with C. parvum oocysts and similar detection limits were 
observed.  One study showed that spiking cat feces with a known number of C. parvum oocysts 
did not affect the much improved sensitivity of the PCR assay in detecting C. parvum DNA 
compared to the IFA method.17  
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 In these experiments, method A was expected to give the highest analytical sensitivity as 
feces was not present which should increase sensitivity because of the lack of potential PCR 
inhibitors.  One study that stated the presence of PCR inhibitors in the sample matrix can lead to 
a reduced efficiency of the PCR assay itself.19 However, all 3 PCR assays had fewer positive 
replicates at the concentration of 104 oocysts than the IFA, a technique that is predicted to be less 
sensitive than PCR (as was documented in Table 3.3).  These results can only be explained by a 
laboratory error.  The diluted oocysts used in method A were stored at 4̊ C for a much longer 
period of time for method A (two months) compared to the other two methods (two months). 
This storage condition might have negatively affected the amplification yield of the DNA. The 
DNA in low DNA concentration samples might degrade and become unavailable for the PCR 
amplification under such storage situations. One study documented that there was significant 
difference in the amplification yield between samples stored frozen in any buffer and those that 
are stored in 4̊ C.18 Additionally, in method C, concentration technique before DNA extraction 
was performed. This technique is reported to enhance the recovery of Cr ptosporidium spp. 
oocysts.15,16   Overall, all replicates were positive consistently only at the concentration of 104 
oocysts/mL regardless of PCR assay.  Due to other published research (as of our knowledge) did 
not report the sensitivity of the gp60, 18SrRNA and the hsp70 PCR assays, we could not 
compare this level of sensitivity (104 oocysts/mL) to that previously reported with these three 
PCR assays.3,13,14 The results of these experiments show that analysis of a single fecal sample in 
a clinically ill person or animal could have false negative results and so the combination of 
assays or evaluating more than one sample might be indicated. 
 Table 3.5 shows the average DNA concentrations for all five replicates in the three 
dilution methods for C. parvum.  In methods B and C, the spiked samples contained a large 
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amount of DNA that can be attributed to the fecal matter. For method C, the hsp70 PCR assay 
performed best compared to other assays, detecting a few more positive replicates at 102 and 103 
oocyst concentrations than the other assays. A possible explanation of this result is that the hsp70 
PCR protocol is nested which increases the sensitivity of this assay.13  
 Since oocysts of C. hominis were not available, the analytic sensitivity of gp60 PCR 
assay could not be completely determined.  In addition, the IFA method could not be assessed at 
all as it requires intact oocysts.  Regardless, the 18SrRNA PCR assay appeared to be less 
sensitive than the other two assays.   This finding may relate to the fact that both the gp60 and 
hsp70 are nested PCR reactions which can be considered more sensitive.  As the C. hominis 
DNA was not diluted in feces, it is unknown the effect PCR inhibitors have on this assay.   
 Evaluation of analytical specificity of the gp60 PCR assay revealed no cross-reactions 
with other genera and detected all the C. parvum and C. hominis isolates correctly. That indicates 
that this PCR assay was 100% specific for C. parvum and C. hominis. Furthermore, another 
study conducted to evaluate the analytical specificity of primers designed to detect C. cuniculus 
using both nested, and real time gp60 PCR assay in a panel of 97 fecal samples contained 
Cryptosporidium spp. and non-Cryptosporidium spp. DNA. The primers amplified all 
Cryptosporidium spp. DNA and did not amplify other non-target DNA.20 The analytic sensitivity 
and specificity of gp60 assay in this study was in accordance with studies conducted 
previously.2,3,9,10 
3.5 Conclusion  
  In the present study, the gp60 PCR assay consistently detected DNA of C. parvum if 
oocysts were present at 104/mL if the spiked fecal sample was concentrated before assay (method 
C).  This method of dilutions is recommended to be used for future fecal samples processing in 
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this research.  The analytic sensitivity of C. hominis in this study was detected in the lowest 
DNA concentration studied, but was not studied in feces and so the effect of fecal inhibitors is 
unknown.  The strength of the optimized Gp60 assay is that it is suitable to genotype and sub-
genotype isolates of human origin.  This assay will be utilized in Chapter 4 of this dissertation.
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3.6 Tables 
















Gp60 0/5 0/5 0/5 1/5 3/5 5/5 
18SrRNA 1/5 1/5 2/5 2/5 4/5 4/5 
Hsp70 0/5 1/5 0/5 1/5 3/5 5/5 
IFA 1/5 2/5 0/5 4/5 5/5 5/5 
 

































Gp60 0/5  0/5 3/5 4/5  4/5 5/5 
18SrRNA 0/5 0/5 2/5 4/5 5/5 5/5 
Hsp70 0/5 0/5 0/5 2/5 3/5 5/5 
IFA 0/5 0/5 0/5 3/5 5/5 5/5 
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Gp60 0/5 0/5 2/5 5/5 5/5 5/5 
18SrRNA 0/5 0/5 1/5 5/5 5/5 5/5 
Hsp70 0/5 2/5 3/5 5/5 5/5 5/5 




1.0 ng/mL 0.1 ng/mL 0.01 ng/mL 0.001 ng/mL 0.0001 ng/mL  
Gp60 5/5 5/5 5/5 5/5 2/5 
18SrRNA 5/5 5/5 5/5 2/5 0/5 
Hsp70 5/5 5/5 5/5 5/5 4/5 
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CHAPTER 4: RISK ASSESSMENT OF FACTORS AND PREVALENCE OF GIARDIA 
DUODENALIS AND CRYPTOSPORIDIUM SPP. INFECTIONS IN VETERINARY 
STUDENTS AND THEIR DOGS AND CATS 
Summary 
 Giardia duodenalis and Cryptosporidium spp. are considered zoonotic agents, however, 
few data are available assessing the genotypes of these organisms in humans and their 
companion animals. The primary objectives of this study were to determine potential risk factors 
associated with G. duodenalis and Cryptosporidium spp. infections in senior veterinary students 
and their dogs and cats. The secondary objective was to identify and to molecularly characterize 
G. duodenalis and Cryptosporidium spp. isolates obtained from feces of senior veterinary 
students, as well from their dogs and cats.  
All senior veterinary students (N=137) were contacted by a hard copy letter as well via 
email and were invited to participate in an anonymous, voluntary study.  The students were 
requested to complete a survey designed to obtain information on potential risk factors 
associated with exposure or infection due to G. duodenalis and Cryptosporidium spp.. 
Additionally, students were requested to supply a personal fecal sample as well as a fecal sample 
from one dog and one cat if present in the household.  Respondents’ demographics, their pet 
demographics, and their clinical rotations were descriptively analyzed.  
Feces were analyzed using microscopic examination for parasite eggs, cysts and oocysts 
after using Sheather’s sugar centrifugation. For detection of Cryptosporidium spp. oocysts and 
Giardia spp. cysts a commercially available IFA (MERIFLUOR® Cryptosporidium/Giardia, 
Meridian Biosciences) was used.  DNA was extracted from each fecal sample and was assayed 
for G. duodenalis using PCR assays for the glutamate dehydrogenase, triosephosphate isomerase, 
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and ß-giardin genes. DNA extracted from each human fecal sample was assayed for 
Cryptosporidium spp. using PCR assays for the 18SrRNA and gp60 genes whereas dog and cat 
DNA extracts were evaluated by PCR assays for the 18SrRNA and heat shock protein 70 genes. 
Fifty-one (n=51) students participated in the online survey, corresponding to a response 
rate of 37.2%. The majority of respondents (72.6%) completed the online survey and supplied 
human and pet fecal samples.  Potential factors evaluated for the risk of G. duodenalis and 
Cryptosporidium spp. in senior veterinary students included: veterinary track preference, gender, 
pet ownership, and farm exposure. Veterinary students supplied 42 personal fecal samples; 31 
dog fecal samples, and 17 cat fecal samples. Giardia duodenalis, Cryptosporidium spp. and 
hookworm were the only parasites detected in the human, dog, and cat samples tested.   
Out of 42 student fecal samples, five students were positive to either G ardia or 
Cryptosporidium. DNA sequencing was conducted in five dogs, one cat and one human fecal 
sample. Two dogs were positive for G. duodenalis Assemblage D using tpi and gdh genes, one 
dog was positive for G. duodenalis Assemblage C using β-giardin and gdh genes. One dog that 
was positive for G. duodenalis was also positive for Cryptosporidium spp. using the 18SrRNA 
gene. The two other dogs were positive for Cryptosporidium spp. and C. felis using the hsp70 
gene. One cat DNA sequencing result showed that this cat was infected with Cryptosporidium 
spp.. The one human positive for C yptosporidium DNA was infected with C. parvum subtype 
family (allele) IIa. 
The stratification of risk factors including track preference, gender, pet ownership and 
farm exposure by laboratory results using IFA and PCR assays showed that none of these factors 
was statistically associated with the risk of infection for either pathogen.  
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The results of this study show that both protozoans are isolated from humans, dogs, and 
cats in the region.  The Giardia positive dogs that were successfully sequenced harbored a host-
adapted assemblage and the owners were negative which suggests that zoonotic transmission did 
not occur in these households.  The strength of this study involved providing valuable 
information about senior veterinary students via the survey and identify and characterize isolates 
using highly sensitive assay. The main limitation of this study is the low participation and a 
single fecal sample collected. For future evaluation of the risk for zoonotic transmission of G. 
duodenalis and Cryptosporidium spp., a larger sample size is required.  
4.1 Introduction  
Based on several studies conducted in developed countries such as the United States of 
America (USA), the United Kingdom (UK) and Australia, the main risk factors associated with 
human cryptosporidiosis are direct contact with Cryptosporidium spp. infected individuals or 
those with diarrhea (< 2 -11 years old), international travel and contact with cattle/calf as well as 
swallowing freshwater that is not filtered.1,2 However, contact with companion animals such as 
pets was not associated with the risk of infection or disease.1,2  Other risk factors can also include 
caregiving to children or toddlers who are < 5 years old and consuming contaminated raw fruits 
and vegetables.3, 4 According to human cryptosporidiosis surveillance conducted in the USA for 
the period of 2011-2012, the risk of infection increased in females rather than males aged more 
than 15 years old. In addition, the peak onset of symptoms increased in late summer months 
about 4.4-fold compared to other seasons.5  
Regarding human giardiasis, the same risk factors associated with cryptosporidiosis seem 
to apply for giardiasis. Based on several case-control studies in industrialized countries, human 
giardiasis can be associated with consumption of contaminated surface water, swallowing 
136 
recreational water, foreign travel, contact with farm animals, contact with pets, presence of 
children or toddler in the house and nursing mothers.6-10 Additionally, cases of human giardiasis 
were more frequently reported in children aged 1-4 years and adults aged 45-49 years old and 
symptoms increased in early summer through fall.5 
Serologic studies report that 25% or more of the U.S. population has been exposed to 
Cryptosporidium spp.11 and giardiasis is the most frequently reported intestinal parasitic infection 
in the USA where it is estimated that 1.2 million cases occurs annually.12  
A very low number (n=10) of Giardia cysts or Cryptosporidium oocysts is enough to 
cause infection in people.11,12 Infected cats and dogs can shed up to 103 Cryptosporidium 
oocysts/gram of feces and up to 105 Giardia cysts/gram of feces.13,14 Infected humans can shed 
up to 108–109 Giardia cysts or Cryptosporidium oocysts in their stool per day and both pets and 
humans can excrete cysts or oocysts for months.11,12 Prevalence estimates can be over 20% for 
both organisms in animals presented with diarrhea.15 
Epidemiological investigations support the theory that zoonotic infections due to G. 
duodenalis and Cryptosporidium spp. amongst humans, dogs and cats exists.16-21 Dogs and cats 
harbor host-adapted strains of Giardia (assemblages C and D for dogs and F for cats) and 
Cryptosporidium (C. canis and C. felis) and also zoonotic strains (Giardia assemblages A and B 
and C. parvum).12-22 Most Cryptosporidium infections in humans are caused by C. hominis and 
C. parvum and less frequently by C. canis and C. felis.22 
While human Giardia genotypes (assemblage A and B) are occasionally detected within 
feces of dogs, and C. felis and C. canis are occasionally detected within feces of people, there 
have been almost no studies that directly compare the results of sensitive assays (immune-
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fluorescent assay (IFA) and polymerase chain reaction assay (PCR) using samples from people 
and their personal dogs or cats.23-24 
Commercial diagnostic laboratories in some countries (including the USA) currently 
offer PCR assays to amplify the DNA of Giardia spp. and Cryptosporidium spp. from feces of 
dogs and cats. However, genotyping assays are not routinely provided and so whether dogs or 
cats are carrying zoonotic or host-adapted genotypes is unknown. An inadvertent sequela from 
increased recognition of G. duodenalis and Cryptosporidium spp. infections in dogs and cats is 
an increase in pet relinquishment due to fear of zoonotic transmission to human family members. 
A study conducted by the National Council on Pet Population and Study Policy showed pet 
illness is one of the top ten reasons why pets are relinquished, which has negative impact on 
companion animal welfare.25 There is a critical need to study and evaluate the role of pets in 
transmitting Giardia and Cryptosporidium related infections to their owners and vice versa.  
To date, there has been no research directly comparing Giardia spp. and Cryptosporidium 
spp. isolates from owners and their pets using highly sensitive assays capable of genotyping. 
Additionally, fewer studies have evaluated factors associated with infections in humans and their 
pets. We selected senior veterinary students and their dogs and cats as our study source 
populations since veterinary students are usually pet owners and occupationally exposed to small 
and large animals. Thus, the objectives of this study were to determine factors associated with G. 
duodenalis and or Cryptosporidium spp. infections in senior veterinary students and to identify 




4.2 Materials and Methods 
4.2.1 Recruitment  
Al l senior veterinary students (N=137) were provided information concerning this 
anonymous, elective study by hard copy and email. This contact was established after an 
approval from the Institutional Review Board (IRB) on June 26, 2014. There were two phases of 
recruitment. The first phase of student recruitment took place in the first six months of the 
curriculum (between May – October). In this phase, students were asked to complete an online 
survey (Appendix 1). Students were also asked to supply a personal fecal sample as well as a 
fecal sample from one dog and one cat if present in the household.  
The IRB approved a compensation of $75.00 for students that submit a personal fecal 
sample, a pet fecal sample and complete the survey, and a stipend of $50.00 for those who take 
the survey and submit a personal fecal sample without pet samples.  
The second phase of the recruitment took place in the last six months of the curriculum 
(November – May). In this phase, due to the low participation, students were requested to submit 
pet samples without the requirement to submit human samples. They were also requested to take 
the survey only without submitting any fecal samples. During this phase, a renewal to the IRB 
protocol was needed and an amendment to the protocol was needed. The amendment involved an 
increase to the student compensation in order to enhance students’ participation in the study. The 
compensation involved a $100.00 for students who take the survey and submit their own fecal 
samples. In addition, those who completed the survey and submit their pet samples, received 
$50.00. Lastly, those who completed the online survey without submitting fecal samples 
received $25.00.  From the beginning of the study until the end, five to six reminders for 
participation in the study were sent via email to the students. The protocol amendment and IRB 
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approval of this protocol was received on April 17, 2015. The study actively started on July 2014 
and ended in May, 2015. The two official IRB letters of approval are provided in Appendices 2 
and 3.  
4.2.2 Questionnaire Development and Delivery  
 
Structured questionnaire was developed using SurveyMonkey® Inc. software. The 
survey entitled “Evaluation of Zoonotic G. duodenalis and Cryptosporidium spp. Infection 
amongst Veterinary Students and their Dogs and Cats”. The objective of the survey was to 
collect information regarding factors that can potentially be risk factors for acquiring G. 
duodenalis and Cryptosporidium spp. infections in human, dog and cat populations. A total of 59 
questions were developed and the survey was pilot tested at the veterinary teaching hospital.   
The survey was divided into seven main sections. The first section involved veterinary students’ 
demographics. The second section involved an assessment of student health of seven required 
questions. Third section consisted of one required pet ownership question. Fourth section 
involved seven questions of dog demographics, health assessment and husbandry practices. The 
fifth section involved seven questions cat demographics, health assessment and husbandry 
practices. The sixth section involved 11 questions of dog and cat demographics, health 
assessment and husbandry practices. The last section involved 14 questions on students’ clinical 
rotations. Closed-ended questions with multiple choice type of questions were provided in the 
survey. Response choices were limited to specified response categories, a (yes or no) question, or 




Fecal Sample Collection   
Students were asked to collect the study fecal sample kits that have their unique sample 
identifier that they should also use in the survey. This approach was used to in linking between 
samples and surveys. Students were provided with sample kits. Each kit included: 1) labeled 
stool container for human sample, 2) labeled stool container for dog sample, 3) labeled stool 
container for cat sample, 4) unlabeled brown bag, 5) pair of latex gloves, and 6) three tongue 
depressors. Pet fecal sample containers were labeled with the same sample identifier as the 
human fecal sample container identifier. Fecal samples submission was anonymous i.e., students 
were directed to submit their samples to the laboratory refrigerator.  
In the recruitment, students were requested to collect their samples in the second week of 
a clinical rotation that involves intensive handling of small or large animals. Fecal character (i.e. 
texture and consistency) for dog and cat samples was reported subjectively by the researcher 
using the Nestle Purina Fecal Scoring System for dogs and cats (Nestle-Purina Pet Food Co, St 
Louis, MO). Fecal scores of 1-3 were considered as normal, whereas scores with 4-7 were 
classified as diarrheic. All fecal samples were stored in the laboratory refrigeator at 4˚C until 
processed.  
4.2.3 Diagnostic Tests and Procedures 
 The diagnostic test for G. duodenalis and Cryptosporidium spp. included microscopic 
examination of the cysts and oocysts and molecular techniques to identify both pathogens 
genomic DNA. G. duodenalis case definition was based on the CDC definition in 2011 of cases 
which involved:  
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Laboratory-confirmed giardiasis should meet the criteria as the detection of 
Giardia organisms/cyst using IFA, or amplification of DNA from stool by PCR (molecular 
characterization (e.g., assemblage designation) should be reported.5 C yptosporidium spp. case 
definition was based on the CDC definition in 2012 of cases which involved: 
A confirmed case of cryptosporidiosis is defined as having evidence of Cryptosporidium oocysts 
by IFA or amplification of DNA from stool by PCR tests.5  
4.2.3.1 Fecal Flotation 
All fecal samples were subjected to fecal flotation procedure as previously described.30 
The protocol involved weighing 2-3 grams of feces. A volume of 3-5 ml of distilled water 
(depending on the stool consistency), were used to wash the fecal matter instead of PBS-EDTA 
which was a little adjustment of the previous protocol. The distilled water was then filtered 
through gauze. The filtrate was placed in a clean 15 ml tube and was centrifuged at 500 X g for 3 
minutes. The filtrate then was mixed with Sheather’s sugar flotation solution (Jorgensen Labs. 
Loveland, CO) with specific gravity of 1.27. The tube was centrifuged at 1,500 X g for 10 
minutes. A coverslip was placed on top of the solution to give a positive meniscus.  After 10 
minutes, the coverslip was transferred on a microscope slide to be later examined under the light 
microscope for Giardia cysts and other potential parasites. The slide was initially screened at 
magnification power with 10x, then if potential parasites were noted, the examination was 
continued at 20x or 40x to confirm the findings.  
4.2.3.2 Concentration Technique and Immuno-Fluorescent Assay (IFA) 
All fecal samples were subjected to fecal concentration technique as described in 
previous study.26,27 This procedure enhances the recovery of Giardia spp. cysts and 
Cryptosporidium spp. oocysts.28  
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4.2.3.3 PCR DNA Extraction 
All fecal specimens were subjected to DNA extraction. The genomic DNA of G. 
duodenalis and Cryptosporidium spp. in the concentrated fecal samples was extracted using 
FastDNA® Kit (MP Biomedicals, LLC. Solon, OH) following published protocols.28,29,30 The 
extracted DNA was stored at 4°C until used for molecular analysis.   
4.2.3.4 Molecular Analysis  
G. duodenalis PCR 
The isolates of G. duodenalis were genetically characterized using gdh26,31, β-giardin32 
and tpi26,33,34 loci.  
Cryptosporidium spp. PCR 
The isolates of Cryptosporidium spp. were genetically characterized using 18SrRNA35,36, 
and gp6037 loci for human isolates and 18SrRNA35,36 and hsp70 for animal isolates38.  
4.2.3.5 Stratification of Laboratory Results by Risk Factors 
Fisher’s exact test was used to assess associations between positive and negative 
laboratory results for IFA and PCR assays of human fecal samples by the study selected risk 
factors. The factors involved in this stratification included: student track preference, gender, pet 
ownership, and farm exposure. This analysis was conducted merely for descriptive purposes.  
4.2.3.6 DNA Sequencing  
All PCR-positive samples were subjected to sequencing as previously published.26 All 
PCR products (10.0 µl) were separated by electrophoresis in 1.5% agarose gels stained with 2.0 
µl EZ-Vision® One DNA dye (Biochemicals and Life Science Research Products, Solon, OH) 
for 30-35 minutes. After the positive band has been identified using the BIO-RAD (Gel DocTM 
EZ Imager), the remaining PCR reaction (40.0 µl) was then re-separated by the electrophoresis 
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in 1.5% agarose gel stained with 5.0 µl EZ-Vision®.  The gel was visualized by the 
Spectroline® UV Transilluminator (Slimline™ Series) and the positive band DNA was sliced. 
The gel was extracted using QIAquick Gel Extraction kit (QIAgen, cat. No. 28704, Germany) 
per the manufacturer’s protocol. PCR products were sequenced in both forward and reverse 
directions. The DNA sequence data from G. duodenalis and Cryptosporidium spp. isolates was 
compared by BLAST analysis with sequences from the nucleotide database from the GenBank. 
4.3 Data Analysis  
STATA® 13.0 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: 
StataCorp LP.) was used for data formatting and descriptive analysis. The survey data analysis 
included descriptive analysis of the characteristics related to students and pet demographics and 
student clinical rotations as previously described and did not contain any open-ended questions. 
Statistical significance was declared at p < 0.05.   
4.4 Results  
4.4.1 Results of the Survey 
Survey Participation 
  Survey responses were received from 51 (37.2%) of senior veterinary students (Table 
4.1). 
Section I – Veterinary Student Demographics 
The majority of respondents (n = 37, 72.6%) took the online survey and also submitted 
human and pet samples. Most samples (n = 12, 23.5%) were submitted in May, 2015 (Table 4.1). 
 The majority of respondents (n = 44), (86.3%; 95% CI: 73, 94%) were females. The 
mean age of all respondents was 28 years old with 95% corresponding confidence interval 
between (27, 28.9%). The majority of respondents were in the small animal track (n = 23), 
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(45.1%; 95% CI: 31, 59%). In terms of the type of residence for the students, the majority (n = 
44), (86.3%; 95% CI: 73, 94%) of students lived in single family residence where no cattle were 
housed. Forty-five percent (n = 23), (45.1%; 95% CI: 31, 59%) of respondents have lived with 
one adult other than the respondent. The majority of students (n = 48), (94.12%; 95% CI: 83, 
98%) had no children under five years old in the household, and only three students (5.9%) had 
children under five years old in their household. The majority of respondents (n = 32, 62.8%;
95% CI: 48, 75.0%) had worked in an operation that was their own or owned by others where 
cattle of any age were housed or fed in the last 10 years and the majority of respondents (n = 21, 
67.7%; 95% CI: 27, 55%) have worked on these farms within last year. In terms of activities 
performed on these farms, the majority of respondents were involved in adult cattle and calf 
treatments (n = 25 (86.2%; 95% CI: 68, 96%), n=21 (72.4%; 95% CI: 52, 87%), respectively 
(Table 4.1).  
Section II – Veterinary Students Health Assessment  
 Forty-nine (n = 49, 96.1%; 95% CI: 86, 99%) respondents had no diabetes, cancer, HIV, 
or leukemia. Of the 44 respondents who were females, only three were pregnant (6.8%). The 
majority of respondents (n = 49, 96.1%; 95% CI: 86, 99%) had not taken medications that 
suppress their immune system. The majority (n = 46, 90.2%; 95% CI: 78, 96%) of students 
responded not-applicable (N/A) to the question asking about use of filter when drinking 
freshwater from water surface that is not chlorinated (Table 4.2). Water sources and number of 
times water swallowed accidentally or intentionally by respondents were displayed in Tables 4.3-
4.4. The majority of respondents reported that they have not swallowed water from the 
mentioned water sources neither accidentally or intentionally. In terms of the frequency of 
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diarrhea, the majority of students had never had diarrhea in the last 3, 6 or 12 months (71.4%, 
75.5%, or 60.8%), respectively (Table 4.5).  
Section III – Pet Ownership 
 In terms of pet ownership, 20 students (39.2%; 95% CI: 25, 53%) of the students had 
dogs only and same percentage of students had both dogs and cats. Whereas 13.7% of 
respondents (n = 7) had cats only and 7.8% (n=4) had neither dogs nor cats (Table 4.6).  
Section IV – Dog Demographics, Health Assessment, Husbandry  
For those students who had only dogs (n=20; 95% CI: 19, 63%), eight students had at 
least one dog that their age range was from 1-5 years old. The majority (n = 13, 65.0%; 95% CI: 
40, 84%) of students adopted their dogs from the shelter or rescue group. Regarding medication 
use such as dewormers and heartworm preventatives, the majority of respondents (n = 13, 
65.0%; 95% CI: 40, 84%) had used Heartgard® for their dogs. Fifty percent (95% CI: 27, 72%) 
of respondents (n = 10) indicated that their dogs did not have abnormal health events. 
Furthermore, 80.0% of respondents (n = 16; 95% CI: 56, 94%) indicated that their dogs have 
never been used for herding or hunting. Additionally, 35.0% of respondents (n = 7; 95% CI: 15, 
59%) had never taken their dogs to a dog park. However, 30.0% of respondents (n = 6) had taken 
their dogs to a dog park at least less than once a week. For the frequency of diarrhea in the last 
three months, 80.0% of students (n=16; 95% CI: 56, 94%) reported that their dogs have never 
had diarrhea, but 15.0% of students (n = 3) reported that their dogs have had diarrhea once in the 
last three months (Table 4.7).  
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Section V – Cat Demographics, Health Assessment, Husbandry  
 For those responders who had only cats (n = 7; 95% CI: 9, 81%), three students had at 
least two cats that their age range was from 6-12 years old. Five responders (71.4%; 95% CI: 29, 
96%) reported that their cats were adopted from the shelter or rescue group. Regarding 
medication use such as dewormers and heartworm preventatives, the majority of respondents (n 
= 6) (85.7%; 95% CI: 42, 99%) had not used any cat dewormers or heart worm preventatives. 
Four respondents (57.1%) indicated that their cats did not have health events. Furthermore, three 
responders (42.9% 95% CI: 9, 81%) indicated that they clean the litterbox daily. Additionally, 
six respondents (85.7%; 95% CI: 42, 99%) have always used to wash their hands after handling 
the litterbox. For the frequency of diarrhea in the last three months, six students (85.7%; 95% CI: 
42, 99%) reported that their cats have never had diarrhea, but one student (14.3%) reported that 
their cat have had diarrhea once per three months (Table 4.8). 
Section VI – Dog and Cat Demographics, Health Assessment, Husbandry  
For those 20 students that had both dogs and cats, nine students (60.0%; 95% CI: 23, 
68%) had at least one dog with an age ranging from 1-5 years old and 10 students (50.0%; 95% 
CI: 27, 72%) had at least one cat aged from 1-5 years old. All owners (100.0%; 95% CI: 83, 
100%) adopted their dogs and cats from the shelter or rescue group. Regarding medication use 
such as dewormers and heartworm preventatives, the majority of responders (n = 11, 55.0%; 
95% CI: 31, 76%) had used Heartgard® for their dogs and (50.0%) of responders (n=10; 95% 
CI: 31, 76%) have not used any cat dewormers or heartworm preventatives. However, seven 
respondents (35.0%) have used Advantage Multi for their cats. Seven responder  (35.0%; CI: 15, 
59%) indicated that their dogs or cats did not have abnormal health events. However, seven 
respondents (35.0%; 95% CI: 15, 59%) also indicated that their dogs or cats have had acute 
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health conditions. Furthermore, 18 responders (90.0%; 95% CI: 68, 98%) indicated that they 
have never used their dogs for herding or hunting. Also, 10 responders (35.0%; 95% CI: 31, 
76%) have taken their dogs to the dog park at least once per week. Additionally, six responders 
(30.0%) have cleaned the litterbox daily and 11 responders (55.0%; 95% CI: 31, 76%) have 
always used to wash their hands after handling the litterbox.  For the frequency of diarrhea in the 
last three months, 15 students (75.0%; 95% CI: 50, 91%) reported that their dogs or cats have 
never had diarrhea, but three students (15.0%) reported that their dogs have had diarrhea at least 
once per three months (Table 4.9). 
Section VII – Clinical Rotations  
 A list of procedures performed for adult cattle or calves on senior practicum whether core 
or elective rotations is displayed in Table 4.10. Those procedures involve intensive exposure to 
large animals such as cattle and calves’ treatments. The majority of respondents responded yes to 
some of these procedures. Table 4.11 displays the frequency of handwashing procedure after 
handling cattle or calves. As shown in the table, the majority of students (n=31, 60.8%; 95% CI: 
46, 74%) have always washed their hands after performing activities listed in Table 4.10. Also, 
forty-nine percent of students (n = 25; 95% CI: 34, 63%) reported that they sometimes would eat 
or drink within an hour after performing any of the activities listed in Table 4.10. In terms of 
washing coveralls or rubber boots, 22 students (43.1%; 95% CI: 29, 57%) indicated that they 
wash their coveralls or boots daily, whereas (41.2%) of students (n = 21; 95% CI: 27, 55%) 
answered not-applicable (Table 4.11). The frequency of use of personal protective equipment 
(PPE) when handling diarrheic and non-diarrheic cattle or claves is displayed in Table 4.12.  The 
majority of students were used the PPE whether cattle or calves were diarrheic or non-diarrheic.  
Additionally, a list of procedures performed for dogs and cats on senior practicum whether core 
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or elective rotations is displayed in Table 4.13. Those procedures involved intensive exposure to 
dogs and cats such as physical exams and diagnostic tests. The majority of students responded 
yes to performing these activities.  
As shown in Table 4.14, 26 students (51.0%; 95% CI: 36, 65%) washed their hands most 
of the time after performing any activities listed in the previous table (Table 4.13). Additionally, 
55% (95% CI: 40, 68%) of students (n = 28) indicated that they have washed their hands 
between patients most of the time. A total of 55% (95% CI: 40.0, 68.0%) of students (n = 28) 
reported that they would eat and drink sometimes within an hour after handling dogs and cats. 
Furthermore, 21 students (41.2%; 95% CI: 27.0, 55.0%) washed their clinic smocks or cloth 
surgical gowns at least once per week (Table 4.14). The frequency of use of personal protective 
equipment when handling diarrheic and non-diarrheic dogs or cats is displayed in Table 4.15. In 
addition, the frequency of rotations that have completed from the beginning of the senior 
practicum until the time of survey was listed in Table 4.16.  
4.4.2 Fecal Samples Diagnostic Tests Results  
A total of 42 human, 31 dog, and 17 cat fecal samples were submitted to the Center of 
Companion Animal Studies at the Department of Clinical Sciences at Colorado State University 
laboratories by the senior veterinary students.  
G. duodenalis Diagnostic Tests  
Results from fecal flotation, IFA, and molecular analysis are shown in Table 4.17. All 
human fecal samples tested negative to the fecal flotation test, one dog fecal sample tested 
positive to G. duodenalis (3.23%; 95% CI: 0.1,16.7%) and one hookworm egg was identified in 
one Giardia negative dog. None of the cat samples tested positive in the fecal flotation test. In 
the IFA, G. duodenalis cysts were identified in one out of 42 human fecal samples (2.38%; 95% 
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CI: 0.1, 12.6%), and three fecal samples from dogs (9.68%; 95% CI: 2.0, 25.8%). None of the cat 
samples tested positive to Giardia using the IFA test. Regarding the PCR results in humans (see 
also Table 4.18), three out of 42 samples (7.14%; 95% CI: 1.5, 19.5%) tested positive for G. 
duodenalis, all the positive human isolates were typed by the tpi gene (7.14%).  Three out of 31 
dog samples (9.68%; 95% CI: 2.0, 25.8%) tested positive to G. duodenalis, two of the isolates 
were typed by the gdh gene (6.45%), three were typed by the tpi gene (9.67%) and one isolate 
were typed by the β-giardin gene (3.22%). Also, one out of 17 samples (5.88%; 95% CI: 0.1, 
28.7) tested positive G. duodenalis in cats. This one isolate was typed by the β-giardin gene. 
Cryptosporidium spp. Diagnostic Tests 
Results of the fecal flotation, IFA, and molecular analysis are shown in Table 4.19. 
Regarding the fecal flotation test, none of human, dog or cat samples tested positive to 
Cryptosporidium spp..  In the IFA, Cryptosporidium spp. oocysts were identified in one of 42 
human samples (2.38%; 95% CI: 0.1, 12.6%) and one of 31 dogs (3.23%; 95% CI: 0.1, 16.7%) 
tested positive. None of the cat samples tested positive to Cryptosporidium spp. using the IFA 
test. Regarding the PCR results in humans (see also Table 4.20), one out of 42 samples (2.38%; 
95% CI: 0.1, 12.6%) tested positive for C yptosporidium spp.. This human positive isolate was 
typed by gp60 gene (2.38%).  Four out of 31 dog samples (12.9%; 95% CI: 3.6, 29.8%) tested 
positive to Cryptosporidium spp.. The four isolates were typed by hsp70 gene (12.9%) and two 
of these isolates were also typed by 18SrRNA gene (6.45%). In cats, one out of 17 samples 
(5.88%; 95% CI: 0.1, 28.7%) tested positive to Cryptosporidium spp. that were typed by hsp70 
gene (5.88%).  
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Stratification of Laboratory Results by Risk Factors 
Tables 4.21-4.23 describe the probability of testing positive to G. duodenalis or 
Cryptosporidium spp. in senior veterinary students by track preference, gender, pet ownership 
and farm exposure. As shown in the Table 4.21, one student of 20 students (5.0%; 95% CI: 0.12, 
25%) in the small animal track was positive to G. duodenalis and Cryptosporidium spp. using the 
IFA test. This student was female (2.8%; 95% CI: 0.1, 14.5%) who owned pets (2.6%; 95% CI: 
0.1, 13.5%) and had worked on a farm that had cattle (3.8%; 95% CI: 0.1, 19.6%). Table 4.22 
shows G. duodenalis PCR test results of veterinary students stratified by track preference, 
gender, pet ownership and farm exposure. Two of 20 students (10.0%; 95% CI: 1.2, 32%) 
positive to G. duodenalis were in the small animal track and one student of 14 (7.1%; 95% CI: 
0.2, 33.9%) was in the general track. Each of these students were females (8.3%; 95% CI: 1.7, 
22.5%), all owned pets (7.7%; 1.6, 20.9%), and all had farm exposure (11.5%; 95% CI: 2.4, 
30.2%). As noted in Table 4.23, one student positive to Cryptosporidium spp. using the PCR test 
was in the large animal track (12.5%; 95% CI: 0.3, 52.7%), male (16.7%; 95% CI: 0.4, 64.1%), 
owned pets (2.6%; 0.1, 13.5%) and had farm exposure (3.8%; 95% CI: 0.1, 19.6%). However, 
none of these factors was significantly associated with using Fisher’s exact test.  
Results of DNA Sequencing  
     The DNA sequencing was completed in one human, five dogs and one cat samples. As 
shown in Table 4.24, dogs who were diagnosed with G. duodenalis were infected with G. 
duodenalis host-adapted assemblages C and D.  The two dogs were identified with 
Cryptosporidium spp. and C. felis, respectively. The one cat isolate was found to be 
Cryptosporidium spp. and species determination failed. One human isolate was identified with C. 
parvum subfamily IIa, which is zoonotic as shown in Table 4.25. 
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4.5 Discussion 
The response of students’ participation to the survey was 37.2%. Compared to another 
study used mailed surveys and several follow up that achieved 19% response rate, our study 
response rate can be considered good.39 Several journals in the USA and Canada, recommend 
survey response rates of at least 60.0% to prevent non-response bias.40,41 
Studying the sample characteristics through the survey in combination with the 
examining each stool sample collected, helped in forming understanding of the risk factors that 
can lead to infection due to G. duodenalis and Cryptosporidium spp.. Regarding fecal sample 
collection, the logic of this emphasis was due to the length of the incubation period for G. 
duodenalis and Cryptosporidium spp.. Based on evidence from experimental infections, it has 
been estimated that the incubation period is between 5 and 7 days for human cryptosporidiosis 
42,43,44 and from 1 to 45 days in human giardiasis. In most cases, the symptoms appear in 1-2 
weeks.45   
From the total of 51 respondents, 42 students (82.4%) provided fecal samples. From the 
laboratory result data of this study, five students out of 42 (11.9%) were positive to G. 
duodenalis and/or Cryptosporidium spp.. One student was positive to both G. duodenalis and 
Cryptosporidium spp. using the IFA test. Three students were positive to G. duodenalis and one 
student was positive to Cryptosporidium spp. using the PCR assays. Therefore, the prevalence of 
G. duodenalis was 9.5% (4/42) and prevalence of Cryptosporidium spp. was 4.8% (2/42) in 
human samples. 
From the survey analysis of these positive cases, four students out of five were females 
(80.0%) and one student was male. From the students’ demographic analysis, the majority of 
respondents were females (86.3%). Therefore, the number of positives were four females 
152 
compared to one male, in this study. According to the Morbidity and Mortality Weekly Report, 
2011-2012 for human giardiasis and cryptosporidiosis, females are more likely to be infected 
with these protozoans due to their care giving to infected infants or toddlers. Gia dia duodenalis 
cases are usually reported in younger populations that age range from 1-9 years old and younger 
adults from 35-39 years.46 Positive females in this study, did not have children under 5 years old 
that have lived in the household. Also, all positive female students were not pregnant and have 
not been diagnosed with any health conditions that can suppress the immune system.  It has been 
reported that the host immunity status can influence the severity of infection due to giardiasis in 
the host. For example, giardiasis is more frequently reported in immune-compromised 
individuals compared to immune-competent individuals.47,48 
From the stratification by risk factor analysis conducted in this study, three students that 
were positive to G. duodenalis, were in the small animal track. A study conducted on Australian 
veterinarians where 63% of participants have worked in the small/companion animal practice. 
That study reported that 45% of respondents have contracted gastrointestinal conditions caused 
by different pathogens during their occupation as veterinarians.49  
In this study, analysis of the laboratory results has shown that the dogs and cats owned by 
the five positive cases, were negative to either Gia dia or Cryptosporidium except for one dog 
that was positive to both pathogens. The owner of this dog was G. duodenalis positive. 
Unfortunately, the DNA sequencing was not completed to this human isolate due to the low 
DNA concentration. Therefore, we were unable to determine which Giardia assemblage this 
isolate was.  However, the DNA sequencing was completed in the dog isolate and that dog 
harbored host–adapted Giardia assemblage D.  Few studies have suggested the zoonotic 
potential of Giardia transmission among dogs and cats and their owners or people live in close 
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proximity.50-53  However, other studies reported that dogs were infected with Giardia either 
assemblage C or D and people were infected with assemblage A, i.e. independent transmission 
cycles among humans, dogs and cats.54,55 Therefore, this finding is consistent with studies 
concluded that the contact with pets can be negatively associated with the risk of infection.1,56,57  
All positive students, including the two Cryptosporidium spp. positive ones, one 
identified by the PCR and one identified by the IFA test have lived in a single-family residence 
where no cattle were housed. Regardless, all positive students have worked on an operation 
where cattle were raised from one year to more than five years. Some studies 58-60 suggested that 
contact with farm animals, especially cattle, are capable of transmitting Cryptosporidium spp. 
infections to farm workers and veterinary students. Also, Cryptosporidium bovis infections have 
been identified in few persons that were living and or working on cattle operations.61,62 One 
report found out that Cryptosporidium infections occurred in approximately 90% of the USA 
dairy farms and about 20% pre-weaned heifers of any given day are shedding Cryptosporidium 
spp.63  
DNA sequencing was completed in one of the two Cryptosporidium student cases. As 
suggested by chapter 3 of this dissertation, this isolate was assessed by the optimized gp60 assay. 
The data showed that this isolate was positive to C. parvum subfamily IIa. Cryptosporidium 
parvum possess complex epidemiology due to its ability to infect humans through zoonotic and 
anthroponotic transmission.64 The demographic data indicated that the student was a 29 years old 
male in the large animal track, and has worked on an operation in adult cattle treatment for three 
to five years. In addition, this student had recently completed the dairy field service, large animal 
emergency medicine, and livestock medicine and surgery rotations. All these rotations involve 
intensive contact with cattle. However, it is unclear whether the student positive to this isolate 
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acquired it due to intensive exposure to cattle or from another human.  However, if it was a 
human exposure, the species would have been more likely to be C. hominis. Farm exposure or 
majoring in large animal track can be considered an important risk factor for the infection due to 
Cryptosporidium since calves are frequently infected with a C. parvum subtype that is commonly 
found in humans in the same geographic areas65 and epidemiologic studies have reinforced the 
occurrence of zoonotic transmission.66 As part of the evaluation process for the optimized gp60 
assay, this assay was compared to the IFA assay.  The gp60 PCR Cryptosporidium spp. positive 
isolate was negative to the IFA assay. On the other hand, one Cryptosporidium oocyst was 
detected in one student by the IFA assay and negative to the gp60 PCR assay. Thi  result can be 
interpreted as a false negative n the gp60 PCR assay. The demographics showed that this student 
is a 26-year-old female, in the small animal track, and all clinical rotations involved small animal 
medicine. This student worked on an operation in cattle milking for three to five years. The 
diagnostic sensitivity and specificity for the gp60 PCR assay and IFA was 50% and 100% 
respectively and this result was in accordance with another study.67 
In terms of seasonality, all our Giardia cases had submitted their fecal samples in July to 
September. This finding is consistent with the Giardia surveillance in the United States that 
stated peak onset of this pathogen is in early summer through early fall.5 Regarding, the one C. 
parvum case, the sample was submitted in February.  
The one student that had dual infection of Giardia and Cryptosporidium, submitted her 
samples in July. In the Cryptosporidium surveillance work, the peak onset of the pathogen was in 
late summer months.5 
Regarding the clinical rotations, most of the positive cases whether Giardia or 
Cryptosporidium as well as negative cases, were more likely to wear personal protective 
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equipment (PPE) and exam gloves when handling small or large animals with diarrhea. This 
finding is in accordance with a study conducted on Australian veterinarians that were more likely 
to use PPE for each case.49 
Regarding pet positive cases in this study, all positive animals had female owners as 
shown in Table 4.26. All owners lived in a single-family  residence with no cattle in the 
surroundings except for one student who lived in a single-family residence where cattle of any 
age were housed or fed. The dog of this student was positive to both pathogens. Also, all positive 
dog owners, except for two, had worked on a farm. It seems that dogs owned by students that 
worked on a farm or lived in a farm were positive to Giardia and Cryptosporidium using at least 
two diagnostic methods due to the intensive exposure to either pathogens.  
In all seven positive dogs to any assay, four dogs (57.1%) dogs that were positive to 
either Giardia or Cryptosporidium or both, have attended the dog park at least once per week. 
Attending dog park was considered a risk factor in a study compared between dog and non-dog 
park attending dogs in the USA that concluded dog park attending dogs were more likely to be 
positive for Giardia or Cryptosporidium than non-dog park-attending dogs.68 However, in this 
study, 14/26 (53.8%) of negative dogs also attended dog parks. Similarly, we had two out of 
seven (28.6%) positive dogs were used for herding or hunting at least once or twice per week. In 
this study, 11.5% of dogs that were negative for both protozoans were also used for herding or 
hunting. Additionally, the age range for positive dogs was from 1-5 years old. That means the 
risk of acquiring Giardia or Cryptosporidium increases as age decreases which agrees with the 
findings reported in Chapter 2 of this dissertation. The one hookworm egg identified in dog 
labeled 82 using the microscopic examination was most likely to belong to Ancylostoma 
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caninum. However, the egg size may overlap with Uncinaria spp. and confirmation was not 
available due to the very low number of eggs.  
Regarding the two positive cats, cat #389 that was positive to Cryptosporidium spp. lived 
in the same household with a dog that was also positive to C. felis. While Cryptosporidium spp. 
can also be reported in cats, it is unusual to identify C. felis in dogs. The only justification for 
this can be that since the dog and the cat live together in the household a cross transmission may 
have occurred and because dogs are likely to eat cat feces.   Cat #300 was positive for Giardia 
DNA by PCR. However, we were unable to determine which Giardia assemblage that cat was 
infected with due to the very low DNA concentration. 
4.6 Conclusion  
Giardia duodenalis and Cryptosporidium spp. isolates were detected in humans and their 
pets. Dogs that were positive to G. duodenalis harbored host-adapted genotypes. Gp60 PCR 
assay had high diagnostic specificity and low diagnostic sensitivity in our studies which were 
comparable to other studies. Additionally, veterinary students that completed the survey were 
more likely to work on farms that contain cattle regardless whether their track is small or large 
animals. The strength of this study is providing valuable information about veterinarians via the 
survey and identifying and characterizing isolates using highly sensitive assay. The main 
limitation of the study was the low participation and single fecal sample collected. It is 
recommended to continue working on the veterinary studen s’ population and collect larger 






Table 4.1 Respondents demographic descriptors of section I in the survey 
Variable Category  Number (%) 95% CI  
Participation Preference Yes 51/137 (37.23)  
 No 86/137 (62.77)  
    
Response Type  Survey Only 8/51 (15.69)   
 Survey and Pet Samples 1/51 (1.96)   
 Survey and Human 
Samples 
5/51 (9.80)  
 Survey, Human, and Pet 
Samples 
37/51 (72.55) (58.0, 84.0) 
    
Time of Participation:    
Month February 4/51 (7.84)  
 April  9/51 (17.65)  
 May 12/51 (23.53) (12.0, 37.0) 
 July 6/51 (11.76)  
 September   9/51 (17.65)  
 October 3/51 (5.88)  
 November 2/51 (3.92)  
    
Year  2014 26/51 (50.98) (36.0, 65.0) 
 2015 25/51 (49.02) (34.0, 63.0) 
    
Respondents’ gender Female 44/51 (86.27) (73.0, 94.0) 
 Male 7/51 (13.73)  
    
Respondents’ age Average age in years 28 years  (27.08, 28.87) 
    
Track Preference Small Animal Track 23/51 (45.10) (31.0, 59.0) 
 General Track 15/51 (29.41)  
 Large Animal Track 13/51 (25.49)  
    
Residence Type  SFR*/No Animals 4/51 (7.84)  
 SFR/No Cattle 44/51 (86.27) (73.0, 94.0) 
 SFR/With Cattle 3/51 (5.88)  
 Other 0/51 (0)  





Table 4.1 Continued   
Variable Category  Number (%) 95% CI  
Number of Adultsa  0 6/51 (11.76)  
 1 23/51 (45.1) (31.0, 59.0) 
 2 15/51 (29.41)  
 3 6/51 (11.76)  
 4 1/51 (1.96)  
    
Number of Childrenb 0 48/51 (94.12) (83.0, 98.0) 
 1 3/51 (5.88)  
    
Take Children to 
Daycare 
N/A 48/51 (94.12) (83.0, 98.0) 
 Daily 2/51 (3.92)  
 Otherc  1/51 (1.96)  
    
Respondent’s Working 
on Farmd 
Yes 32/51 (62.75) (48.0, 75.0) 
 No 19/51 (37.25)  
aAdults other than the respondent 
bChildren under 5 years and live within the household 
c5 days/week 
















Table 4.1 Continued (optional questions) 
Variable Category  Number (%) 95% CI  
Respondent’s Time 
Spent Working on 
Farm* 
Within last year 21/51 (67.74) (27.0, 55.0) 
 1-2 Years 2/31 (6.45)  
 3-5 Years 5/31 (16.13)  
 >5 Years 3/31 (9.68)  
    
Type of Work on Farm  1. Adult cattle barn 
cleaning  
8/29 (27.59)  
 2. Adult cattle barn 
bedding changing 
8/29 (27.59)  
 3. Adult cattle feeding 13/29 (44.83)  
 4. Adult cattle birthing 
assistance  
10/29 (34.48)  
 5. Adult cattle fecal 
disposal 
8/29 (27.59)  
 6. Cattle milking 15/29 (51.72)  
 7. Cattle breeding 9/29 (31.03)  
 8. Adult cattle 
treatments 
25/29 (86.21) (68.0, 96.0) 
 9. Adult cattle 
vaccinations 
19/29 (65.52)  
 10. Newborn calf care 14/29 (48.28)  
 11. Newborn calf 
feeding 
13/29 (44.83)  
 12. Calf treatments 21/29 (72.41) (52.0, 87.0) 
 13. Calf vaccinations 15/29 (51.72)  
 14. Care of recumbent 
cattle or calves 
15/29 (51.72)  
 15. Cow/calf movement 
and transportation 
10/29 (34.48)  
 16. Other 2/29 (6.90)  








Table 4.2 Respondents health assessment of section II in the survey 
Variable Category  Number (%) 95% CI  
Diagnosed conditions None  49/51 (96.08) (86.0, 99.0) 
 Diabetes 0/51 (0)  
 Cancer 0/51 (0)  
 HIV/AIDS 0/51 (0)  
 Leukemia 0/51 (0)  
 Othera 3/51 (5.88)  
    
Pregnancy  Yes 3/51 (5.88)  
 No 41/51 (80.39) (66.0, 90.0) 
 Unsure  0/51 (0)  
 N/A if male 7/51 (13.73)  
    
Medications that suppress 
the immune system  
None  49/51 (96.08) (86.0, 99.0) 
 Oral steroids  2/51 (3.92)   
 Azathioprine 0/51 (0)  
 Mycophenolate  0/51 (0)  
 Other  0/51 (0)  
    
Use of water filters before 
drinking waterb 
Yes 3/51 (5.88)  
 No 2/51 (3.92)  
 N/A 46/51 (90.20) (78.0, 96.0) 
aHypothyroidism, Systemic lupus erythematosus 











Table 4.3 Water sources and number of times water swallowed accidentally by respondents   
Source  
                  Time  








Swimming pools 39/51 (76.47) 8/51 (15.69) 0/51 (0) 2/51 (3.92) 2/51 (3.92) 51 
Water play 45/52 (88.24) 5/51 (9.80) 1/51 
(1.96) 
0/51 (0) 0/51 (0) 51 
Hot tubs 40/51 (80.00) 9/51 (18.00) 0/50 (0) 0/50 (0) 1/50 (2.00) 50 
Lakes 41/51 (80.39) 7/51 (13.73) 0/51 (0) 2/51 (3.92) 1/51 (1.96) 51 
Rivers 44/51 (86.27) 5/51 (9.80) 0/51 (0) 1/51 (1.96) 1/51 (1.96) 51 
Springs 48/51 (94.12) 0/51 (0) 1/51 
(1.96) 
0/51 (0) 2/51 (3.92) 51 
Hot springs 45/51 (88.24) 5/51 (9.80) 0/51 (0) 0/51 (0) 1/51 (1.96) 51 
Ponds 48/51 (94.12) 1/51 (1.96) 0/51 (0) 1/51 (1.96) 1/51 (1.96) 51 
Streams 48/51 (94.12) 0/51 (0) 0/51 (0) 1/51 (1.96) 2/51 (3.92) 51 
Other 27/28 (96.43) 0/28 (0) 0/28 (0) 1/28 (3.57) 0/28 (0) 28 
  
Table 4.4 Water sources and number of times water swallowed intentionally by respondents   
Source  
                  Time  








Lakes 50/51 (98.04) 1/51 (1.96) 0/51 (0) 0/51 (0) 0/51 (0) 51 
Rivers 50/51 (98.04) 1/51 (1.96) 0/51 (0) 0/51 (0) 0/51 (0) 51 
Springs 48/51 (94.12) 2/51 (3.92) 0/51 (0) 0/51 (0) 1/51 (1.96) 51 
Ponds 50/51 (98.04) 1/51 (1.96) 0/51 (0) 0/51 (0) 0/51 (0) 51 
Streams 48/50 (96.00) 1/50 (2.00) 0/50 (0) 0/50 (0) 1/50 (2.00) 50 
Other 32/33 (96.97) 1/33 (3.03) 0/33 (0) 0/33 (0) 0/33 (0) 33 
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Table 4.5 Frequency of watery non-bloody diarrhea self-reported by respondents   
  
                    
Never Once Twice 3-5 
times 
>5 times  Total 
Respondents 


































Table 4.6 Owning dogs and cats – ection III  
Variable Category  Number (%) 95% CI  
Pet ownership Dogs only 20/51 (39.22) (25.0, 53.0) 
 Cats only 7/51 (13.73)  
 Dogs and cats 20/51 (39.22) (25.0, 53.0) 



















Table 4.7 Dog demographics, health assessment, and husbandry – section IV 







95% CI  
Dog age  < 1 mo. 0 0/20 (0)  
 1-6 mo. 0 0/20 (0)  
 < 1 yr. 1 2/20 (10.00)  
 1-5 yrs. 1 8/20 (40.00) (19.0, 63.0) 
  2 4/20 (20.00)  
  3 1/20 (4.00)  
  4 1/20 (5.00)  
 6-10 yrs. 1 4/20 (20.00)  
  2 3/20 (15.00)  
  3 1/20 (5.00)  
 >10 yrs. 1 1/20 (5.00)  
Dog source  Pet shop  0/20 (0)   
 Former research 
animal 
 0/20 (0)  
 Breeders  5/20 (25.00)  
 Shelter or rescue 
group  
 13/20 (65.00)  (40.0, 84.0) 
 Friend  3/20 (15.00)  
 Other*  3/20 (15.00)   











Table 4.7 Continued  
Variable Category  Number of 
respondents (%) 
95% CI  
Dog dewormers and 
heart worm 
preventatives 
 None  1/20 (5.00)  
 Advantage Multi® 3/20 (15.00)  
 Sentinel® 1/20 (5.00)  
 Heartgard® 13/20 (65.00) (40.0, 84.0) 
 Othera  
 
 
Dog health events No health events 10/20 (50.00) (27.0, 72.0) 
 Acute conditions 7/20 (35.00)  
 Chronic conditions 3/20 (15.00)  
 Behavioral issues 1/20 (5.00)  
 Otherb 3/20 (15.00)  
    
Dog use for herding 
or hunting 
Never 16/20 (80.00) (56.0, 94.0) 
 Daily 1/20 (5.00)  
 Twice/wk. 0/20 (0)  
 Once/wk. 1/20 (5.00)  
 <Once/wk. 1/20 (5.00)  
 Other  1/20 (5.00)  
aHeartgard plus, Advantage multi, and fenbendazole all together, Sentinel and heartgard plus 














Table 4.7 Continued  
Variable Category  Number of 
respondents (%) 
95% CI  
Taking dogs to dogs 
park 
Never 7/20 (35.00) (15.0, 59.0) 
 Daily 1/20 (5.00)  
 Twice/wk. 2/20 (10.00)  
 Once/wk. 2/20 (10.00)  
 <Once/wk. 6/20 (30.00)  
 Othera 2/20 (10.00)  
    
Frequency of diarrhea 
in dogsb 
None  16/20 (80.00) (56.0, 94.0) 
 Once/3 mo. 3/20 (15.00)  
 Twice/3 mo. 0/20 (0)  
 3 times/3 mo. 0/20 (0)  
 >3 times/3 mo. 1/20 (5.00)  
 I don’t know 0/20 (0)  
aOnce in past 3 months, no dog parks, but she has been to the beach in California about 3 times/week     over the 
previous 6 weeks 

















Table 4.8 Cat demographics, health assessment, and husbandry – section V 







95% CI  
Cat age  < 1 mo. 0 0/7 (0)  
 1-6 mo. 0 0/7 (0)  
 < 1 yr. 1 1/7 (14.28)  
 1-5 yrs. 1 2/7 (28.57)  
  2 1/7 (14.28)  
 6-12 yrs. 2 3/7 (42.85) (9.0, 81.0) 
 >12 yrs. 0 0/7 (0)  
     
Cat source  Pet shop  0/7 (0)   
 Former research 
animal 
 1/7 (14.29)  
 Breeders  0/7 (0)  
 Shelter or rescue 
group  
 5/7 (71.43)  (29.0, 96.0) 
 Friend  1/7 (14.29)  
 Othera  1/7 (14.29)  
     
Cat dewormers 
and heart worm 
preventatives 
 None   6/7 (85.71) (42.0, 99.0) 
 Advantage 
Multi® 
 1/7 (14.29)  
     
Cat health events No health events  4/7 (57.14)  
 Acute conditions  3/7 (42.86)  
 Otherb  1/7 (14.29)  
aSt. Kitts Stray 





Table 4.8 Continued 
Variable Category  Number of respondents 
(%) 
95% CI  
Litter box cleaning 
frequency  
 Daily 3/7 (42.86) (9.0, 81.0) 
 3-4 times/wk. 1/7 (14.29)  
 Twice/wk. 2/7 (28.57)  
 Once/wk. 0/7 (0)  
 <Once/wk. 1/7 (14.29)  
 Other 0/7 (0)  
    
Washing hands 
frequency after 
handling the litter box 
Always  6/7 (85.71) (42.0, 99.0) 
 Most of the time 0/7 (0)  
 Sometimes 0/7 (0)  
 Rarely 1/7 (14.29)  
 Never 0/7 (0)  
    
Frequency of diarrhea 
in cats* 
None  6/7 (85.71) (42.0, 99.0) 
 Once/3 mo. 1/7 (14.29)  
 Twice/3 mo. 0/7 (0)  
 3 times/3 mo. 0/7 (0)  
 >3 times/3 mo. 0/7 (0)  
 Unsure 0/7 (0)  













Table 4.9 Dog and cat demographics, health assessment, and husbandry – section VI 
Variable Category  Number of 





95% CI  
Dog age  < 1 mo. 0 0/20 (0)  
 1-6 mo. 0 0/20 (0)  
 < 1 yr. 2 1/20 (5.00)  
 1-5 yrs. 1 9/20 (60.00) (23.0, 68.0) 
  2 3/20 (15.00)  
  3 3/20 (15.00)  
  4 1/20 (5.00)  
 6-10 yrs. 1 3/20 (15.00)  
  2 3/20 (15.00)  
  3 2/20 (10.00)  
 >10 yrs. 1 2/20 (5.00)  
  2 1/20 (5.00)  
     
Cat age  < 1 mo. 0 0/7 (0)  
 1-6 mo. 0 0/7 (0)  
 < 1 yr. 1 1/20 (5.00)  
  2 1/20 (5.00)  
 1-5 yrs. 1 10/20 (50.00) (27.0, 72.0) 
  2 4/20 (20.00)  
 6-12 yrs. 1 2/20 (5.00)  
  2 3/20 (15.00)  
 >12 yrs. 1 4/20 (20.00)  






Table 4.9 Continued  
Variable Category  Number of 
respondents (%) 
95% CI  
Dog and cat source  Pet shop 0/20 (0)   
 Former research 
animal 
1/20 (5.00)  
 Breeders 7/20 (35.00) (15.0, 59.0) 
 Shelter or rescue 
group  
20/20 (100.00)  (83.0, 100.0) – 
One-sided CI 
(97.5%) 
 Friend 4/20 (20.00)  
 Other 1/20 (5.00)   
    
Dog dewormers and 
heart worm 
preventatives 
None 1/20 (5.00)  
 Advantage Multi 4/20 (20.00)  
 Sentinel 3/20 (15.00)  
 Heartgard 11/20 (55.00) (31.0, 76.0) 
 Othera 1/20 (5.00)  
    
Cat dewormers and 
heart worm 
preventatives 
None 10/20 (50.00) (31.0, 76.0) 
 Advantage Multi 7/20 (35.00)  
 Revolution 1/20 (5.00)  
 Drontal 1/20 (5.00)  
 Otherb 1/20 (5.00)  
Dogs and cats health 
events 
No health events 7/20 (35.00) (15.0, 59.0) 
 Acute conditions 7/20 (35.00) (15.0, 59.0) 
 Chronic conditions 2/20 (10.00)  
 Diseases 4/20 (20.00)  
 Internal parasitic 
infections 
2/20 (10.00)  
 Behavioral issues 5/20 (25.00)  
aStray cats 


































Variable Category  Number of 
respondents (%) 
95% CI  
Dogs used for hunting/ 
herding  
Never 18/20 (90.00) (68.0, 98.0) 
 Daily 0/20 (0)  
 Twice/wk. 1/20 (5.00)  
 Once/wk. 0/20 (0)  
 <Once/wk. 1/20 (5.00)  
 Othera 0/20 (0)  
Taking dogs to a dog 
park 
Never 10/20 (50.00) (31.0, 76.0) 
 Daily  1/20 (5.00)  
 Twice/wk. 0/20 (0)  
 Once/wk. 2/20 (10.00)  
 <Once/wk. 7/20 (35.00)  
 Other 0/20 (0)  
Cleaning the litterbox 
frequency  
Daily  6/20 (30.00)  
 3-4 times/wk. 3/20 (15.00)  
 Twice/wk.  5/20 (25.00)  
 Once/wk. 2/20 (10.00)  
 <Once/wk. 2/20 (10.00)  
 Otherb 2/20 (10.00)  
Washing hands after 
handling the litterbox 
Always 11/20 (55.00) (31.0, 76.0) 
 Most of the 
time 
8/20 (40.00)  
 Sometimes 1/20 (5.00)  
 Rarely 0/20 (0)  
 Never 0/20 (0)  
Diarrhea in dogs and 
cats  
None 15/20 (75.00) (50.0, 91.0) 
 Once/3 mo. 3/20 (15.00)  
 Twice/3 mo. 1/20 (5.00)  
 3 times/3 mo. 0/20 (0)  
 >3 times/3 mo. 1/20 (5.00)  
 I don’t know 0/20 (0)  
171 
Table 4.10 Procedures frequency performed on senior practicum core, elective or externship 
rotations, have you performed for adult cattle and/or calves – section VII of the survey 
Variable  Yes (%) No (%) Total 
Cattle rectal palpation 
exams 
26 (50.98) 25 (49.02) 51  
Cattle physical exams 27 (52.94) 24 (47.06) 51 
Cattle treatments  27 (52.94) 24 (47.06) 51 
Diagnostic tests for 
cattle 
27 (52.94) 24 (47.06) 51 
Calving assistance  12 (23.53) 39 (76.47) 51 
Breeding soundness 
exams 
22 (43.14) 29 (56.86) 51 
Calves physical 
exams 
24 (47.06) 27 (52.94) 51 
Calves treatments  25 (49.02) 26 (50.98) 51 
Diagnostic tests for 
calves 
25 (49.02) 26 (50.98) 51 
Brucellosis 
vaccinations 
20 (39.22) 31 (60.78) 51 
Postmortem 
diagnosis 
















Table 4.11 Activities frequency after handling cattle and/or calves in the clinical rotations – 
section VII of the survey 
Variable Category  Number of 
respondents (%) 
95 % CI  
Washing hands  Always 31/51 (60.78) (46.0, 74.0) 
 Most of the time  9/51 (17.65)  
 Sometimes 6/51 (11.76)  
 Rarely 1/51 (1.96)  
 Never  4/51 (7.84)  
    
Eating/drinking  Always 6/51 (11.76)  
 Most of the time  8/51 (15.69)  
 Sometimes 25/51 (49.02) (34.0, 63.0) 
 Rarely 5/51 (9.80)  
 Never  7/51 (13.73)  




N/A 21/51 (41.18) (27.0, 55.0) 
 Daily 22/51 (43.14) (29.0, 57.0) 
 Twice/wk. 3/51 (5.88)  
 Once/wk. 0/51 (0)  
 <Once/wk. 3/51 (5.88)  















Table 4.12 Use of personal protective equipment when handling cattle and/or calves in the 








Rarely (%) Never (%) Total  
PPE/Diarrheic 
cattle or calves 
      
Exam gloves 33 (64.71) 8 (15.69) 4 (7.84) 1 (1.96) 5 (9.80) 51 
Coveralls  39 (76.47) 5 (9.80) 1 (1.96) 1 (1.96) 5 (9.80) 51 
Rubber boots 39 (76.47) 4 (7.84) 2 (3.92) 0 (0) 6 (11.76) 51 
Surgical mask 
or N95 




      
Exam gloves 25 (49.02) 9 (16.65) 9 (17.65) 3 (5.88) 5 (9.80) 51 
Coveralls  37 (72.55) 4 (7.84) 4 (7.84) 1 (1.96) 5 (9.80) 51 
Rubber boots 37 (72.55) 3 (5.88) 5 (9.80) 0 (0) 6 (11.76) 51 
Surgical mask 
or N95 














Table 4.13 Procedures frequency performed on senior practicum core, elective or externship 



























Variable  Yes (%) No (%) Total 
Physical exams 51 (100.00) 0 (0) 51 
Diagnostic tests 51 (100.00) 0 (0) 51 
Taking animals to defecate or urinate 50 (98.04) 1 (1.96) 51 
Change bedding 50 (98.04) 1 (1.96) 51 
Cleaning exam rooms or tables  51 (100.00) 0 (0) 51 
Cleaning cages, kennels or runs 49 (96.08) 2 (3.92) 51 
Monitoring animals under sedation 
or anesthesia  
48 (96.000 2 (4.000 50 
Restraining animals for procedures 51 (100.00) 0 (0) 51 
Post-operative care  50 (98.04) 1 (1.96) 51 
Postmortem diagnosis 39 (76.47) 12 (23.53) 51 
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Table 4.14 Activities frequency after handling dogs and cats in the clinical rotations – section 
VII of the survey 
Variable Category  Number of 
respondents (%) 
95% CI  
Washing hands after 
procedures 
Always 11/51 (21.57)  
 Most of the time  26/51 (50.98) (36.0, 65.0) 
 Sometimes 12/51 (23.53)  
 Rarely 2/51 (3.92)  
 Never  0/51 (0)  
    
Washing hands 
between patients 
Always 9/51 (17.65)  
 Most of the time  28/51 (54.90) (40.0, 68.0) 
 Sometimes 9/51 (17.65)  
 Rarely 5/51 (9.80)  
 Never  0/51 (0)  
    
Eating/drinking  Always 7/51 (13.73)  
 Most of the time  14/51 (27.45)  
 Sometimes 28/51 (54.90) (40.0, 68.0) 
 Rarely 2/51 (3.92)  
 Never  
 
0/51 (0)  
Washing clinic 
smocks or cloth 
surgical gowns 
N/A 3/51 (5.88)  
 Daily 6/51 (11.76)  
 Twice/wk. 14 (27.45)  
 Once/wk. 21/51 (41.18) (27.0, 55.0) 
 <Once/wk. 7/51 (13.73)  









Table 4.15 Use of personal protective equipment when handling diarrheic and non-diarrheic dogs and cats in the clinical rotations – 
section VII of the survey 





Rarely (%) Never (%) Total  
PPE/Diarrheic dogs 
and cats 
      
Exam gloves 25 (49.02) 
 





























Masks 0 (0) 
 



















dogs and cats 
      

















0 (0) 0 (0) 51 

























Table 4.16 Rotations completed from the beginning of the senior practicum until the time of the 
survey 
Clinical Rotation Number of Respondents 
(%)  
Total 
Dairy Field Service 19 (37.25) 
 
51 
Herd Management 5 (9.80) 
 
51 
Livestock Medicine any Surgery 0 (0) 
 
51 
Large Animal Emergency Medicine 20 (39.22) 
 
51 











Small Animal Internal Medicine 36 (70.59) 
 
51 
Community Practice 31 (60.78) 
 
51 
Critical and Emergency Care 29 (56.86) 
 
51 
Afterhours Small Animal Urgent Care 33 (64.71) 
 
51 

















Table 4.17 Fecal flotation (FF) immuno-fluorescent assay (IFA), and polymerase chain reaction 
(PCR) results of G. duodenalis for human, dog and cat samples 
 Species Diagnostic 
Test 
Positives Percentage 95% CI 
Humans (42) FF 0  N/A N/A 
Dogsa (31) FF 1  3.23 (0.1, 16.7) 
Cats  (17) FF 0  N/A N/A 
     
Humans (42) IFA 1  2.38 (0.1, 12.6) 
Dogs (31) IFA 3  9.68 (2.0, 25.8) 
Cats  (17) IFA 0  N/A N/A 
     
Humans (42) PCR 3 7.14 (1.5, 19.5) 
Dogs (31) PCR 3 9.68 (2.0, 25.8) 
Cats  (17) PCR 1 5.88 (0.1, 28.7) 
aOne dog was identified with hookworm egg that was G. duodenalis negative 
 
Table 4.18 Polymerase chain reaction (PCR) results distributed by genes of G. du denalis for 
human, dog and cat samples 
Species gdh tpi β-giardin 
Humans (42) 0/42 (0%) 3/42 (7.14%) 0/42 (0%) 
Dogs (31) 2/31 (6.45%) 3/31 (9.67%) 1/31 (3.22%) 














Table 4.19 Fecal flotation (FF), immuno-fluorescent assay IFA, and polymerase chain reaction 
(PCR) results of Cryptosporidium spp. for human, dog and cat samples 
Species Diagnostic 
Test 
Positives Percentage 95% CI 
Humans (42) FF 0 N/A N/A 
Dogs (31) FF 0 N/A N/A 
Cats (17) FF 0 N/A N/A 
     
Humans (42) IFA 1 2.38 (0.1, 12.6) 
Dogs (31) IFA 1 3.23 (0.1, 16.7) 
Cats (17) IFA 0 N/A N/A 
     
Humans (42) PCR 1  2.38 (0.1, 12.6) 
Dogs (31) PCR 4 12.9 (3.6, 29.8) 
Cats (17) PCR 1 5.88 (0.1, 28.7) 
 
Table 4.20 Polymerase chain reaction (PCR) results distributed by genes of Crypt sporidium 
spp. for human, dog and cat samples 
Species 18SrRNA hsp70 gp60 
Humans (42) 0/42 (0%) N/A 1/42 (2.38%) 
Dogs (31) 2/31 (6.45%) 4/31 (12.9%) 0/31 (0%) 
















Table 4.21 Stratification of positive and negative human samples due to G. du denalis and 
Cryptosporidium spp. by risk factors using the IFA test 
 
Table 4.22 Stratification of positive and negative human samples due to G. du denalis by risk 






Variable Level  Positive (%) Total  Fisher’s exact 
P value 
95% CI 
Track Preference  SA 1 (5.0%) 20 0.65  (0.12, 25.0) 
 GEN 0  14   
 LA 0 8   
      
Gender M 0 6 0.86 (0.1, 14.5) 
 F 1 (2.8%) 36   
      
Pet Ownership Yes 1 (2.6%) 39 0.93 (0.1, 13.5) 
 No 0  3   
      
Work on Farm Yes 1 (3.8%) 26 0.61 (0.1, 19.6) 
 No 0 16   
Variable Level  Positive (%) Total  Fisher’s exact 
P value 
95% CI 
Track Preference  SA 2 (10.0%) 20 0.59  (1.2, 32.0) 
 GEN 1 (7.1%) 14  (0.2, 33.9) 
 LA 0 8   
      
Gender M 0 6 0.62  
 F 3 (8.3%) 36  (1.7, 22.5) 
      
Pet Ownership Yes 3 (7.7%) 39 0.79 (1.6, 20.9) 
 No 0 3   
      
Work on Farm Yes 3 (11.5%) 26 0.23 (2.4, 30.2) 
 No 0 16   
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Table 4.23 Stratification of positive and negative human samples due to Crypt sporidium spp. by 

















Variable Level  Positive (%) Total  Fisher’s exact 
P value 
95% CI 
Track Preference  SA 0 20 0.32   
 GEN 0 14   
 LA 1 (12.5%) 8  (0.3, 52.7) 
      
Gender M 1 (16.7%) 6 0.14 (0.4, 64.1) 
 F 0  36   
      
Pet Ownership Yes 1 (2.6%) 39 0.93 (0.1, 13.5) 
 No 0 3   
      
Work on Farm Yes 1 (3.8%) 26 0.62 (0.1, 19.6) 
 No 0 16   
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Table 4.24 DNA sequencing results for G. duodenalis  
Sample ID Species Age Stool Character Typed by 
gene  
Parasite 
242 Dog 1-5 yr. Score = 4 tpi G. duodenalis Assemblage D 
    gdh G. duodenalis Assemblage D 
      
276 Dog 1-5 yr. Score = 2 tpi G. duodenalis Assemblage D 
    gdh G. duodenalis Assemblage D 
      
204 Dog <1 yr. Score = 2 β-giardin G. duodenalis Assemblage C 
    gdh G. duodenalis Assemblage C 
 
Table 4.25 DNA sequencing results for Cryptosporidium spp. 
Sample ID Species Age Stool Character Typed by 
gene  
Parasite 
242 Dog 1-5 yr. Score = 4 18SrRNA Cryptosporidium spp. 
      
389 Cat 1-5 yr. Score = 1 hsp70 Cryptosporidium spp. 
      
389 Dog 6-10 yr. Score = 4 hsp70 C. felis 
      
575 Dog 1-5 yr. Score = 3 hsp70 Cryptosporidium spp. 
      





Table 4.26 Positive dog, cat and owner demographics  
Animal ID Pet Demographics  Owner Demographics 
Dog #448  G. duodenalis (IFA)  Age from <1 year and 6-10 years  Breeders  Chronic health conditions  Herding or hunting – once/wk.  Dog park – attended daily  Had diarrhea > 3 times /3 mo.  
 Giardia/Cryptosporidium –negative  Female   Large animal track  Lived in single family residence/no 
cattle  Worked on a farm   Owned multiple dogs 
 
 
Dog #242  G. duodenalis (FF, IFA, PCR)  Cryptosporidium spp. (PCR)  Age 1-5 yrs.  Shelter   Acute health conditions  Behavioral issues  Never used for herding  Dog park – attended once/wk.  No diarrhea 
 Giardia/Cryptosporidium –negative 
 Female  Small animal track  Lived in single family residence/no 
cattle  Worked on a farm  Owned dogs and cats 
 
Dog #204  G. duodenalis (IFA, PCR)  Cryptosporidium spp. (IFA, PCR)  Age <1 yr.  Breeder and shelter  No health events  Herding or hunting – twice/wk.  Dog park – not attended  No diarrhea  
 Giardia/Cryptosporidium –negative 
 Female   Large animal track  Lived in single family residence/with 





Table 4.26 Continued 
Animal ID Pet Demographics  Owner Demographics 
Dog# 276  G. duodenalis (PCR)  Cryptosporidium spp. (PCR)  Age 1-5 yr.  Shelter  Acute conditions and diseases 
such as diabetes  Herding or hunting – never  Dog park – not attended  No diarrhea 
 G. duodenalis (PCR)  Female   Small animal track  Lived in single family 




































Animal ID Pet Demographics  Owner Demographics 
Dog #575  Cryptosporidium spp. (PCR)  Age 1-5 yrs.  Shelter   No health events  Herding or hunting – never  Dog park – once/wk.  No diarrhea 
 Giardia/Cryptosporidium –negative 
 Female   Small animal track  Lived in single family residence/no 
cattle  Have not worked on a farm   Owned one dog only 
 
Dog #389  Cryptosporidium spp. (PCR)  Age 6-10 yrs.  Shelter   No health events  Herding or hunting – never 
 Dog park – not attended 
 No diarrhea 
 Giardia/Cryptosporidium –negative 
 Female   Small animal track  Lived in single family residence/no 
cattle  Have not worked on a farm   Owned dogs and cats 
 
Dog#82  Hookworm  Giardia/Cryptosporidium –
negative 
 Age 1-5 yrs.  Breeder/shelter   No health events  Herding or hunting – never 
 Dog park – <1/wk. 
 No diarrhea 
 Giardia/Cryptosporidium –negative 
 Female   Small animal track  Lived in single family residence/no 
cattle  Have not worked on a farm   Owned dogs and cats 
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Table 4.26 Continued 
Animal ID Pet Demographics  Owner Demographics 
Cat #389  Cryptosporidium spp. (PCR)  Age 1-5 yrs.  Shelter   No health events 
            No diarrhea 
Same owner as Dog #398 
Cat #300  G. duodenalis (PCR)  Age 1-5 yrs.  Breeder and Shelter   Acute conditions 
           Had diarrhea > 3 times /3 mo. 
 Giardia/Cryptosporidium –negative 
 Female   Small animal track  Lived in single family residence/no 
cattle  Worked on a farm   Owned dogs and cats 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 Conclusions 
 Giardia spp. and Cryptosporidium spp. are the leading causal agents of parasitic diarrhea 
in humans, dogs and cats. Our studies highlight that these two protozoans can be isolated from 
all three species. Both pathogens contain host-adapted and zoonotic strains. Dogs and cats can be 
infected with both strains. Assessing exposure factors that are associated with the increased 
probability of infection to these two pathogens as well as identifying and characterizing the 
isolates that infect dogs, cats and humans could help in understanding which factors are 
significantly associated with the infection due to these two pathogens that will ultimately aid in 
disease management and control. Furthermore, molecular characterization of the human, dog or 
cat fecal isolates identifies zoonotic genotypes in these species which may point out to the 
transmission routes of infection or disease among humans, dogs and cats.  
 Our study results showed that all G. duodenalis assemblages were host-adapted in dogs 
and was not identified in cats. In addition, most cats in the national study were infected with C. 
felis. This finding could indicate that pet dogs and cats are not potential reservoirs for zoonotic 
transmission in humans.  
Even though the senior veterinary student track preference was not significantly 
associated with the increased probability of infection or disease of Giardia or Cryptosporidium, 
C. parvum was identified in cats and dogs who their owners have previously worked in farms 
contained cattle. There is baseline exposure to these two pathogens due to intensive contact with 
cattle. Thus, humans can potentially transmit the infection to their pets. Regardless, this 
conclusion needs further investigation by collecting more samples from veterinary students who 
have previously worked in the farm.  
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Even though the majority of dogs or cats owned by senior veterinary students that 
participated in this study were adopted from the shelter, we did not identify any other protozoan 
or intestinal parasites. This indicates that these dogs are well taken care of by their owner, 
especially, the majority of students have used the dewormers or heartworm preventative 
programs for their dogs, but not their cats. Regardless, we have not identified other intestinal 
parasites in cats as well.  
In one research study conducted for this dissertation, molecular genotyping to 
Cryptosporidium spp. using gp60 locus was more specific for samples of human origin and not 
of dog or cat origin.  
The importance of the timely processing of fecal samples was noted to reserve as much 
pathogen DNA as possible for detection. Another technique followed for diagnostic tests 
conducted in this dissertation, the PCR assay was applied to all samples regardless whether they 
are tested positive or negative to the IFA assay that is the gold standard. Additionally, it is 
recommended to use multilocus PCR protocol to characterize Giardia spp. isolates due to the 
divergent agreement between genes in the Giardia genome.  
It is worth noting from conducting research that involved human subjects, that tudents’ 
participation was lower than expected most likely because of the requirement to collect fecal 
samples. That could be attributed to cultural perspectives or recruitment methods. Therefore, it is 
suggested that multiple face-face recruiting approach can be more efficient than recruiting via 
email alone. Also, students were more willing to take the anonymous online survey without 
submitting fecal samples.   
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5.2 Future Directions 
 To continue investigating potential risk factors that can associate with the infection of G. 
duodenalis and Cryptosporidium spp. in veterinary students, research is needed to identify those 
factors in both junior and senior veterinary students in collaboration with other universities in the 
USA. This will allow for a larger sample size and to compare the risk in these two segments of 
populations. In addition, it will be helpful to identify a baseline exposure of the faculty that work 
on large animal rotations. More particularly, it is helpful to determine zoonotic or anthroponotic 
transmission of Cryptosporidium spp. in large animal track veterinarians, those who have worked 
or are working on a dairy farm and faculty veterinarians and their pet dogs or cats.  
 As a follow up of research conducted in Chapter 2 of this dissertation, an evaluation for 
zoonotic transmission can be determined. This evaluation can be conducted for associations of 
positive test results tested by the PCR assays with the clinical findings and determine the 
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